Professor Dr. med. Dr. med. h.c. Jules Angst

Jules Angst ist emeritierter Professor für Psychiatrie an der Universität Zürich, Schweiz, und Ehrendoktor der Universität Heidelberg, Deutschland.

Von 1969 bis 1994 war er Professor für Klinische Psychiatrie und Direktor der Forschungsabteilung der Psychiatrischen Universitätsklinik Zürich. Bis heute widmete er sich kontinuierlich der epidemiologischen und klinischen Forschung an der Universität.

Für sein wissenschaftliches Werk erhielt er zahlreiche internationale Preise und Auszeichnungen, u.a. den Anna Monika-Preis (1967/1969), den Paul Martini-Preis für Methodologie in Medizin (1969), den Otto Naegeli- Preis (1983), die Erik Strömgren-Medaille (1987), die -Medaille des Max Planck Instituts, München (1992), den Selo-Preis NARSAD/ Research, USA (1994), den Mogens Schou Award for Research in , USA (2001), den Burghölzli Award for Social Psychiatry (2001), den Lifetime Achievement Award of the International Society of Psychiatric Genetics (2002), die Wagner-Jauregg-Medaille (2007), den Juan J. López-Ibor Award (2010) und den WFSBP Lifetime Achievement Award in Biological Psychiatry (2011).

Professor Angst ist Ehrenmitglied folgender Gesellschaften: Royal College of Psychiatrists, Psychiatrische Gesellschaften von Mexico, Chile, Polen, Deutschland und Oesterreich, Europäisches College für Neuropychopharmakologie, Europäische Gesellschaft für Psychiatrie, Deutsche Gesellschaft für Biologische Psychiatrie, Schweizerische Gesellschaft für Biologische Psychiatrie, Schweizerische Gesellschaft für Psychiatrische Epidemiologie, Assoziation Europäischer Psychiater, International Group on Studies of (IGSLI) und International Distinguished Fellow der Amerikanischen Gesellschaft für Psychiatrie.

1 Publikationen von Prof. Dr. med. Jules Angst 1953 -2012

1. Angst J. Familienuntersuchung zur Frage des Zusammenhanges zwischen Diabetes insipidus und Persönlichkeitsstörungen. [Med Diss]. Zurich: University of Zurich; 1953. 2. Angst J. Zur Frage der Psychosen bei Behandlung mit Disulfiram (Antabus). Literaturübersicht und kasuistischer Beitrag. Schweiz Med Wochenschr. 1956;46:1304-11. 3. Angst J. Über die Behandlung der multiplen Sklerose mit Rimifon und Marsilid. Schweiz Med Wochenschr. 1956;86:501-3. 4. Angst J. Gibt es ein neues, von Antabus verschiedenes Mittel gegen den Alkoholabusus? Dtsch Med Wochenschr. 1959;84:2175. 5. Angst J. Die Psychiatrie des Diabetes insipidus. Arch Psychiat Neurol. 1959;199:663-707. 6. Angst J, Oppenheim Y, Keller R. Disulfirampsychose bei der Psoriasis-Behandlung. Dermatologica. 1959;119:238-40. 7. Angst J. Begleiterscheinungen und Nebenwirkungen moderner Psychopharmaka. Schweiz Rundsch Med Prax. 1960;20:506-11. 8. Angst J, Oppenheim Y, Keller R. Disulfirampsychose bei der Psoriasis-Behandlung. Nervenarzt. 1960;31:179-80. 9. Angst J. Tofranil: A cinical analysis. The Third World Congress of Psychiatry Montréal Canada; 1961: University of Toronto Press, McGill University Press; 1961. p. 1383-7. 10. Angst J. A clinical analysis of the effects of Tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations. Psychopharmacologia. 1961;2:381-407. 11. Angst J. Psychopharmakologie und Familienforschung. Schweiz Arch Neurol Psychiatr. 1963;91:267- 72. 12. Angst J. Insidon als Antidepressivum. Vergleich mit Tofranil; Katamnesen. Nervenarzt. 1963;34:76-80. 13. Angst J. Antidepressive Behandlungen im Längsschnitt. (Anamnesen und Katamnesen). Schweiz Rundsch Med Prax. 1963;52:1044-5. 14. Angst J. Vergleich der antidepressiven Eigenschaften von Amitriptylin und Imipramin. Psychopharmacologia. 1963;4:389-401. 15. Angst J, Poeldinger W. Klinische Erfahrungen mit dem Butyrophenonderivat Methylperidol (Luvatren). Vergleichender Beitrag zur Methodik pharmakopsychiatrischer Untersuchungen. Schweiz Rundsch Med Prax. 1963;52:1348-54. 16. Angst J, Pöldinger W. Experiences cliniques d'un dérivé de la butyrophénone, le méthylpéridol (Luvatrène). Contribution à l'étude comparative des méthodes d'expérimentation pharmacologique en psychiatrie. Schweiz Rundsch Med Prax. 1963;52:1348-54. 17. Angst J, Pöldinger W. Clinical experiences with the butyrophenone derivative methylperidol (Luvatren). A comparative contribution to the methodology of pharmacopsychiatric investigations. Schweiz Rundsch Med Prax. 1963;52:1348-54. 18. Angst J. Antidepressiver Effekt und genetische Faktoren. Arzneimittelforschung. 1964;14:496-500.

2 19. Angst J. Genetische Aspekte der antidepressiven Wirkung. In: Bente D, Bradley PB, editors. Neuropsychopharmacology The Fourth Meeting of the Collegium Internationale Neuro- Psychopharmacologicum Birmingham; 1964: Elsevier Publishing Company; 1964. p. 221-3. 20. Angst J, Battegay R, Poeldinger W. Zur Methodik der statistischen Bearbeitung des Therapieverlaufs depressiver Krankheitsbilder. Methods Inf Med. 1964;3:54-6. 21. Angst J, Kind H. Poliklinische und klinische Erfahrungen mit einem Dibenzodiazepinderivat bei depressiven Zustandsbildern. Traduction: Experiences policliniques et cliniques avec la preparation W 91/HF 1927 dans les etats depressifs. Translation: Clinical Experiences with W 91/HF 1927 in the In- and Out-Patient Treatment of Depressive States. Traduccion: Experiencias policlinicas y clinicas hechas con el farmaco W 91/HF 1927, en los estados depresivos. Schweiz Med Wochenschr. 1964;94:759-64. 22. Angst J, Kind H. Clinical experiences with W 91/HF 1927 in the in- and out-patient treatment of depressive states. Schweiz Med Wochenschr. 1964;94:759-64. 23. Angst J, Kind H. Expériences policliniques et cliniques avec la préparation W 91/HF 1927 dans les états dépressifs. Schweiz Med Wochenschr. 1964;94:759-64. 24. Angst J, Kind H. Experiencias policlínicas y clínica hechas con el fármaco W 91/FH 1927, en los estados depresivos. Schweiz Med Wochenschr. 1964;94:759-64. 25. Angst J, Poeldinger W. Klinische Erfahrungen mit Protriptylin (MK-240). Vorläufiger Bericht. (Votum zur Mitteilung von F.J. Ayd, jr.). Schweiz Arch Neurol Psychiatr. 1964;94:480-1. 26. Kind H, Angst J. Zur ambulanten und stationären Behandlung depressiver Zustände mit einem Dibenzodiazepin-Derivat. Arzneimittelforschung. 1964;14:550-1. 27. Angst J. The prognosis of antidepressive treatments. Longitudinal and genetic studies. - Zur Prognose antidepressiver Behandlungen. Verlaufsuntersuchungen und genetische Studie. Anglo-German Med Rev. 1965;2:733-51. 28. Angst J. Intoxikationen mit Psychopharmaka. Ther Umsch. 1965;22:178-80. 29. Angst J. Pharmacological and Clinical Action of Antidepressive Drugs. (discussion). In: Bente D, Bradley PB, editors. Fourth Meeting of the Collegium Internationale Neuro-Psychopharmacologicum Birmingham; 1965; Birmingham: Elsevier; 1965. p. 221-3. 30. Angst J. Psychometrie und Pharmakopsychiatrie. (Diskussionsvotum). Schweiz Arch Neurol Psychiatr. 1965;95:178-9. 31. Angst J. Erfolg und Misserfolg der psychopharmakologischen Therapie am Beispiel der Depression. Hippokrates. 1965;36:946-51. 32. Angst J, Poeldinger W. Psychopharmaka. Ther Umsch. 1965;22:222-30. 33. Angst J. Zur Ätiologie und Nosologie endogener depressiver Psychosen. Eine genetische, soziologische und klinische Studie. Berlin Heidelberg New York: Springer; 1966. 34. Angst J. Diskussionsbemerkungen zu: Kanig, K. "Zum biochemischen Wirkungsmechanismus der Psychopharmaka". In: Scholibo T, editor. Probleme der Pharmakospychiatrie Stanberger Gespräche Stuttgart; 1966: Thieme Verlag; 1966. p. 36.

3 35. Angst J. Diskussionsbemerkungen zu: Schaumann, W. "Die Bedeutung pharmakologischer Testmethoden für die Klinik der Psychopharmaka". In: Scholibo T, editor. Probleme der Pharmakopsychiatrie Starnberger Gespräche Stuttgart; 1966: Thieme Verlag; 1966. p. 83-4, 6. 36. Angst J, Poeldinger W. Vergleichende klinische Erfahrungen mit Protriptylin bei depressiven Verstimmungszuständen verschiedener Genese. Arzneimittelforschung. 1966;16:893-6. 37. Angst J, Varga E, Shepherd M. Preliminary report of a retrospective study of the treatments of depression. In: Brill H, Cole JO, Deniker P, Hippius H, Bradley PB, editors. Neuropsychopharmacology Proceedings of the Fifth International Congress of the Collegium Internationale Neuropsychopharmacologicum Washington DC 1966; 1966 28-31 March 1966: Excerpta Medica Foundation; 1966. p. 993-6. 38. Angst J, Weis P. Periodicity of depressive psychoses. In: Brill H, Cole JO, Deniker P, Hippius H, Bradley PB, editors. Neuropsychopharmacology Proceedings of the Fifth International Congress of the Collegium Internationale Neuropsychopharmacologicum Washington DC 1966; 1966 28-31 March 1966: Excerpta Medica Foundation; 1966. p. 703-10. 39. Cornu F, Angst J, Dick P, Heimann H, Poeldinger W. Prüfungsergebnisse mit Antidepressiva an den psychiatrischen Universitätskliniken der Schweiz. In: Lopez Ibor JJ, editor. Proceedings of the Fourth World Congress of Psychiatry Madrid 1966; 1966: Excerpta Medica Foundation; 1966. p. 818-22. 40. Dick P, Angst J, Battegay R, Cornu F, Heimann H, Poeldinger W, et al. Problemes des essais therapeutiques pluricentriques. A propos d'une tentative de collaboration des 5 cliniques psychiatriques universitaires suisses. In: Lopez Ibor JJ, editor. Proceedings of the Fourth World Congress of Psychiatry Madrid 1966; 1966 5-11 September 1966: Excerpta Medica Foundation; 1966. p. 823-5. 41. Poeldinger W, Angst J, Battegay R, Cornu F, Dick P, Heimann H, et al. Methodik und Ergebnisse einer Zusammenarbeit zwischen fünf Schweizer Kliniken. In: Brill H, Cole JO, Deniker P, Hippius H, Bradley PB, editors. Neuropsychopharmacology Proceedings of the Fifth International Congress of the Collegium Internationale Neuropsychopharmacologicum Washington DC 1966; 1966 28-31 March 1966: Excerpta Medica Foundation; 1966. p. 34-7. 42. Poeldinger W, Angst J, Cornu F, Dick P, Heimann H. Therapeutische Erfahrungen an fünf Kliniken mit einem Dibenzoxepin-Derivat bei depressiven Zustandsbildern. Arzneimittelforschung. 1966;16:650-3. 43. Varga E, Angst J, Shepherd M. A depressiók kezelésének értékelésec (összehasonlító, retrospektív elemzés). (engl.: Preliminary Report about the evaluation of the treatment of depression). Ideggyogy Sz. 1966;6:169-71. 44. Angst J. Zur Ätiologie und Nosologie endogener depressiver Psychosen. Fortschr Med. 1967;85:977-8. 45. Angst J. Symposiumbericht. Internationale Symposium über Psychosedierung in Geriatrie und Pädiatrie Wien 1967; 1967 24.-25.2.1967; Wien: Kongress-Dienst Laboratorien Hausmann AG St. Gallen; 1967. p. 2-15. 46. Angst J. Psychosedierung in Geriatrie und Pädiatrie. Internationales Symposium, Laboratorien Hausmann AG Wien 24-2521967; 1967; 1967. 47. Angst J, Battegay R, Bente D, Cornu F, Dick P, Engelmeier MP, et al. Über das gemeinsame Vorgehen einer deutschen und schweizerischen Arbeitsgruppe auf dem Gebiet der psychiatrischen Dokumentation. Schweiz Arch Neurol Psychiatr. 1967;100:207-11.

4 48. Angst J, Brandenberger H, Herrmann B. Suicid mit Opipramol (Insidon). Psychopharmacologia. 1967;11:174-8. 49. Angst J, Hicklin A. Deliriöse Psychosen unter Neuroleptica und Antidepressiva. Häufigkeit, Ursachen, Prophylaxe. Schweiz Med Wochenschr. 1967;97:546-9. 50. Hicklin A, Angst J. Retrospektive und prospektive Studie über die klinische Wirkung von Clopenthixol (Sordinol) bei endogenen Psychosen. Schweiz Med Wochenschr. 1967;97:615-21. 51. Varga E, Angst J, Shepherd M. Retrospektives Studium über die Behandlung der Depression in London und Budapest. Vorläufige Mitteilung. Acta Med Acad Sci Hung. 1967;23:105-8. 52. Angst J. Psychiatrische Pharmakogenetik. Klinische Psychopharmakologie Mod Probl Pharmakopsychiat. 1968;1:260-72. 53. Angst J. "Placebo" - Leerpräparate in Therapie und Forschung. (Antrittsvorlesung). Neue Zürcher Zeitung. 1968 12.05.1968;Sect. 49-50. 54. Angst J. Neuere Entwicklungen der Pharmako-Psychiatrie. Schweiz Rundsch Med Prax. 1968;57:143- 8. 55. Angst J. Symposium: Erkennung und Behandlung von Depressionen in der Allgemeinpraxis. (Begrüssung). Ther Umsch. 1968;25:2. 56. Angst J. Nebenwirkungen der Antidepressiva. Ther Umsch. 1968;25:37-40. 57. Angst J. Panelgespräch zum Thema Ätiologie, Diagnose und Therapie der Depression. Ther Umsch. 1968;25:40-4. 58. Angst J. Zur Ätiologie und Nosologie endogener depressiver Psychosen. Dtsch Med Wochenschr. 1968;93:1451-4. 59. Angst J. Etiologia y nosologia de las psicosis depresivas endogenas. Med Alemana. 1968;9:1242-50. 60. Angst J, Battegay R, Bente D, Berner P, Broeren W, Cornu C, et al. Das Dokumentations-System der Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie (AMP). Arzneimittelforschung. 1968;18:3-8. 61. Angst J, Battegay R, Bente D, Berner P, Broeren W, Cornu F, et al. Das AMP-System. In: Hippius H, editor. Das depressive Syndrom Internationales Symposion Berlin 1968; 1968: Urban und Schwarzenberg; 1968. p. 615-6. 62. Angst J, Grof P, Hippius H, Poeldinger W, Weis P. La psychose maniaco-dépressive est-elle périodique ou intermittente? In: De Ajuriaguerra J, editor. Cycles biologiques et psychiatrie Paris; 1968: Masson; 1968. p. 339-51. 63. Angst J, Perris C. Zur Nosologie endogener Depressionen. Vergleich der Ergebnisse zweier Untersuchungen. Arch Psychiat Neurol. 1968;210:373-86. 64. Angst J, Weis P. Aetiologie und Verlauf endogener Depressionen. Fortbildungskurse Schweiz Ges Psych. 1968;1:8-16. 65. Angst J. Leerpräparate in Therapie und Forschung. Prakt Psychiat. 1969;1:1-12. 66. Angst J. Der depressive Patient - Erkennung und diagnostische Zuordnung. Ther Berichte. 1969;41:139-45.

5 67. Angst J. Geschlecht, Intelligenz, prämorbide Persönlichkeit und Manifestationsalter in ihrer Bedeutung für Prognose und Verlauf endogen-depressiver Psychosen. In: Huber G, editor. Schizophrenie und Zyklothymie Ergebnisse und Probleme. Stuttgart: Thieme; 1969. p. 57-62. 68. Angst J. Die somatische Therapie der Schizophrenie. Suttgart: Georg Thieme Verlag; 1969. 69. Angst J. Genetik der Depressionen. In: Hippius H, Selbach H, editors. Das depressive Syndrom Internationales Symposion, Berlin 1968; 1969: Urban und Schwarzenberg; 1969. p. 57. 70. Angst J. Manfred Bleuler. Neue Zürcher Zeitung. 1969 19.10.1969;Sect. 51. 71. Angst J. Leerpräparate in Therapie und Forschung. (gekürzte Fassung). Universitas. 1969;24:1069-76. 72. Angst J. Verlaufs- und Rhythmusforschungen. In: Hippius H, Selbach H, editors. Das depressive Syndrom Internationales Symposion Berlin 1968; 1969: Urban und Schwarzenberg; 1969. p. 124. 73. Angst J. Psychopathologie und Klinik der depresiven Syndrome. In: Hippius H, Selbach H, editors. Das depressive Syndrom Internationales Symposion Berlin 1968; 1969: Urban und Schwarzenberg; 1969. p. 422. 74. Angst J, Baastrup P, Grof P, Schou M, Weis P. Die Prophylaxe manisch-depressiv-schizophrener Mischpsychosen. In: Heinrich K, editor. Neuroleptische Dauer- und Depottherapie in der Psychiatrie Frankfurter Arbeitstagung am 7 und 8 März 1969; 1969: Schnetztor-Verlag; 1969. p. 106-12. 75. Angst J, Baastrup PC, Grof P, Schou M, Weis P. Die Prophylaxe manisch-depressiv-schizophrener Mischpsychosen. In: Heinrich K, editor. Neuroleptische Dauer- und Depottherapie in der Psychiatrie Frankfurter Arbeitstagung 1969. Konstanz: Schnetztor; 1969. p. 106-12. 76. Angst J, Battegay R, Bente D, Berner P, Broeren W, Cornu F, et al. Documentation clinique en psychopharmacologie: Le systeme A.M.P. (Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie). In: Cerletti A, Bove FJ, editors. The Present Status of Psychotropic Drugs Pharmacological and Clinical Aspects Proceedings of the 6th International Congress of the Collegium Internationale Neuro- Psychopharmacologicum Tarragona Spain 1968; 1969: Excerpta Medica Foundation; 1969. p. 361-5. 77. Angst J, Battegay R, Bente D, Berner P, Broeren W, Cornu F, et al. Das AMP-System. . In: Hippius H, Selbach H, editors. Das depressive Syndrom Internationales Symposium Berlin 16 und 17 Februar 1968; 1969: Urban & Schwarzenberg; 1969. p. 615-6. 78. Angst J, Battegay R, Bente D, Berner P, Broeren W, Cornu F, et al. Das Dokumentations-System der Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie (AMP). Arzneimittelforschung. 1969;19:399-405. 79. Angst J, Dittrich A, Grof P. Course of endogenous affective psychoses and its modification by prophylactic administration of Imipramine and Lithium. Int Pharmacopsychiat. 1969;2:1-11. 80. Angst J, Grof P, Hippius H, Poeldinger W, Varga E, Weis P, et al. Verlaufsgesetzlichkeiten depressiver Syndrome. In: Hippius H, Selbach H, editors. Das depressive Syndrom Internationales Symposion Berlin 1968; 1969 16-17 Februar 1968: Urban und Schwarzenberg; 1969. p. 93-100. 81. Angst J, Grof P, Schou M. Lithium. (letter to the editor). Lancet. 1969 May 31;293:1097. 82. Angst J, Hippius H. Pharmakotherapie depressiver Syndrome. In: Schulte W, Mende W, editors. Melancholie in Forschung, Klinik und Behandlung. Stuttgart: Georg Thieme Verlag; 1969. p. 188-200.

6 83. Angst J, Weis P. Zum Verlauf depressiver Psychosen. In: Schulte W, Mende W, editors. Melancholie in Forschung, Klinik und Behandlung. Stuttgart: Thieme; 1969. p. 2-9. 84. Angst J. Halluzinogen-Abusus. Schweiz Med Wochenschr. 1970;100:710-5. 85. Angst J. Psychopharmaka und neurologische Nebenwirkungen. Ther Umsch. 1970;27:356-60. 86. Angst J. Die Lithiumprophylaxe affektiver Psychosen. Ars Medici. 1970;60:29-40. 87. Angst J. Die Entstehung der Schizophrenie. Neue Zürcher Zeitung. 1970 27.08.1970;Sect. 19. 88. Angst J. Körperliche Behandlungsverfahren. Hundert Jahre Kantonale Psychiatrische Universitätsklinik Burhözli Zürich 1870-1970. Zürich; 1970. p. 49-51. 89. Angst J. Clinical aspects of Imipramine. Tofranil (Imipramine). Bern: Verlag Stämpfli & Cie. AG; 1970. p. 3-263. 90. Angst J. Persönlichkeit und Arzneitmittelbedarf bei Geisteskranken. Weltwoche. 1970 10.07.1970;28:25. 91. Angst J. Klinischer Teil. Tofranil (Imipramin). Bern: Verlag Stämpfli & Cie. AG; 1970. p. 3-263. 92. Angst J. Parte clínica. Tofranil (Imipramine). Bern: Verlag Stämpfli & Cie. AG; 1970. p. 3-265. 93. Angst J, Baastrup PC, Grof P, Hippius H, Poeldinger W, Weis P. Zum Verlauf affektiver Psychosen. (russisch). In: Sternberg EJ, Smulewitsch AB, editors. Die Depression und ihre Behandlung Vorträge am Symposium in Moskau 1970; 1970: Ciba-Geigy; 1970. p. 17-27. 94. Angst J, Cornu F, Heimann H, Poeldinger W, Steiner H. 2-Chlor-11 (4'-methylpiperazino) - dibenzo - [b,f] [1,4] - oxazepin (Sum 3170), ein neues Neurolepticum. Ergebnisse einer interklinischen Prüfung. Arzneimittelforschung. 1970;20:967-70. 95. Angst J, Dittrich A. Persönlichkeit und Arzneimittelbedarf bei Geisteskranken. In: Bättig K, editor. Psychologische Experimente in Psychiatrie, Hirnforschung und Industrie. Bern Stuttgart Wien: Huber; 1970. p. 39-43. 96. Angst J, Dittrich A, Krueger MA. Beziehungen zwischen Rauchen und Persönlichkeit bei Stellungspflichtigen der Schweizer Armee. Z Präventivmed. 1970;15:97-105. 97. Angst J, Dittrich I. Amerikaner sind schwerer zu beruhigen. Die Weltwoche. 1970 10.07.1970:25. 98. Angst J, Weis P, Grof P, Baastrup PC, Schou M. Lithium prophylaxis in recurrent affective disorders. Br J Psychiatry. 1970;116:604-14. 99. Grof P, Schou M, Angst J, Baastrup PC, Weis P. Methodological problems of prophylactic trials in recurrent affective disorders. Br J Psychiatry. 1970;116:599-619. 100. Poeldinger W, Angst J, Cornu F, Gander V, Gyr H, Sutter W. Die Wirkung der Infusionsbehandlung mit Clomipramin (Anafranil) unter besonderer Berücksichtigung therapierefraktärer Depressionen. In: Kugler J, Lechner H, Fontanari D, editors. Die Infusionsbehandlung von depressiven Kranken Zweites Venezianisches Symposium 1968; 1970: Verlag Ulrich Moser; 1970. p. 53-8. 101. Schou M, Baastrup PC, Grof P, Weis P, Angst J. Pharmacological and clinical problems of Lithium prophylaxis. Br J Psychiatry. 1970;116:615-9. 102. Weis P, Angst J. Die Prognose der endogenen Psychose. 15 Jahrestagung, Deutsche Gesellschaft für Medizinische Dokumentation und Statistik in der DGD, 05-07101970, Frankfurt am Main; 1970.

7 103. Angst J. Persönlichkeitsentwicklung und psychotische Komplikationen bei Drogenabusus. Psychosom Med. 1971;3:146-50. 104. Angst J, Bente D, Berner P, Heimann H, Helmchen H, Hippius H. Das klinische Wirkungsbild von Clozapin (Untersuchung mit dem AMP-System). Pharmakopsychiat. 1971;4:201-11. 105. Angst J, Dittrich A, Woggon B. Wie wirkt Haschisch? Psychopharmakologische Aspekte des Cannabiskonsums. Neue Zürcher Zeitung. 1971 26.02.1971;Sect. 27. 106. Angst J, Dittrich A, Woggon B. Wie wirkt Haschisch? Psychopharmakologische Aspekte des Cannabiskonsums. Drogen - Meinungen und Fakten Fachleute äussern sich zum Rauschmittelproblem. Zürich: Neue Zürcher Zeitung; 1971. p. 37-48. 107. Angst J, Dittrich A, Woggon B. Wie wirkt Haschisch? Psychopharmakologische Aspekte des Cannabiskonsums. (gekürzte Fassung). Universitas. 1971;12:1325-32. 108. Angst J, Jaenicke U, Padrutt A, Scharfetter C. Ergebnisse eines Doppelblindversuches von HF 1854* (8-Chlor-11- (4-methyl-1-piperazinyl)-5H-dibenzo (b, e) (1,4) diazepin) im Vergleich zu Levomepromazin. Pharmakopsychiat. 1971;4:192-200. 109. Angst J, Jaenicke U, Peter J, Poeldinger W. Vergleichende Studie mit den tricyclischen Antidepressiva Noxiptilin und Dibenzepin. Arzneimittelforschung. 1971;21:635-8. 110. Bleuler M, Angst J. Vorwort - Introduction. Die Entstehung der Schizophrenie - The Origin of Schizophrenia. Bern Stuttgart Wien: Huber; 1971. p. 9-10. 111. Bleuler M, Angst J, editors. Die Entstehung der Schizophrenie. The Origin of Schizophrenia. Bern Stuttgart Wien: Verlag Hans Huber; 1971. 112. Dostal T, Angst J, Dittrich A, Grof P. Profylakticke ucinky Lithiovych soli u periodickych afektivnich psychoz. Csl Psychiat. 1971;67:151-6. 113. Hell D, Baumann U, Angst J. Drogenkonsum und Persönlichkeit. 1971;22:511-4. 114. Rüegg R, Dittrich A, Angst J. Die Wirkung von Chlordiazepoxyd und Plazebos auf die Leistungsfähigkeit von Pilotenanwärtern der Schweizer Armee. Eine experimentelle Untersuchung im gekreuzten Blindversuch. Pharmakopsychiat. 1971;4:276-85. 115. Angst J. Diskussionsbeitrag zu: N. Matussek "Biochemie der Depression". In: Kielholz P, editor. Depressive Zustände Erkennung, Bewertung, Behandlung Internationales Symposium St Moritz 1972; 1972 10.-11. Januar 1972: Verlag Hans Huber; 1972. p. 24-7. 116. Angst J. Importancia del sexo, inteligencia, personalidad premorbosa y edad de manifestacion para el pronostico y curso de las psicosis endogeno-depresivas. In: Valenciano L, editor. Esquizofrenia y ciclotimia Resultados y problemas: Ediciones Morata; 1972. p. 85-92. 117. Angst J. Genetische Aspekte der Depression. In: Kielholz P, editor. Depressive Zustände Erkennung, Bewertung, Behandlung Internationales Symposium St Moritz 1972; 1972: Verlag Hans Huber; 1972. p. 28-37. 118. Angst J. Schlussdiskussion. In: Kielholz P, editor. Depressive Zustände Erkennung, Bewertung, Behandlung Internationales Symposium St Moritz 1972; 1972: Verlag Hans Huber; 1972. p. 269. 119. Angst J. Somatische psychiatrische Therapie. Eine Standortbestimmung. In: Meyer HH, editor. Nervenheilkunde - Rückblick und Ausblick Wissenschaftliche Tagung Homburg/Saar; 1972; Homburg/Saar: Werk-Verlag; 1972. p. 76-80.

8 120. Angst J, Dittrich A, Woggon B. Psychologische und klinische Aspekte des Cannabis-Missbrauches. Z Allgemeinmed Landarzt. 1972;48:94-9. 121. Angst J, Frei M, Beck M, Jaenicke U, Mueller W, Padrutt A, et al. Vergleich von Perphenazin (Trilafon- Tabletten) und Perphenazin-Oenanthat (Trilafon-Depot-Injektionen) im Doppelblindversuch. Pharmakopsychiat. 1972;5:169-76. 122. Angst J, Frei M, Koukkou M, Padrutt A, Vetter P. Doppelblindversuch zum Wirkungsvergleich von Maprotilin (Ludiomil) und Imipramin (Tofranil) bei endogenen Depressionen. In: Kielholz P, editor. Depressive Zustände Erkennung, Bewertung, Behandlung Internationales Symposium St Moritz 1972; 1972: Verlag Hans Huber; 1972. p. 246-53. 123. Angst J, Perris C. The nosology of endogenous depression. Comparison of the results of two studies. Int J Ment Health. 1972;1:145-58. 124. Angst J, Scharfetter C. Der heutige Stand der Genetik endogener Psychosen. Arch Genet. 1972;45:1- 16. 125. Baumann U, Angst J. Die Marke-Nyman-Temperamantskala (MNT). Z Klin Psychol. 1972;1:189-212. 126. Müller U, Ruppen R, Baumann U, Angst J. Mehrdimensionale Klassifikation des Drogenkonsums bei Jugendlichen. Arch Psychiat Nervenkr. 1972;216:255-64. 127. Angst J. Schmerzmittelkonsum 19jähriger gesunder Frauen. Sozialer Hintergrund und Persönlichkeitsaspekte. Schweiz Arch Neurol Psychiatr. 1973;112:7-19. 128. Angst J. The etiology and nosology of endogenous depressive psychoses. A genetic, sociological, and clinical study.: Foreign Psychiatry; 1973. p. 1-108. 129. Angst J. Statistische Aspekte des Beginns und Verlaufs schizophrener Psychosen. (Diskussionsbeitrag). In: Huber G, editor. Verlauf und Ausgang schizophrener Erkrankungen 2 Weissenauer Schizophreniesymposion; 1973: Schattauer; 1973. p. 79-83. 130. Angst J. Verlaufstypologie und Prognose bei sogenannten Spätschizophrenien. In: Huber G, editor. Verlauf und Ausgang schizophrener Erkrankungen 2 Weissenauer Schizophreniesymposion; 1973: Schattauer; 1973. p. 97. 131. Angst J. Adipositas durch Psychopharmaka. Dtsch Med Wochenschr. 1973;98:1306-7. 132. Angst J. Doppelblindversuch. In: Müller C, editor. Lexikon der Psychiatrie Gesammelte Abhandlungen der gebräuchlichsten psychopathologischen Begriffe. Berlin Heidelberg New York: Springer-Verlag; 1973. p. 140. 133. Angst J. Drogenkonsum im Kanton Zürich. Uni Zürich. 1973;1:1. 134. Angst J. Heredity seen as major factor in depressive psychoses. Roche Report: Frontiers of Psychiatry. 1973;3:6. 135. Angst J. Manipulation mit Psychopharmaka. Neue Zürcher Zeitung. 1973 6. August 1973;Sect. 17-8. 136. Angst J. Somatische psychiatrische Therapie. Eine Standortbestimmung. Arztl Parx. 1973;25:545-7. 137. Angst J. Verlaufsuntersuchungen bei Schizophrenen. (Diskussionsbeitrag). In: Huber G, editor. Verlauf und Ausgang schizophrener Erkrankungen 2 Weissenauer Schizophreniesymposion; 1973: Schattauer; 1973. p. 116-7.

9 138. Angst J. Über Einflüsse der Hospitalisierung auf den Verlauf der Schizophrenie. (Diskussionsbeitrag). In: Huber G, editor. Verlauf und Ausgang schizophrener Erkrankungen 2 Weissenauer Schizophreniesymposion; 1973: Schattauer; 1973. p. 188. 139. Angst J. Kybernetik. In: Müller C, editor. Lexikon der Psychiatrie Gesammelte Abhandlungen der gebräuchlichsten psychopathologischen Begriffe. Berlin Heidelberg New York: Springer-Verlag; 1973. p. 318-20. 140. Angst J. Manie. In: Müller C, editor. Lexikon der Psychiatrie Gesammelte Abhandlungen der gebräuchlichsten psychopathologischen Begriffe. Berlin Heidelberg New York: Springer-Verlag; 1973. p. 328-9. 141. Angst J. Equivalents dépressifs. (Discussion). In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 114. 142. Angst J. Le déclenchement psychogène de la dépression endogène masquée. (Discussion). In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 182-3. 143. Angst J. Le traitement des algies isolées par les antidépresseurs. (Discussion). In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 201. 144. Angst J. L'aspect clinique de la dépression masquée considérée sous un angle pratique et socio- psychiatrique. (Discussion). In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 246-7. 145. Angst J. Masked depression viewed from the cross-cultural standpoint. In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 269-74. 146. Angst J. Depressive equivalents. (Discussion). In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 113. 147. Angst J. Psychogenic factors responsible for triggering off masked endoenous depression. (Discussion). In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 184-5. 148. Angst J. The use of anitdepressants in the treatment of isolated aches and pains. (Discussion). In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 204. 149. Angst J. Observations on the clinical picture of masked depression from the standpoint of practical social psychiatry. (Discussion). In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 253-4. 150. Angst J. Die larvierte Depression in transkultureller Sicht. In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 276-81.

10 151. Angst J. Depressive Äquivalente. (Diskussionsbeitrag). In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 121. 152. Angst J. Psychogene Auslösung. (Diskussionsbeitrag). In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 190-1. 153. Angst J. Behandlung isolierter Alergien mit Antidepressiva. (Diskussionsbeitrag). In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 210. 154. Angst J. Das Krankheitsbild aus praktisch-sozialpsychologischer Sicht. (Diskussionsbeitrag). In: Kielholz P, editor. Die larvierte Depression - La dépression masquée - Masked depression International Symposium St Moritz; 1973: Hans Huber; 1973. p. 259-60. 155. Angst J, Baastrup PC, Grof P, Hippius H, Poeldinger W, Varga E, et al. Paranoide Schizophrenie meist nach 30. - Katatone Form und schizoaffektive Psychose manifestieren sich früher. Med Tribune. 1973;29:3. 156. Angst J, Baastrup PC, Grof P, Hippius H, Poeldinger W, Weis P. The course of monopolar depression and bipolar psychoses. Psychiat Neurol Neurochir. 1973;76:489-500. 157. Angst J, Baumann U. Militärische Tauglichkeit. Soziale Merkmale und Persönlichkeit. Schweiz Z Milit Med. 1973;50:8-19. 158. Angst J, Baumann U. Drogenkonsum im Kanton Zürich. Repräsentative Umfrage bei 6315 Zürchern und 1381 Zürcherinnen (Alter: 19 Jahre). Recht und Praxis. 1973;Juli:1-4. 159. Angst J, Baumann U, Mueller U, Ruppen R. Epidemiologie des Drogenkonsums im Kanton Zürich. Repräsentative Umfrage bei 6315 Zürchern und 1381 Zürcherinnen (Alter: 19 Jahre). Arch Psychiat Nervenkr. 1973;217:11-24. 160. Angst J, Dinkelkamp T, Ernst K. Manfred Bleuler zum 70. Geburtstag. Neue Zürcher Zeitung. 1973 4. April 1973;Sect. 17. 161. Angst J, Frei M, Scharfetter C. Das Depotneurolepticum Fluspirilen. Klinische Prüfung im offenen Versuch und als Doppelblindstudie im Vergleich zu Fluphenazin-Decanoat. Pharmakopsychiat. 1973;6:13-28. 162. Ernst K, Angst J. Die Organisation der Psychiatrie im Kanton Zürich. Schweiz Arch Neurol Psychiatr. 1973;112:49-50. 163. Fleischhauer J, Angst J, Padrutt A, Vetter P. An open study with a new long-acting neuroleptic. Activ Nerv Sup (Praha). 1973;15:85-6. 164. Frei M, Angst J, Scharfetter C. Vergleich von Fluphenazin Decanoat und Fluspirilen im Doppelblindversuch. In: Uchtenhagen A, Heimann H, editors. Fluphenazin Decanoat Davoser Symposium 1972; 1973: Schwarzeck; 1973. p. 65-74. 165. Mueller U, Ruppen R, Baumann U, Angst J. Persönlichkeitsaspekte jugendlicher Drogenkonsumenten. Eine repräsentative Umfrage an 6315 neunzehnjährigen Zürchern. Arch Psychiat Nervenkr. 1973;217:207-22.

11 166. Ruppen R, Mueller U, Baumann U, Angst J. Zur Prüfung der Aussagegenauigkeit bei einer Befragung über Drogenkonsum. Z Präventivmed. 1973;18:173-81. 167. Angst J. Unipolar and bipolar depressions. (Discussion). In: Angst J, editor. Classification and prediction of outcome of depression Symposia Medica Hoechst 8 Schloss Reinhartshausen/Rhein 1973; 1974: F.K. Schattauer Verlag; 1974. p. 85-6, 8. 168. Angst J. Genetic aspects of depression. In: Kline NS, editor. Factors in depression. New York: Raven Press; 1974. p. 1-19. 169. Angst J. Summary of the session on genetic aspects of therapy resistance. Contribution to genetic aspects. Pharmakopsychiat. 1974;7:127. 170. Angst J. Zum Gedenken an Fräulein Thilde Dinkelkamp, 1913-1974. PUK "information" (Zürich). 1974;22:8-9. 171. Angst J. Diagnostik der Depression. (Diskussion). In: Kielholz P, editor. Die Depression in der täglichen Praxis Internationales Symposium St Moritz; 1974: Verlag Hans Huber; 1974. p. 61-2, 4. 172. Angst J. The classification of affective psychoses. Lecture given at the meeting of the Royal College of Psychiatrists, London.; 1974. 173. Angst J. Classification and prediction of outcome of depression. In: Angst J, editor. Classification and prediction of outcome of depression Symposia Medica Hoechst 8 Schloss Reinhartshausen/Rhein 1973; 1974: F.K. Schattauer Verlag; 1974. 174. Angst J. Drug plasma levels. (Discussion). In: Angst J, editor. Classification and prediction of outcome of depression Symposia Medica Hoechst 8 Schloss Reinhartshausen/Rhein 1973; 1974: F.K. Schattauer Verlag; 1974. p. 218. 175. Angst J. Introductory remarks. In: Angst J, editor. Classification and prediction of outcome of depression Symposia Medica Hoechst 8 Schloss Reinhartshausen/Rhein 1973; 1974: F.K. Schattauer Verlag; 1974. p. XI-XII. 176. Angst J. Conclusions. In: Angst J, editor. Classification and prediction of outcome of depression Symposia Medica Hoechst 8 Schloss Reinhartshausen/Rhein 1973; 1974: F.K. Schattauer Verlag; 1974. p. 311-3. 177. Angst J. Epidemiologie der Depression. (Diskussion). In: Kielholz P, editor. Die Depression in der täglichen Praxis Internationales Symposium St Moritz; 1974: Verlag Hans Huber; 1974. p. 152-3. 178. Angst J. Somatische Symptomatik Depressiver. (Diskussion). In: Kielholz P, editor. Die Depression in der täglichen Praxis Internationales Symposium St Moritz; 1974: Verlag Hans Huber; 1974. p. 189. 179. Angst J. Phenelzin. (Diskussion). In: Kielholz P, editor. Die Depression in der täglichen Praxis Internationales Symposium St Moritz; 1974: Verlag Hans Huber; 1974. p. 233. 180. Angst J. The diagnosis of depression. (Discussion). In: Kielholz P, editor. Depression in everyday practice International Symposium St Moritz; 1974: Hans Huber Verlag; 1974. p. 62-3, 6-7. 181. Angst J. Epidemiology of depression. (Discussion). In: Kielholz P, editor. Depression in everyday practice International Symposium St Moritz; 1974: Verlag Hans Huber; 1974. p. 149-50. 182. Angst J. Somatic anxiety in depression. (Diskussion). In: Kielholz P, editor. Depression in everyday practice International Symposium St Moritz; 1974: Verlag Hans Huber; 1974. p. 184.

12 183. Angst J. Phenelzine. (Discussion). In: Kielholz P, editor. Depression in everyday practice International Symposium St Moritz; 1974: Verlag Hans Huber; 1974. p. 225. 184. Angst J, Baumann U, Hippius H, Rothweiler R. Clinical aspects of resistance to Imipramine therapy. Pharmakopsychiat. 1974;7:211-6. 185. Angst J, Dinkelkamp T. Die somatische Therapie der Schizophrenie. Literatur der Jahre 1966-1972. Stuttgart: Georg Thieme Verlag; 1974. 186. Angst J, Dinkelkamp T. Die somatische Therapie der Schizophrenie. Literatur der Jahre 1966-1972. (Japanische Ausgabe) Tokyao: Seiwa Shoten; 1974. 187. Angst J, Dittmer TLJ, Heinrich K, Hippius H, Seibel I, Woggon B. A double-blind study comparing Clofepramine and Imipramine. (Communications libres. Résumés). Collegium Internationale Neuro- Psychopharmacologicum, IXe Congres Paris; 1974: J Pharmacol; 1974. p. 3. 188. Angst J, Gmuer M, Hess K, Hurwitz E, Martens H, Steiner A. Zwei Doppelblindstudien mit Maprotilin. (Diskussion). In: Kielholz P, editor. Die Depression in der täglichen Praxis Internationales Symposium St Moritz; 1974: Verlag Hans Huber; 1974. p. 260-4. 189. Angst J, Gmür M, Hess K, Hurwitz E, Martens H, Steiner A. Two double-blind studies with Ludiomil. (Discussion). In: Kielholz P, editor. Depression in everyday practice International Symposium St Moritz; 1974: Verlag Hans Huber; 1974. p. 253-6. 190. Angst J, Koukkou M, Bleuler-Herzog M, Martens H. Ergebnisse eines offenen und eines Doppelblindversuches von Nomifensin im Vergleich zu Imipramin. Arch Psychiat Nervenkr. 1974;219:265-76. 191. Angst J, Maurer-Groeli YA. Blutgruppen und Persönlichkeit. Arch Psychiat Nervenkr. 1974;218:291- 300. 192. Angst J, Rothweiler R. Blood levels and clinical effects of Maprotiline (Ludiomil). A preliminary study. (Discussion). In: Angst J, editor. Classification and prediction of outcome of depression Symposia Medica Hoechst 8 Schloss Reinharshausen/Rhein 1973; 1974: F.K. Schattauer Verlag; 1974. p. 246- 50. 193. Angst J, Scharfetter C. Depression heute und morgen. In: Kielholz P, editor. Die Depression in der täglichen Praxis Internationales Symposium St Moritz; 1974: Verlag Hans Huber; 1974. p. 25-32. 194. Angst J, Scharfetter C. Depression today and tomorrow. In: Kielholz P, editor. Depression in everyday practice International Pymposium St Moritz; 1974: Verlag Hans Huber; 1974. p. 25-32. 195. Baumann U, Angst J. Methodological development of the AMP-System. (Communication libers. Résumés). Collegium Internationale Neuro-Psychopharmacologicum, IXe Congres Paris; 1974: J Pharmacol; 1974. p. 12. 196. Grof P, Angst J, Haines T. The clinical course of depression: practical issues. (Discussion). In: Angst J, editor. Classification and prediction of outcome of depression Symposia Medica Hoechst 8 Schloss Reinharshausen/Rhein 1973; 1974: F.K. Schattauer Verlag; 1974. p. 150-3, 5. 197. Matussek N, Angst J, Benkert O, Gmür M, Papousek M, Rüther E, et al. The effect of L-5- hydroxytryptophan alone and in combination with a decarboxylase inhibitor (Ro 4-4602) in depressive patients. In: Costa E, Glessa GL, Sandler M, editors. Serotonin - New Vistas Biochemistry and behavioral and clinical studies. New York: Raven Press; 1974. p. 399-404.

13 198. Shah BK, Kline NS, Angst J. Explicit solution to pharmacokinetic first-order rate constants of Maprotilin. Int Pharmacopsychiat. 1974;9:230-4. 199. Angst J. Indikationen für Schlafkuren. Selecta. 1975;44:4056. 200. Angst J. Zur Nosologie von Manien und Depressionen. Zbl ges Neurol Psychiat. 1975;212:534. 201. Angst J. Methodology for the clinical testing of psychotropic agents. Comparison of clozapine with methotrimeprazine (levomepromazine), perphenazine and lenperone (AHR 2277). On the methodology of the pharmacological and clinical trials of psychotropic drugs Symposium Moscow 1974; 1975 Conference Date 1974: Sandoz; 1975. p. 23-35. 202. Angst J. Final Comments. Assessment of pharmacodynamic effects in human pharmacology Part I: Psychopharmacological screening tests Symposium Mainz 1974; 1975 Conference Date 25th November 1974: F.K. Schattauer Verlag; 1975. p. 147-50. 203. Angst J. Drugs in depression. South Afr Med J. 1975;49:981. 204. Angst J, Baastrup PC, Grof P, Hippius H, Poeldinger W, Scharfetter C, et al. The onset and course of schizophrenia. The results of a statistic investigation. (Russian, English Summary). Z Nevropat Psihiat. 1975;75:1354-8. 205. Angst J, Dittmer TLJ, Heinrich K, Hippius H, Seibel I, Woggon B. Klinische Prüfung von Lofepramin im Vergleich zu Imipramin. Int Pharmacopsychiat. 1975;10:65-71. 206. Angst J, Woggon B. Klinische Prüfung von fünf Depotneuroleptika. Vergleich der Wirkungsprofile von Fluphenazindecanoat, Fluspirilen, Penfluridol, Perphenazinoenanthat und Pipothiazinpalmitat. Arzneimittelforschung. 1975;25:267-70. 207. Baumann U, Angst J. Methodological development of the AMP system. In: Boissier JR, Hippius H, Pichot P, editors. Proceedings of the 9th International Congress of the Collegium Internationale Neuro- Psychopharmacologicum Paris 1974; 1975 Conference Date 7.-12. July 1974: Excerpta Medica International Congress Series No. 359; 1975. p. 72-8. 208. Baumann U, Angst J. Datenverarbeitung bei epidemiologischen Studien. In: Battegay R, Pfister- Ammende M, Burner M, Labhardt F, Luban-Plozza B, editors. Aspekte der Sozialpsychiatrie und Psychohygene Aspects of social psychiatry and mental health Aspects de la psychiatrie sociale et santé mental. Bern Stuttgart Wien: Verlag Hans Huber; 1975. p. 34-45. 209. Baumann U, Angst J, Henne A, Muser FE. Der Gray-Wheelwright-Test. Diagnostica. 1975;21:66-83. 210. Baumann U, Schneidewind G, Angst J, Helmchen H, Hippius H. Zur Entscheidungslogik bei Symptom- Beurteilungen. Arch Psychiat Nervenkr. 1975;220:225-35. 211. Kline NS, Angst J. Side effects of psychotropic drugs. Psychiat Ann. 1975;5:441-58. 212. Woggon B, Angst J, Bleuler M, Dittmer TLJ, Heinrich K, Hippius H, et al. Comparison of a new antidepressive, Lofepramine, with Imipramine in a double-blind multicentre trial. Arch Psychiat Nervenkr. 1975;221:157-65. 213. Woggon B, Angst J, Margoses N. Gegenwärtiger Stand der neuroleptischen Langzeitbehandlung der Schizophrenie. Nervenarzt. 1975;46:611-6. 214. Angst J. Privatdozent Professor Dr. Herbert Binswanger - 6.9.1900 bis 14.12.1975. Universität Zürich, Jahresbericht 1975/76. 1976:71-2.

14 215. Angst J. Einzelne Aspekte der Behandlung mit Depotneuroleptika. (Diskussionsbeitrag). In: Huber G, editor. Therapie, Rehabilitation und Prävention schizophrener Erkrankungen 3 Weissenauer Schizophreniesymposion Lübeck-Travemünde 1975; 1976: Schattauer; 1976. p. 203-5. 216. Angst J. Therapie und Rückfallverhütung bei schizoaffektiven Psychosen. (Diskussionsbeitrag). In: Huber G, editor. Therapie, Rehabilitation und Prävention schizophrener Erkrankungen 3 Weissenauer Schizophreniesymposion Lübeck-Travemünde 1975; 1976: Schattauer; 1976. p. 260-1. 217. Angst J. Einführung. In: Angst J, Burner M, editors. Schweizerische Studie über die Behandlung mit Depotneuroleptika Rundtischgespräch vom 12 September 1975 in Bern; 1976: Squibb; 1976. p. 3-4. 218. Angst J. Schlusswort. In: Angst J, Burner M, editors. Schweizerische Studie über die Behandlung mit Depotneuroleptika Rundtischgespräch vom 12 September 1975 in Bern; 1976: Squibb; 1976. p. 6. 219. Angst J, Baastrup PC, Grof P, Hippius H, Poeldinger W, Weis P. Zum Verlauf affektiver Psychosen. Multifaktorielle Probleme in der Medizin. Wiesbaden: Akademische Verlagsgesellschaft; 1976. p. 137- 52. 220. Angst J, Baumann U. Zur Methodik klinischer Prüfungen von Antipsychotika. Psychofarmakoterapia schizofrenii leki o przedluzonym dzialaniu Symposium 1973; 1976: Polskie Towarzystwo Psychiatryczne Oddzial Wroclawski, Wroclaw; 1976. p. 59-72. 221. Angst J, Burner M, editors. Schweizerische Studie über die Behandlung mit Depotneuroleptika. Rundtischgespräch vom 12. September 1975 in Bern. Zürich: Squibb; 1976. 222. Angst J, Frey R. Die Prognose endogener Depressionen jenseits des 40. Lebensjahres. Zbl ges Neurol Psychiat. 1976;215:235. 223. Angst J, Frey R. Endogene Früh- und Spät-Depressionen zeigen mehr Gemeinsamkeiten als Unterschiede. Med Tribune. 1976;39:5. 224. Angst J, Grof P. The Course of monopolar depressions and bipolar psychoses. In: Villeneuve A, editor. Lithium in psychiatry A synopsis Proceedings of the First Canadian International Symposium on Lithium, Québec 1974; 1976: Les Presses de l'Université Laval, Québec; 1976. p. 93-103. 225. Angst J, Scheidegger P. Tierkreiszeichen und Persönlichkeit. Soz Präventivmedizin. 1976;21:39-41. 226. Angst J, Woggon B. Pharmacological treatment of affective disorders. Advances in the drug therapy of mental illness Based on the proceedings of a symposium jointly sponsored by the World Health Organization and the International Task Force on World Health Manpower; 1976: World Health Organization; 1976. p. 15-22. 227. Baumann U, Schneidewind G, Angst J, Helmchen H, Hippius H. Untersuchungen zum AMP-System. Symptomvergleich zwischen Berlin und Zürich. Arzneimittelforschung. 1976;26:1111-4. 228. Heimann H, Angst J, Bente D, Berner P, Helmchen H, Hippius H. Verbundforschung: Erfahrungen der Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie (AMP). In: Bochnik HJ, Pittrich W, editors. Multifaktorielle Probleme in der Medizin. Wiesbaden: Akademische Verlagsgesellschaft; 1976. p. 43-55. 229. Hucker H, Woggon B, Angst J. Präparatspezifische Ergebnisse der Auswertung. In: Angst J, Burner M, editors. Schweizerische Studie über die Behandlung mit Depotneuroleptika Rundtischgespräch vom 12 September 1975 in Bern1975; 1976: Squibb; 1976. p. 26-59.

15 230. Sieber M, Angst J, Baumann U. Entwicklung des Drogen-, Alkohol- und Tabakkonsums. Vergleich zweier Untersuchungen von 1971 und 1974 im Kanton Zürich. Schweiz Med Wochenschr. 1976;106:1- 7. 231. Woggon B, Angst J. Das Wirkungsprofil von Carpipramin. Ergebnisse einer offenen Prüfung und einer Doppelblindprüfung gegen Doxepin. Arzneimittelforschung. 1976;26:2226-30. 232. Woggon B, Angst J. Einzelne Aspekte der Behandlung mit Depotneuroleptika. In: Huber G, editor. Therapie, Rehabilitation und Prävention schizophrener Erkrankungen 3 Weissenauer Schizophreniesymposion Lübeck - Travemünde 1975; 1976: Schattauer; 1976. p. 191-200. 233. Woggon B, Angst J, Gmuer M, Hess K, Hurwitz E, Martens H, et al. Klinische Doppelblindstudie mit zwei verschiedenen Dosierungen von Maprotilin (150 und 225 mg pro die). Arch Psychiat Nervenkr. 1976;222:13-25. 234. Woggon B, Hucker H, Angst J. Allgemeine, nicht präparatspezifische Ergebnisse. In: Angst J, Burner M, editors. Schweizerische Studie über die Behandlung mit Depotneuroleptika Rundtischgespräch vom 12 September 1975 in Bern; 1976: Squibb; 1976. p. 16-25. 235. Angst J. Herbert Binswanger (1900-1975). Schweiz Arch Neurol Psychiatr. 1977;121:134-5. 236. Angst J. Antidepressiver Effekt und genetische Faktoren. In: Selbach H, editor. Pharmako-Psychiatrie. Darmstadt: Wissenschaftliche Buchgesellschaft; 1977. p. 265-76. 237. Angst J. Vorwort. In: Pöldinger W, Woggon B, editors. Beiträge aus dem Symposium "Depressionsbehandlung in der Praxis" Zürich 1977; 1977: Hoechst; 1977. p. 1. 238. Angst J. Lithium in the perspective of a follow-up study of affective disorders. (Abstract No. 320). VIth World Congress of Psychiatry Honolulu, Hawaii, USA 1977; 1977; 1977. p. 62. 239. Angst J. Préface. In: Pöldinger W, Woggon B, editors. Exposé sur "Le traitement des dépressifs en consultation médicale" à l'occasion du séminaire de Zurich de 1977; 1977: Hoechst; 1977. p. 1. 240. Angst J, Frey R. Die Prognose endogener Depressionen jenseits des 40. Lebensjahres. Nervenarzt. 1977;48:571-4. 241. Angst J, Maurer Y. Blutgruppen, Persönlichkeit und Krankheiten. Medita. 1977;5:39-40. 242. Angst J, Woggon B, Schoepf J. The treatment of Depression with L-5-Hydroxytryptophan versus Imipramine. Results of two open and one double-blind study. Arch Psychiat Nervenkr. 1977;224:175- 86. 243. Baumann U, Angst J. AMP-System: Verlaufsanalysen psychopathologischer und somatischer Symptome. Eine empirische Untersuchung zum Problem der Nebenwirkungen. Arch Psychiat Nervenkr. 1977;233:227-38. 244. Gmuer M, Angst J. Kombination von Phenylpyrrolidinopentan (Katovit) mit Oxazepam (Adumbran). Ein Wirkungsvergleich im Doppelblindversuch mit Opipramol (Insidon) bei depressiven Syndromen. Int Pharmacopsychiat. 1977;12:100-12. 245. Hucker H, Woggon B, Angst J. Wirkungsvergleich von Amitriptylin (Saroten (R) und Amitriptylin retard (Saroten (R) retard). Papers read at the symposium for Swiss and Dutch psychiatrists Copenhagen 1976; 1977: Lundbeck; 1977. p. 51-60. 246. Sieber M, Angst J. Zur Epidemiologie des Drogen-, Zigaretten- und Alkoholkonsums bei jungen Männern. Schweiz Med Wochenschr. 1977;107:1912-20.

16 247. Woggon B, Angst J. Open trial and double-blind clinical trial of the antidepressant Ro 8-1998 in comparison with Imipramine. Int Pharmacopsychiat. 1977;12:38-48. 248. Woggon B, Angst J. Depotneuroleptika. Die ambulante Behandlung chronisch schizophrener Patienten. Der informierte Arzt. 1977;12:47-9. 249. Woggon B, Angst J. Die Bedeutung der Depotneuroleptika für die Langzeitbehandlung schizophrener Patienten. Schweiz Rundsch Med Prax. 1977;66:421-7. 250. Woggon B, Angst J. Wirkungsvergleich von Nomifensin und Imipramin. Alival (Nomifensin) Symposium über Ergebnisse der experimentellen und klinischen Prüfung Berlin 1976; 1977: Schattauer; 1977. p. 179-87. 251. Woggon B, Angst J. Comparison of the efficacy of Nomifensine and Imipramine. Alival (Nomifensin) Symposium über Ergebnisse der experimentellen und klinischen Prüfung Berlin 1976; 1977: Schattauer; 1977. p. 3-10. 252. Woggon B, Dick P, Fleischhauer J, Gmuer M, Gruber G, Angst J, et al. Wirkungsvergleich von Pipothiazinpalmitat und Fluphenazindecanoat. Ergebnisse einer multizentrischen klinischen Doppelblindprüfung. Int Pharmacopsychiatry. 1977;12:193-209. 253. Woggon B, Franke A, Hucker H, Ruether E, Athen D, Angst J, et al. effects, side effects and effective dosis of the Butyrophenone Lenperone (AHR 2277). Int Pharmacopsychiat. 1977;12:113- 26. 254. Woggon B, Hucker H, Angst J. Offene klinische Prüfung von Alpha-Clopenthixoldecanoat (Sordinol- Depot). Papers read at the symposium for Swiss and Dutch psychiatrists Copenhagen 1976; 1977: Lundbeck; 1977. p. 23-9. 255. Woggon B, Stassen HH, Angst J. Differences between hospitals vs. differences between drugs in multicenter trials. (Abstract No. 11). VIth World Congress of Psychiatry (New Research) Honolulu, Hawaii, USA, 1977; 1977; 1977. p. 6. 256. Angst J. Klinische Verlaufsgesetzlichkeit monopolarer und bipolarer affektiver Psychosen. In: Hippius H, editor. Zum Stand der Depressionsforschung Symposium 1976; 1978: Das ärztliche Gespräch; 1978. p. 27-35. 257. Angst J. L-5-HTP. (Discussion). Depressive disorders Symposia Medica Hoechst 13 Rome 1977; 1978: Schattauer; 1978. p. 54-6. 258. Angst J. Drug Evaluation. In: Deniker P, Radouco-Thomas C, Villeneuve A, editors. Neuro- Psychopharmacology, Vol 2 Proceedings of the 10th Congress of the Collegium Internationale Neuro- Psychopharmacologicum Quebec 1976; 1978: Pergamon-Press; 1978. p. 1023-31. 259. Angst J. The course of affective disorders. II. Typology of bipolar manic-depressive illness. Archiv für Psychiatrie und Nervenkrankheiten. 1978;226:65-73. 260. Angst J. Verlauf endogener Psychosen. In: Finke J, Tölle R, editors. Aktuelle Neurologie und Psychiatrie. Berlin Heidelberg New York: Springer; 1978. p. 203-10. 261. Angst J. The reliability of morbidity risk figures in affective disorders. Results of a reinvestigation. Psychiatrie des Jahres 1978, Nachrichten Nr 49 des Psychiatrischen Forschungsinstitutes Prag. 1978:96-104.

17 262. Angst J. Drug-induced with amphetamines in depression. (Discussion). Depressive disorders Symposia Medica Hoechst 13 Rome 1977; 1978: Schattauer; 1978. p. 441. 263. Angst J. Time-lag of antidepressant effect. (Discussion). Depressive disorders Symposia Medica Hoechst 13 Rome 1977; 1978: Schattauer; 1978. p. 468. 264. Angst J, Felder W, Frey R, Stassen HH. The course of affective disorders. I. Change of diagnosis of monopolar, unipolar, and bipolar illness. Arch Psychiatr Nervenkr. 1978;226:57-64. 265. Angst J, Felder W, Lohmeyer B. A genetic study on schizoaffective psychoses. (Abstract No. 24). Developments in psychiatry, Vol 2 A: Biological psychiatry today Proceedings of the Second World Congress on Biological Psychiatry Barcelona Spain, 1978; 1978; 1978. p. 14. 266. Angst J, Koukkou M, Stassen HH. Clinical and EEG changes in depressive patients after a single injection of beta-endorphin. (Abstract 318). Developments in psychiatry, Vol 2 A: Biological psychiatry todayProceedings of the Second World Congress on Biological Psychiatry Barcelona Spain, 1978; 1978; 1978. p. 77. 267. Angst J, Scharfetter C. Subtypes of schizophrenia from a genetic point of view. (Abstract No. 5). Developments in psychiatry, Vol 2 A: Biological psychiatry today Proceedings of the Second World Congress on Biological Psychiatry Barcelona Spain, 1978; 1978; 1978. p. 9. 268. Angst J, Woggon B. Lithium hilft Depressiven. Rückschläge und Erfolge einer revolutionären Therapie. Weltwoche. 1978 27.09.1978;39:69. 269. Hucker H, Angst J. Klinische Prüfung des Depotneuroleptikums Alpha-Clopenthixoldecanoat. Die Praxis der Depotneurolepsie Symposion der Troponwerke Lahnstein 1976; 1978: Tropon Arzneimittel; 1978. p. 140-9. 270. Scharfetter C, Angst J. Depressionen. Epidemiologie und transkulturell vergleichende Psychiatrie. Dtsch Med Wochenschr. 1978;103:913-8. 271. Woggon B, Angst J. Grundlagen und Richtlinien für erste klinische Psychopharmaka-Prüfungen (Phase I, II) aus der Sicht des klinischen Prüfers. Arzneimittelforschung. 1978;28:1257-9. 272. Woggon B, Angst J. Double-blind comparison of Bromperidol and Perphenazine. Int Pharmacopsychiat. 1978;13:165-76. 273. Woggon B, Baumann U, Angst J. Interrater-Reliabilität von AMP-Symptomen. Arch Psychiat Nervenkr. 1978;225:73-85. 274. Woggon B, Stassen HH, Angst J. Differences between hospitals vs. differences between drugs in multicenter trials. (Abstract). 11th International Congress of the Collegium Internationale Neuro- Psychopharmacologicum Vienna Austria; 1978; 1978. p. 303. 275. Angst J. Was sind schizo-affektive Psychosen? Med Tribune. 1979;10:22-3. 276. Angst J. The reliability of morbidity risk figures in affective disorders: results of a reinvestigation. In: Mendlewicz J, Shopsin B, editors. Genetic aspects of affective Iillness. New York London: Spectrum Publications; 1979. p. 21-6. 277. Angst J. Fortbildungskurs der SGP, Zürich 1979: "Biologische Aspekte der Psychiatrie". (Schlusswort). Schweiz Arch Neurol Psychiatr. 1979;125:315-8. 278. Angst J. Affekterkrankungen. Psychiatrische Universitätsklinik Zürich, Forschungsdirektion: Zehnjahresbericht 1969-1979. 1979:37-48.

18 279. Angst J. Dépressions chez le sujet âgé. Résultat d'une étude longitudinale. Encephale. 1979;5:463-73. 280. Angst J. Affective disorders. Psychiatrische Universitätsklinik Zürich, Forschungsdirektion: Zehnjahresbericht 1969-1979. 1979:164-74. 281. Angst J, Autenrieth V, Brem F, Koukkou M, Meyer H, Stassen HH, et al. Preliminary results of treatment with beta-endorphin in depression. In: Usdin E, Bunney WEj, Kline NS, editors. Endorphins in Mental Health Research Conference Puerto Rico 1977; 1979: Macmillan Press; 1979. p. 518-28. 282. Angst J, Baastrup PC, Grof P, Hippius H, Poeldinger W, Varga E, et al. Statistische Aspekte des Beginns und Verlaufs schizophrener Psychosen. In: Bleuler M, editor. Beiträge zur Schizophrenielehre der Zürcher Psychiatrischen Universitätsklinik Burghölzli (1902-1971) Einleitende Übersicht und gekürzter Nachdruck von Veröffentlichungen. Darmstadt: Wissenschaftliche Buchgesellschaft; 1979. p. 337-8. 283. Angst J, Dittrich A, Woggon B. Reproduzierbarkeit der Faktorenstruktur des AMP-Systems. Int Pharmacopsychiat. 1979;14:319-24. 284. Angst J, Felder W, Frey R. The Course of Unipolar and Bipolar Affective Disorders. In: Schou M, Strömgren E, editors. Origin, prevention and treatment of affective disorders. London New York San Francisco: Academic Press; 1979. p. 215-26. 285. Angst J, Felder W, Lohmeyer B. Schizoaffective disorders. Results of a genetic investigation (I). J Affect Disord. 1979;1:139-53. 286. Angst J, Felder W, Lohmeyer B. Are schizoaffective psychoses heterogeneous? Results of a genetic investigation (II). J Affect Disord. 1979;1:155-65. 287. Angst J, Felder W, Lohmeyer B. A genetic study on schizoaffective disorders. In: Obiols J, Ballus C, Gonzales Monclus E, Pujol J, editors. Developments in psychiatry, Vol 2 A: Biological psychiatry today Proceedings of the Second World Congress on Biological Psychiatry Barcelona Spain, 1978; 1979: Elsevier; 1979. p. 12-8. 288. Angst J, Grof P. Selection of patients with recurrent affective illness for a long-term study: testing research criteria on prospective follow-up data. In: Cooper TB, Gershon S, Kline NS, Schou M, editors. Lithium - controversies and unresolved issues Proceedings of the International Lithium Conference New York 1978; 1979: Excerpta Medica Foundation; 1979. p. 355-69. 289. Angst J, Grof P, Karasek M, Keitner G. Patient selection for long-term lithium treatment in clinical practice. Arch Gen Psychiatry. 1979;36:894-7. 290. Angst J, Koukkou M, Stassen HH. Clinical and EEG changes in depressive patients after a single injection of beta-endorphin. In: Obiols J, Ballus C, Gonzales Monclus E, Pujol J, editors. Developments in psychiatry, Vol 2 A: Biological sychiatry Today Proceedings of the Second World Congress on Biological Psychiatry Barcelona Spain 1978; 1979: Elsevier; 1979. p. 806-11. 291. Angst J, Scharfetter C. Subtypes of schizophrenia and affective disorders from a genetic viewpoint. In: Obiols J, Ballus C, Gonzales Monclus E, Pujol J, editors. Developments in psychiatry, Vol 2 A: Biological psychiatry today Proceedings of the Second World Congress on Biological Psychiatry Barcelona Spain, 1978; 1979: Elsevier; 1979. p. 351-7. 292. Angst J, Scharfetter C, Felder W, Lohmeyer B. Heterogeneity of schizophrenia. (Discussion). In: Fukuda T, Mitsuda H, editors. Genetics, environment and psychopathology in schizophrenic psychoses

19 World issues in the problems of schizophrenic psychoses Conference in Kyoto 1977; 1979: Igaku- Shoin; 1979. p. 145-7. 293. Angst J, Scharfetter C, Woggon B. AMP-System. Psychiatrische Universitätsklinik Zürich, Forschungsdirektion: Zehnjahresbericht 1969-1979. 1979:11-5. 294. Angst J, Scharfetter C, Woggon B. AMP-System. Psychiatrische Universitätsklinik Zürich, Forschungsdirektion: Zehnjahresbericht 1969-1979. 1979:153. 295. Binder J, Sieber M, Angst J. Verzerrungen bei postalischen Befragungen: das Problem der Nichtantworter. Z Exp Psychol. 1979;26:53-71. 296. Binder J, Sieber M, Angst J. Entwicklung des Suchtmittelkonsums bei 19-/20-jährigen Jugendlichen von 1971 bis 1978. Drogenbulletin. 1979;2:3-8. 297. Binder J, Sieber M, Angst J. Entwicklung des Suchtmittelkonsums bei 19/20jährigen Jugendlichen. Ein Vergleich im Kanton Zürich 1971, 1974 und 1978. Schweiz Med Wochenschr. 1979;109:1298-305, 331-335. 298. Grof P, Angst J, Karasek M, Keitner G. Selection of an individual patient for long-lerm lithium treatment in clinical practice. In: Cooper TB, Gershon S, Kline NS, Schou M, editors. Lithium - Controversies and unresolved issues Proceedings of the International Lithium Conference New York 1978; 1979: Excerpta Medica Foundation; 1979. p. 370-80. 299. Kline NS, Angst J. Psychiatric syndromes and drug treatment. New York: Jason Aronson; 1979. 300. Koukkou M, Angst J, Zimmer D. Paroxysmal EEG activity and psychopathology during the treatment with clozapine. Pharmakopsychiat. 1979;12:173-83. 301. Scharfetter C, Angst J, Nuesperli M. Suizid und endogene psychose. Soz Präventivmedizin. 1979;24:37-42. 302. Scharfetter C, Dittrich A, Angst J. Schizophrenien. Psychiatrische Universitätsklinik Zürich, Forschungsdirektion: Zehnjahresbericht 1969-1979. 1979:25-36. 303. Scharfetter C, Dittrich A, Angst J. Schizophrenia. Psychiatrische Universitätsklinik Zürich, Forschungsdirektion: Zehnjahresbericht 1969-1979. 1979:157-63. 304. Sieber M, Angst J. Risikofaktoren für starkes Zigarettenrauchen bei jungen Männern. Eine Längsschnittuntersuchung. Schweiz Med Wochenschr. 1979;109:115-22. 305. Angst J. Verlauf unipolar depressiver, bipolar manisch-depressiver und schizo-affektiver Erkrankungen und Psychosen. Ergebnisse einer prospektiven Studie. Fortschr Neurol Psychiatr. 1980;48:3-30. 306. Angst J. Geleitwort. In: Hartwich P, editor. Zur Psychopathologie der kognitiven Verarbeitung von Aufmerksamkeitsleistungen. Berlin Heidelberg New York: Springer; 1980. p. V-VI. 307. Angst J. Genetics and psychopathology - clinical aspects. In: Koukkou M, Lehmann D, Angst J, editors. Functional states of the brain: their determinants. Amsterdam New York Oxford: Elsevier; 1980. p. 225- 41. 308. Angst J. Genetische und ontogenetische Aspekte in der Depressionsforschung. (Diskussion). In: Heimann H, Giedke H, editors. Neue Perspektiven in der Depressionsforschung; 1980: Huber; 1980. p. 53-4, 60-2.

20 309. Angst J. Clinical typology of bipolar illness. In: Belmaker RH, Van Praag HM, editors. - an evolving concept. Jamaica New York: Spectrum Publications; 1980. p. 61-76. 310. Angst J. Psychopathogenetische Aspekte in der Depressionsforschung. (Diskussion). In: Heimann H, Giedke H, editors. Neue Perspektiven in der Depressionsforschung; 1980: Huber; 1980. p. 197-8. 311. Angst J. Therapeutische und prophylaktische Aspekte in der Depressionsforschung. (Diskussion). In: Heimann H, Giedke H, editors. Neue Perspektiven in der Depressionsforschung; 1980: Huber; 1980. p. 272. 312. Angst J, Bendel H, Binder J. Unterschiedliche Entwicklung des Suchtmittelkonsums bei jungen Zürchern und Zürcherinnen - Ein Vergleich 1971/1978. Schweiz Ärztezeitung. 1980;61:447-50. 313. Angst J, Binder J. Immer daran denken: Depressionen blühen meist im verborgenen. Med Tribune. 1980;12:36. 314. Angst J, Binder J. Epidemiology of depressive symptoms in a 20-year-old Swiss population. In: Achte K, Aalberg V, Lönnqvist J, editors. Psychopathology of depression Symposium by the Section of Clinical Psychopathology of the World Psychiatric Association 1979; 1980: Psychiatria Fennica; 1980. p. 65-70. 315. Angst J, Felder W, Lohmeyer B. Course of schizoaffective psychoses: results of a followup study. Schizophr Bull. 1980;6:579-85. 316. Angst J, Felder W, Lohmeyer B. Verlauf schizoaffektiver Psychosen. Ergebnisse katamnestischer Untersuchungen. In: Schimmelpenning GW, editor. Psychiatrische Verlaufsforschung Methoden und Ergebnisse. Bern Stuttgart Wien: Huber; 1980. p. 176-94. 317. Angst J, Frey R, Lohmeyer B, Zerbin-Ruedin E. Bipolar manic-depressive psychoses: results of a genetic investigation. Hum Genet. 1980;55:237-54. 318. Angst J, Mueller-Oerlinghausen B. Methodologische Anmerkungen zur Langzeitbehandlung mit Lithium. Pharmakopsychiat. 1980;13:152-5. 319. Angst J, Scharfetter C. Essunlust und Schlafstörungen: Auch an depressive Störungen denken. Med Tribune. 1980;18:7. 320. Angst J, Scharfetter C. Depressive symptoms in functional psychoses based on the AMP-system. In: Achte K, Aalberg V, Lönnqvist J, editors. Psychopathology of depression Proceedings of the Symposium by the Section of Clinical Psychopathology of the World Psychiatric Association 1979; 1980: Psychiatria Fennica; 1980. p. 55-61. 321. Angst J, Woggon B. Psychopharmakotherapie. In: Kisker KP, Meyer JE, Müller C, Strömgren E, editors. Psychiatrie der Gegenwart - Forschung und Praxis. Berlin Heidelberg New York: Springer; 1980. p. 243-314. 322. Binder J, Bendel H, Angst J. Veränderungen und Tendenzen im Suchtmittelkonsum bei jungen Zürchern und Zürcherinnen. Uni Zürich. 1980;5:2-4. 323. Binder J, Bendel H, Angst J. Wie hat sich der Suchtmittelkonsum bei Jugendlichen von 1971 bis 1978 entwickelt und verändert? Drogalcool. 1980;1:3-18. 324. Binder J, Bendel H, Angst J. Evolution et modifications de la consommation de produits engendrant la dépendance par les jeunes entre 1971 et 1978. Drogalcool. 1980;1:15-30.

21 325. Fontana A, Storck U, Angst J, Dubs R, Abegg A, Grob PJ. An immunological basis of schizophrenia and affective disorders? Neuropsychobiology. 1980;6:284-9. 326. Koukkou M, Lehmann D, Angst J, editors. Functional states of the brain: their determinants. Amsterdam New York Oxford: Elsevier; 1980. 327. Scharfetter C, Angst J. La depression chez le sujet age. Rev Medecine. 1980;21:83-8. 328. Angst J. Die Anwendung der Psychopharmaka und ihre Aspekte. Universitas. 1981;36:503-8. 329. Angst J. Ungelöste Probleme bei der Indikationsstellung zur Lithiumprophylaxe affektiver und schizoaffektiver Erkrankungen. In: Berner P, Lenz G, Wolf R, editors. Current perspectives in lithium prophylaxis International Symposium Vienna 1979; 1981: Karger; 1981. p. 32-44. 330. Angst J. Affective disorders: heterogeneity from a genetic viewpoint. In: Schmid W, Nielsen J, editors. Human behavior and genetics Proceedings of the symposium of the European Society of Human Genetics Zurich 1981; 1981: Elsevier; 1981. p. 231-43. 331. Angst J. Course of affective disorders. In: Van Praag HM, Lader MH, Rafaelsen OJ, Sachar EJ, editors. Handbook of biological psychiatry, part IV: brain mechanisms and abnormal behavior-chemistry. New York Basel: Marcel Dekker; 1981. p. 225-42. 332. Angst J. Genetica de los trastornos afectivos y esquizo-afectivos. Compendio de clasificación, pronóstico y tratamiento. Trabajo presentado en la VIIIa Reunión Anual de la Sociedad Española de Psiquiatría Biológica Pamplona 1981; 1981: Hoechst Iberica; 1981. 333. Angst J. Konzepte und Kriterien der Schizophreniediagnose in der gegenwärtigen englischsprachigen Psychiatrie. (Diskussionsbeitrag zu Koehler, K.. In: Huber G, editor. Schizophrenie - Stand und Entwicklungstendenzen der Forschung 4 "Weissenauer" Schizophrenie-Symposion Bonn-Bad Godesberg 1980; 1981: Schattauer; 1981. p. 94-5. 334. Angst J. Clinical indications for a prophylactic treatment of depression. In: Mendlewicz J, Coppen A, van Praag HM, editors. Depressive illness - biological and psychopharmacological issues Symposium on depressive illness Amsterdam 1980; 1981: S. Karger; 1981. p. 218-29. 335. Angst J. Clinical subgroups of affective disorders - results of a genetic study. In: Perris C, Struwe G, Jansson B, editors. Biological psychiatry 1981 Proceedings of the IIIrd World congress of biological psychiatry Stockholm, Sweden, 1981; 1981: Elsevier; 1981. p. 148-56. 336. Angst J. Organisation-Klinikstruktur. (Diskussionsbeitrag). Rolle und Probleme der Forschung in der klinischen Medizin Symposium 1980; 1981: Kamillo-Eisner-Stiftung; 1981. p. 91. 337. Angst J. Interdisziplinäre Zusammenarbeit. (Diskussionsbeitrag). Rolle und Probleme der Forschung in der klinischen Medizin Symposium 1980; 1981: Kamillo-Eisner-Stiftung; 1981. p. 103, 10-11. 338. Angst J, Frey R. Genetische Aspekte und Verlauf der endogenen Depression. In: Pflug B, editor. Depressive Syndrome Klinik Forschung und Praxis. Stuttgart New York: Gustav Fischer Verlag; 1981. p. 11-9. 339. Angst J, Frey R, Felder W, Lohmeyer B. The course of monopolar depression and bipolar manic- depressive psychoses and schizoaffective psychoses (Switzerland). In: Mednick SA, Baert AE, Phillips Bachmann B, editors. Prospective longitudinal research An empirical basis for the primary prevention of psychosocial disorders. Oxford New York Toronto Melbourne: Oxford University Press; 1981. p. 260- 2.

22 340. Angst J, Grigo H, Lanz M. Classification of depression. In: Carlsson A, Gottfries C-G, Holmberg G, Modigh K, Svensson T, Ögren S-O, editors. Recent advances in the treatment of depression Proceedings of an international symposium Corfu, Greece, 1980; 1981: Acta Psychiatr Scand; 1981. p. 23-8. 341. Angst J, Grigo H, Lanz M. A genetic validation of diagnostic concepts for schizoaffective psychoses. In: Perris C, Struwe G, Jansson B, editors. Biological psychiatry 1981 Proceedings of the IIIrd world congress of biological psychiatry Stockholm, Sweden 1981; 1981: Elsevier; 1981. p. 486-95. 342. Angst J, Scharfetter C. Studies in functional psychoses (Switzerland). In: Mednick SA, Baert AE, Phillips Bachmann B, editors. Prospective longitudinal research An empirical basis for the primary prevention of psychosocial disorders. Oxford New York Toronto Melbourne: Oxford University Press; 1981. p. 259-60. 343. Angst J, Scharfetter C, Stassen HH. Syndromwechsel und Remission schizophrener Psychosen. In: Huber G, editor. Schizophrenie - Stand und Entwicklungstendenzen der Forschung 4 "Weissenauer" Schizophrenie-Symposion Bonn - Bad Godesberg 1980; 1981: Schattauer; 1981. p. 117-33. 344. Binder J, Angst J. Soziale Konsequenzen psychischer Störungen in der Bevölkerung. Eine Feldstudie an jungen Erwachsenen. Arch Psychiat Nervenkr. 1981;229:355-70. 345. Binder J, Angst J. A prospective epidemiological study of depressive, psychosomatic and neurotic disturbances (Switzerland). In: Mednick SA, Baert AE, Phillips Bachmann B, editors. Prospective longitudinal research An empirical basis for the primary prevention of psychosocial disorders. Oxford New York Toronto Melbourne: Oxford University Press; 1981. p. 157-60. 346. Binder J, Dobler-Mikola A, Angst J. An epidemiological study of minor psychiatric disturbances. A field study among 20-year-old females and males in Zurich. Soc Psychiatry. 1981;16:31-41. 347. Dobler-Mikola A, Gmuer M, Angst J. Erfolgsdeterminanten bei der Behandlung von Rauchern durch den Handaufleger Hermano. Arch Psychiat Nervenkr. 1981;230:31-40. 348. Sieber M, Angst J. Drogen-, Alkohol- und Tabakkonsum. Ein Beitrag zur Epidemiologie und Ätiologie bei jungen Erwachsenen. Bern Stuttgart Wien: Verlag Hans Huber; 1981. 349. Sieber M, Angst J. A prospective follow-up study on the epidemiology of drug, tobacco, and alcohol consumption (Switzerland). In: Mednick SA, Baert AE, Phillips Bachmann B, editors. Prospective longitudinal research An empirical basis for the primary prevention of psychosocial disorders. Oxford New York Toronto Melbourne: Oxford University Press; 1981. p. 171-2. 350. Angst J. The classification of affective disorders from a genetic point of view.Paper read at the Maudsley Bequest Lecture, Royal College of Psychiatrists, London (1982) (Unpublished Manuscript). 1982. 351. Angst J. Behandlung von Schlafstörungen. (Diskussionsbeitrag). In: Hippius H, editor. Benzodiazepine in der Behandlung von Schlafstörungen Internationales Symposium Frankfurt 1981; 1982: Upjohn; 1982. p. 131. 352. Binder J, Dobler-Mikola A, Angst J. A prospective epidemiological study of psychosomatic and psychiatric syndromes in young adults. In: Krakowski AJ, Kimball CP, editors. Psychosomatic medicine in a changing world: theoretical, clinical and transcultural aspects Proceedings of the 6th world congress of the International College of Psychosomatic Medicine Montreal 1981; 1982: Karger; 1982. p. 128-40.

23 353. Binder J, Dobler-Mikola A, Angst J. Soziokulturelle Aspekte der Depression. Ergebnisse einer epidemiologischen Studie an jungen Erwachsenen im Kanton Zürich. Schweiz Arch Neurol Neurochir Psychiat. 1982;130:179-94. 354. Isele R, Angst J. Life-Events und prämorbide soziale Beziehungen bei ersterkrankten Schizophrenen. In: Huber G, editor. Endogene Psychosen: Diagnostik, Basissymptome und biologische Parameter 5 "Weissenauer" Schizophrenie-Symposion Bonn 1982; 1982: Schattauer; 1982. p. 43-63. 355. Rzewuska M, Angst J. Prognosis of periodic bipolar manic depressive and schizo-affective psychoses. A comparison of two studies. Arch Psychiat Nervenkr. 1982;231:471-86. 356. Rzewuska M, Angst J. Aspects of the course of bipolar manic-depressive, schizo-affective, and paranoid schizophrenic psychoses. Arch Psychiat Nervenkr. 1982;231:487-501. 357. Angst J. Aktuelle Aspekte der Depressionsbehandlung. (Diskussionsbemerkungen). In: Pöldinger W, editor. Aktuelle Aspekte der Depressionsbehandlung Grundlagen - Diagnostik - Therapie Ergebnisse des Int Vivalan-Symposiums Rigi 1982; 1983: Huber; 1983. p. 154, 8-9. 358. Angst J. Genetic aspects of manic-depressive and schizoaffective psychoses. (Abstract PL 25). VII World Congress of Psychiatry Vienna 1983; 1983; 1983. p. 15. 359. Angst J. Geleitwort. In: Woggon B, editor. Prognose der Psychopharmakotherapie Klinische Untersuchung zur Voraussagbarkeit des Kurzzeittherapieerfolges von Neuroleptika und Antidepressiva. Stuttgart: Ferdinand Enke Verlag; 1983. p. VII-VIII. 360. Angst J. Patient selection for a long-term lithium treatment in clinical practice. In: Dufour H, Pringuey D, Milech T, editors. La prédiction de la reponse au lithium - The prediction of lithium response Colloque de l'évolution psychiatrique Marseille 1980; 1983; 1983. p. 35-41. 361. Angst J. Psychopharmaka für den Internisten. Verhandlungen der Deutschen Gesellschaft für innere Medizin. München: J.F. Bergmann Verlag; 1983. p. 143-9. 362. Angst J. Introduction. In: Angst J, editor. The origins of depression: current concepts and approaches Report of the Dahlem-Workshop Berlin 1982; 1983: Springer; 1983. p. 1-3. 363. Angst J. Grusswort. In: Gross G, Schüttler R, editors. Empirische Forschung in der Psychiatrie Symposion zum 60 Geburtstag von Prof Dr med G Huber Bonn 1981; 1983: Schattauer; 1983. p. 9. 364. Angst J, Dobler-Mikola A. Diagnostik und Epidemiologie depressiver Syndrome. Ther Umsch. 1983;40:750-5. 365. Angst J, Dobler-Mikola A. Epidemiologische Untersuchung über Kopfschmerzen bei 20jährigen. In: Barolin GS, Kugler J, Soyka D, editors. Kopfschmerz 1983 Nomenklatur und Klassifizierung des Kopfschmerzes in bezug auf Praxis und Klinik Kopfschmerz-Bezüge zu Arbeit und Wetter Die Sanol- Migräne-Studie: Neue Ergebnisse in den Beziehungen zu Depressivität, Neurotizismus, Arbeitsverhalten; transkulturelle Vergleiche. Stuttgart: Ferdinand Enke Verlag; 1983. p. 120-30. 366. Angst J, Dobler-Mikola A, Binder J. Zur Diagnostik der Depression - epidemiologische und genetische Aspekte. (+ Diskussionsbemerkungen). In: Pöldinger W, editor. Aktuelle Aspekte der Depressionsbehandlung Grundlagen - Diagnostik - Therapie Ergebnisse des Int Vivalan- Symposiums Rigi 1982; 1983: Huber; 1983. p. 68-81, 91-3. 367. Angst J, Dobler-Mikola A, Binder J. Zur Diagnostik der Depression - epidemiologische und genetische Aspekte. In: Pöldinger W, editor. Aktuelle Aspekte der Depressionsbehandlung Grundlagen -

24 Diagnostik - Therapie Ergebnisse des Int Vivalan- Symposiums Rigi 1982. Bern Stuttgart Wien: Hans Huber; 1983. p. 68-81, 91-3. 368. Angst J, Rzewuska M, Stassen HH. Methodologische Probleme in der Verlaufsforschung endogener Psychosen. In: Gross G, Schüttler R, editors. Empirische Forschung in der Psychiatrie Symposion zum 60 Geburtstag von Prof Dr med G Huber, Bonn 1981; 1983: Schattauer; 1983. p. 37-53. 369. Angst J, Scharfetter C, Stassen HH. Classification of schizo-affective patients by multidimensional scaling and cluster-analysis. Psychiatria Clin. 1983;16:254-64. 370. Angst J, Scharfetter C, Stassen HH. Clinical homogeneity for biological studies. In: Perris C, Kemali D, Koukkou M, editors. Neurophysiological correlates of normal cognition and psychopathology 4th Int Symposium on Clinical Neurophysiological Aspects of Psychopathological Conditions Feusisberg 1982; 1983: S. Karger; 1983. p. 26-35. 371. Angst J, Woggon B. Validity of the AMP-System for its use in clinical psychopharmacology. In: Bobon D, Baumann U, Angst J, Helmchen H, Hippius H, editors. The AMDP-System in Pharmacopsychiatry. Basel München Paris London New York Tokyo Sydney: S. Karger; 1983. p. 174-84. 372. Binder J, Dobler-Mikola A, Angst J, Bendel H. Soziokulturelle Aspekte depressiver Verstimmungen. UNI Zürich. 1983;1/2:14-6. 373. Bobon D, Baumann U, Angst J, Helmchen H, Hippius H, editors. The AMDP-System in pharmacopsychiatry. Basel München Paris London New York Tokyo Sydney: S. Karger; 1983. 374. Curtius HC, Niederwieser A, Levine RA, Lovenberg W, Woggon B, Angst J. Successful treatment of depression with tetrahydrobiopterin. Lancet. 1983;321:657-8. 375. Deniker P, Schou M, Angst J, Grof P. Discussion generale - General Discussion. In: Dufour H, Pringuey D, Milech T, editors. La prediction de la reponse au lithium - The prediction of lithium response Colloque de l'evolution psychiatrique Marseille 1980; 1983; 1983. p. 231-43. 376. Ernst C, Angst J. Birth order. Its influence on personality. Berlin Heidelberg New York: Springer; 1983. 377. Katschnig H, Angst J, Clayton PJ, Gershon ES, Hautzinger M, Helmchen H, et al. Risk factors. (Group Report). In: Angst J, editor. The origins of depression: current concepts and approaches Report of the Dahlem Workshop Berlin 1982; 1983: Springer; 1983. p. 385-403. 378. Angst J. Introduction. Fluperlapine (NB 106-689) A new nonclassical neuroleptic Free symposium at the VIIth World Congress of Psychiatry Vienna 1983; 1984: Arzneimittelforschung; 1984. p. 109. 379. Angst J. A prospective study on the course of affective disorders. (Abstract). Mood disorders Pharmacologic prevention of recurrences Consensus development conference, National Institute of Mental Health Bethesda 1984; 1984; 1984. p. 23-6. 380. Angst J. Psychische und psychosomatische Störungen bei jungen Erwachsenen. Jahresbericht Schweizerischer Nationalfonds. 1984;32:211-6. 381. Angst J. Features and diagnosis of anxiety. (Abstract). Symposium Vienna 1984; 1984; 1984. p. 5. 382. Angst J. Seite der Klinikleitung. Bli-Info. 1984;55:2. 383. Angst J. Abschied von Frau Frey. Bli-Info. 1984;55:11.

25 384. Angst J. Pharmacology and EEG. (Discussion). Fluperlapine (NB 106-689) A new nonclassical neuroleptic Free symposium at the VIIth World Congress of Psychiatry Vienna 1983; 1984: Anrzneimittelforschung; 1984. p. 121. 385. Angst J. Fluperlapine (NB 106-689). A new nonclassical neuroleptic. Free symposium at the VIIth World Congress of Psychiatry Vienna 1983; 1984: Arzneimittelforschung; 1984. p. 135-6. 386. Angst J, Dobler-Mikola A. Do the diagnostic criteria determine the sex ratio in depression? J Affect Disord. 1984;7:189-98. 387. Angst J, Dobler-Mikola A. The definition of depression. J Psychiatr Res. 1984;18:401-6. 388. Angst J, Dobler-Mikola A. The Zurich Study. II. The continuum from normal to pathological depressive mood swings. Eur Arch Psychiatr Neurol Sci. 1984;234:21-9. 389. Angst J, Dobler-Mikola A. The Zurich Study. III. Diagnosis of depression. Eur Arch Psychiatr Neurol Sci. 1984;234:30-7. 390. Angst J, Dobler-Mikola A, Binder J. The Zurich Study - A prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. I. Problem, methodology. Eur Arch Psychiatr Neurol Sci. 1984;234:13-20. 391. Angst J, Dobler-Mikola A, Hagnell O. How many, and which patients with affective disorders need long- term maintenance therapy? 14th CINP Congress Satellite Meeting on "Chronic Treatments in Neuro- Psychiatry" Monte Catini, Italy, June 24-26, 1984; 1984; 1984. 392. Ernst C, Angst J. Das gesunde Einzelkind. Eine Zürcher Untersuchung über die Geschwisterreihe. Frankfurter Allgemeine Zeitung. 1984 13.08.1984;Sect. 17. 393. Ernst C, Angst J. Geschwisterzahl und Persönlichkeitsentwicklung. Bewertungen der Familiengrösse ohne psychologische Basis. Neue Zürcher Zeitung. 1984 17.10.1984;Sect. 35. 394. Schoepf J, Angst J, Beckmann H, Gaillard JM, Gastpar M, Kuepfer A, et al. Dépressions résistant au traitement: nouvelles approches de recherche et leurs implications thérapeutiques. Rapport de la 3e réunion de la Société Suisse de psychiatrie biologique du 20 janvier 1984 à la Clinique psychiatrique universitaire de Prilly-Lausanne. Schweiz Med Wochenschr. 1984:1984. 395. Woggon B, Angst J, Bartels M, Heinrich K, Hippius H, Koukkou M, et al. Antipsychotic efficacy of fluperlapine. An open multicenter trial. Neuropsychobiology. 1984;11:116-20. 396. Woggon B, Angst J, Curtius HC, Niederwieser A. Unsuccessful treatment of depression with tetrahydrobiopterin. Lancet. 1984;324:1463. 397. Angst J. Genetics of affective psychoses - Some methodological considerations. In: Pichot P, Berner P, Wolf R, Thau K, editors. Psychiatry - The state of the art Vol 2: Biological psychiatry, higher nervous activity Proceedings of the VIIth World Congress of Psychiatry Vienna 1983; 1985: Plenum Press; 1985. p. 67-76. 398. Angst J. Angstsyndrome: Verbessert neue Klassifikation die Therapie? Med Tribune. 1985;12:38-9. 399. Angst J. Switch from depression to mania - A record study over decades between 1920 and 1982. Psychopathology. 1985;18:140-54. 400. Angst J. Features and diagnosis of anxiety. In: Lader MH, Davies HC, editors. Drug treatment of neurotic disorders: Focus on alprazolam Proceedings of an International Symposium Vienna 1984; 1985: Churchill Livingstone; 1985. p. 70-5.

26 401. Angst J. Diskussionsbemerkungen. In: Huber G, editor. Basisstadien endogener Psychosen und das Borderline-Problem 6 "Weissenauer" Schizophrenie-Symposion Bonn 1984; 1985: Schattauer; 1985. p. 22-3, 160-1, 90, 206. 402. Angst J, Baenninger R, Nuesperli M, Scharfetter C, Stassen HH. Syndromale Gruppierungen endogener Psychosen in genetischer Sicht. In: Pflug B, Foerster K, Straube E, editors. Perspektiven der Schizophrenie-Forschung. Stuttgart New York: Gustav Fischer Verlag; 1985. p. 25-38. 403. Angst J, Dobler-Mikola A. The Zurich Study - A prospective epidemiological study of depressive, neurotic, and psychosomatic syndromes. IV. Recurrent and nonrecurrent brief depression. Eur Arch Psychiatry Neurol Sci. 1985;234:408-16. 404. Angst J, Dobler-Mikola A. The Zurich Study - V. Anxiety and phobia in young adults. Eur Arch Psychiatr Neurol Sci. 1985;235:171-8. 405. Angst J, Dobler-Mikola A. The Zurich Study - VI. A continuum from depression to anxiety disorders? Eur Arch Psychiatr Neurol Sci. 1985;235:179-86. 406. Angst J, Dobler-Mikola A, Hagnell O. How many, and which patients with affective disorders need long- term maintenance therapy? In: Kemali D, Racagni G, editors. Chronic treatments in neuropsychiatry. New York: Raven Press; 1985. p. 169-72. 407. Angst J, Isele R, Scharfetter C, Scheidegger P. Zur prämorbiden Persönlichkeit Schizophrener. Schweiz Arch Neurol Neurochir Psychiat. 1985;136:45-53. 408. Angst J, Scharfetter C. Familial aspects of . (Abstract S104). Affective disorders The World Psychiatric Association Regional Symposium Athens 1985; 1985; Athens; 1985. p. 39. 409. Dobler-Mikola A, Angst J. Depressive syndromes in field studies: problems of case definition. (Abstract S114). Affective disorders The World Psychiatric Association Regional Symposium Athens 1985; 1985; 1985. p. 41. 410. Isele R, Angst J. Social disability in schizophrenia: the controlled prospective Burghölzli Study. I. Case- finding, research design, and characteristics of samples. Europ Arch Psychiat Neurol Sci. 1985;234:341-7. 411. Isele R, Merz J, Malzacher M, Angst J. Social disability in schizophrenia: the controlled prospective Burghölzli Study. II. Premobid living situation and social adjustment - comparison with a normal control sample. Europ Arch Psychiat Neurol Sci; 1985; 1985. p. 348-56. 412. Koukkou M, Woggon B, Angst J. A psychophysiological information processing approach to psychopathology: Longitudinal studies of EEG reactivity. (Abstract). IVth World Congress of Biological Psychiatry Philadelphia 1985; 1985; 1985. p. 432. 413. Koukkou M, Woggon B, Angst J. A psychophysiological information processing approach to psychopathology: Longitudinal studies of EEG reactivity. (Abstract). Electroencephalogr Clin Neurophysiol. 1985;61:S151. 414. Sieber M, Staehli R, Angst J. Entwicklung des Alkohol-, Tabak- und Medikamentenkonsums bei 19jährigen Männern. Ein Querschnittsvergleich 1971 - 1978 - 1982. Schweiz Med Wochenschr. 1985;115:865-70.

27 415. Winokur G, Angst J. Independent familial transmission of psychotic symptomatology in the affective disorders. (Abstract). IVth World Congress of Biological Psychiatry Philadelphia 1985; 1985; 1985. p. 306. 416. Winokur G, Scharfetter C, Angst J. A family study of psychotic symptomatology in schizophrenia, schizoaffective disorder, unipolar depression, and bipolar disorder. Europ Arch Psychiat Neurol Sci. 1985:295-8. 417. Winokur G, Scharfetter C, Angst J. The diagnostic value in assessing mood congruence in and and their relationship to the affective state. Europ Arch Psychiat Neurol Sci. 1985;234:299-302. 418. Winokur G, Scharfetter C, Angst J. Stability of psychotic symptomatology (delusions, hallucinations), affective syndromes, and schizophrenic symptoms (thought disorder, incongruent affect) over episodes in remitting psychoses. Europ Arch Psychiat Neurol Sci. 1985;234:303-7. 419. Woggon B, Angst J. Behandlung depressiver Syndrome mit Antidepressiva. Med Montasschr Pharm. 1985;8:130-6. 420. Woggon B, Angst J, Bleuler M, Dittmer TLJ, Heinrich K, Hippius H, et al. Wirkungsvergleich von Lofepramin und Imipramin - Ergebnisse einer multizentrischen Doppelblindstudie. In: Hippius H, Rickels K, editors. Lofepramin Dokumentation der Entwicklung eines Antidepressivums. München Wien Baltimore: Urban & Schwarzenberg; 1985. p. 179-90. 421. Woggon B, Angst J, Curtius HC, Niederwieser A, Levine RA, Borbely AA, et al. Tetrahydrobiopterin (BH4) in endogenous depression. Pharmacopsychiat. 1985;18:98-9. 422. Angst J. Verlauf und Ausgang affektiver und schizo-affektiver Erkrankungen. In: Huber G, editor. Zyklothymie - offene Fragen 2 Hans-Jörg Weitbrecht-Symposion, 22Juni 1985, Bonn. Köln: Tropon Arzneimittel; 1986. p. 75-87. 423. Angst J. Die Psychosomatik erklärt vieles nur scheinbar. (Interview). Aerztez. 1986;195:19. 424. Angst J. Epidemiologie der Spätdepression. In: Kielholz P, Adams C, editors. Der alte Mensch als Patient Symposium St Moritz 1985; 1986: Deutscher Aerzteverlag; 1986. p. 83-100. 425. Angst J. The course of schizoaffective disorders. In: Marneros A, Tsuang MT, editors. Schizoaffective psychoses. Berlin Heidelberg New York: Springer; 1986. p. 63-93. 426. Angst J. The course of major depression, atypical bipolar disorder, and bipolar disorder. In: Hippius H, Klerman GL, Matussek N, editors. New results in depression research. Berlin Heidelberg New York London Paris Tokyo: Springer; 1986. p. 26-35. 427. Angst J. Ausblick, Kritik, Zusammenfassung. Allgemeine Aspekte zur Behandlung mit Antidepressiva. In: Schmid-Burgk W, Koella W, editors. Neue Aspekte der Therapie mit Antidepressiva Grundlagen, experimentelle Befunde und klinische Erfahrungen mit Diclofensin; 1986: Gustav Fischer Verlag; 1986. p. 357-64. 428. Angst J. Verlauf und Ausgang affektiver und schizo-affektiver Erkrankungen. In: Huber G, editor. Zyklothymie - offene Fragen 2 Hans Jörg Weitbrecht-Symposion Bonn 1985; 1986: Das Aerztliche Gespräch; 1986. p. 75-87.

28 429. Angst J. Angst und Depression: Symptomatik - Klassifikation - Epidemiologie. Angstsyndrome und Depression - aktuelle therapeutische Möglichkeiten Symposium Schaffhausen 1985; 1986: Ciby-Geigy; 1986. p. 13-25. 430. Angst J. Doppelblindversuch. In: Müller C, editor. Lexikon der Psychiatrie Gesammelte Abhandlungen der gebräuchlichsten psychiatrischen Begriffe. Berlin Heidelberg New York London Paris Tokyo: Springer-Verlag; 1986. p. 200-1. 431. Angst J. The course of affective disorders. (Abstract 007). In: Kielholz P, Pöldinger W, editors. Latest findings on the aetiology and therapy of depression An International Commemorative Symposium organized in collaboration with the WHO and WPA Basle 1986; 1986: Psychopathology; 1986. p. 10. 432. Angst J. Premorbid personality, onset, and course of unipolar and bipolar disorders. (Abstract). American College of Neuropsychopharmacology 25th Annual Meeting Washington DC 1986; 1986; 1986. p. 108. 433. Angst J. The course of affective disorders. In: Kielholz P, Pöldinger W, editors. Latest findings on the aetiology and therapy of depression An International Commemorative Symposium organized in collaboration with the WHO and WPA Basle 1986; 1986: Psychopathology; 1986. p. 47-52. 434. Angst J. Die somatische Therapie der Schizophrenie. (Japanese edition). Tokyo: Seiwa Shoten Publishers; 1986. 435. Angst J. Der ältere Rheumapatient und sein Arzt. (Diskussionsbeitrag zu A. Weintraub). In: Kielholz P, Adams C, editors. Der alte Mensch als Patient Symposium St Moritz 1985; 1986: Deutscher Aerzteverlag; 1986. p. 54-5. 436. Angst J. Dilemmata und Schwierigkeiten der Diagnostik bei älteren depressiven Patienten. (Diskussionsbeitrag zu H. Helmchen). In: Kielholz P, Adams C, editors. Der alte Mensch als Patient Symposium St Moritz 1985; 1986: Deutscher Aerzteverlag; 1986. p. 106-8. 437. Angst J. Suizidalität im höheren Lebensalter. (Diskussionsbeitrag zu K. Achté). In: Kielholz P, Adams C, editors. Der alte Mensch als Patient Symposium St Moritz 1985; 1986: Deutscher Aerzteverlag; 1986. p. 124-6. 438. Angst J. The epidemiology of late-onset depression. In: Kielholz P, Adams C, editors. The elderly person as a patient Symposium St Moritz 1985; 1986: Deutscher Aerzteverlag; 1986. p. 83-99. 439. Angst J. The elderly rheumatic patient and his physician. (Discussion). In: Kielholz P, Adams C, editors. The elderly person as a patient Symposium St Moritz 1985; 1986: Deutscher Aerzteverlag; 1986. p. 53- 4. 440. Angst J. Diagnostic dilemmas and difficulties in elderly depressed patients. (Discussion). In: Kielholz P, Adams C, editors. The elderly person as a patient Symposium St Moritz 1985; 1986: Deutscher Aerzteverlag; 1986. p. 105-7. 441. Angst J. Suicidal tendencies in the elderly. (Discussion). In: Kielholz P, Adams C, editors. The elderly person as a patient Symposium St Moritz 1985; 1986: Deutscher Aerzteverlag; 1986. p. 123-5. 442. Angst J. Präklinische Untersuchungen mit Diclofensin. (Diskussionsbemerkungen). In: Schmid-Burgk W, Koella W, editors. Neue Aspekte der Therapie mit Antidepressiva Grundlagen, experimentelle Befunde und klinische Erfahrungen mit Diclofensin; 1986: Gustav Fischer Verlag; 1986. p. 127.

29 443. Angst J. Zusätzliche Indikationen. (Diskussionsbemerkungen). In: Schmid-Burgk W, Koella W, editors. Neue Aspekte der Therapie mit Antidepressiva Grundlagen, experimentelle Befunde und klinische Erfahrungen mit Diclofensin; 1986: Gustav Fischer Verlag; 1986. p. 331-3. 444. Angst J. Sicherheitsaspekte. (Diskussionsbemerkungen). In: Schmid-Burgk W, Koella W, editors. Neue Aspekte der Therapie mit Antidepressiva Grundlagen, experimentelle Befunde und klinische Erfahrungen mit Diclofensin; 1986: Gustav Fischer Verlag; 1986. p. 353-6. 445. Angst J. Schlussdiskussion. In: Schmid-Burgk W, Koella W, editors. Neue Aspekte der Therapie mit Antidepressiva Grundlagen, experimentelle Befunde und klinische Erfahrungen mit Diclofensin; 1986: Gustav Fischer Verlag; 1986. p. 365-8. 446. Angst J. Zum Problem des Suizids unter besonderer Berücksichtigung intraindividueller Fluktuationen im Krankheitsverlauf endogener Psychosen. (Diskussionsbemerkungen). In: Huber G, editor. Zyklothymie - offene Fragen 2 Hans Jörg Weitbrecht-Symposion Bonn 1985; 1986: Das Aerztliche Gespräch; 1986. p. 53-7. 447. Angst J. Fortschritte in der Psychopharmakotherapie der Zyklothymien? (Diskussionsbemerkungen). In: Huber G, editor. Zyklothymie - offene Fragen 2 Hans Jörg Weitbrecht-Symposion Bonn 1985; 1986: Das Aerztliche Gespräch; 1986. p. 70-3. 448. Angst J. Basissymptome und Basisstadien bei Zyklothymie. (Diskussionsbemerkungen). In: Huber G, editor. Zyklothymie - offene Fragen 2 Hans Jörg Weitbrecht-Symposion Bonn 1985; 1986: Das Aerztliche Gespräch; 1986. p. 102-6. 449. Angst J. Kybernetik. In: Müller C, editor. Lexikon der Psychiatrie Gesammelte Abhandlungen der gebräuchlichsten psychiatrischen Begriffe. Berlin Heidelberg New York London Paris Tokyo: Springer- Verlag; 1986. p. 418-21. 450. Angst J. Manie. In: Müller C, editor. Lexikon der Psychiatrie Gesammelte Abhandlungen der gebräuchlichsten psychiatrischen Begriffe. Berlin Heidelberg New York London Paris Tokyo: Springer- Verlag; 1986. p. 436-8. 451. Angst J. Premorbid personality of depressive, bipolar and schizophrenic patients. With special reference to suicidal issues. The Royal College of Psychiatrists Annual Meeting 8th - 10th July 1986 Southampton; 1986; 1986. 452. Angst J, Clayton PJ. Extrapunitive aggression in a representative sample of subjects who died by suicide or accident. (Abstract). ISRA International Society for Research on Aggression Seventh Biennial World Meeting Chicago 1986; 1986; 1986. p. 21. 453. Angst J, Clayton PJ. Premorbid personality of depressive, bipolar, and schizophrenic patients with special reference to suicidal issues. Comp Psychiatry. 1986;27:511-32. 454. Angst J, Clayton PJ. Aspekte der präsuizidalen Persönlichkeit. In: Amelang M, editor. Bericht über den 35 Kongress der Deutschen Gesellschaft für Psychologie Heidelberg 1986; 1986: Verlag für Psychologie; 1986. p. 466. 455. Angst J, Dobler-Mikola A. Indikationsstellung bei ängstlichen und depressiven Syndromen. In: Hippius H, Engel RR, Laakmann G, editors. Benzodiazepine Rückblick und Ausblick. Berlin Heidelberg New York Tokyo: Springer-Verlag; 1986. p. 71-83.

30 456. Angst J, Dobler-Mikola A. Assoziation von Angst und Depression auf syndromaler und diagnostischer Ebene. In: Helmchen H, Linden M, editors. Die Differenzierung von Angst und Depression Tropon Symposium 1 Köln 1985; 1986: Springer-Verlag; 1986. p. 75-82. 457. Dobler-Mikola A, Angst J. Suizidgedanken bei jungen Erwachsenen: Klinische und soziale Aspekte. In: Specht F, Schmidtke A, editors. Selbstmordhandlungen bei Kindern und Jugendlichen Proceedings der 3 Jahrestagung der Arbeitsgemeinschaft zur Erforschung suizidalen Verhaltens; 1986: Roderer-Verlag; 1986. p. 83-96. 458. Koukkou M, Woggon B, Angst J. Longitudinal studies of EEG reactivity: a psychophysiological information processing approach to psychopathology. In: Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM, editors. Biological Psychiatry 1985 Proceedings of the IVth World Congress of Biological Psychiatry Philadelphia 1985; 1986: Elsevier; 1986. p. 427-9. 459. Oliva K, Sieber M, Staehli R, Angst J. Konsum von Haschisch, Tabak und Alkohol sowie Einstellungen zu Jugendunruhen als Korrelat zur Status- Inkonsistenz. Kölner Z Soziol Sozialpsychol. 1986;1:110-22. 460. Winokur G, Angst J. Independent familial transmission of psychotic symptomatology in the affective disorders. In: Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM, editors. Biological Psychiatry 1985 Proceedings of the IVth World Congress of Biological Psychiatry Philadelphia 1985; 1986: Elsevier; 1986. p. 49-51. 461. Winokur G, Dennert J, Angst J. Independent familial transmission of psychotic symptomatology in the affective disorders or does delusional depression breed true? Psychiatria Fennica. 1986;14:9-16. 462. Woggon B, Angst J. Medikamentöse Behandlung chronischer Schizophrenien. (Deutsch-Japanisch). Jpn J Neuropsychopharmacol. 1986;8:775-830. 463. Angst J. Switch from depression to mania, or from mania to depression. J Psychopharmacol. 1987;1:13-9. 464. Angst J. "Eine Jungfrau namens Jürg Kaufmann". Bli-Info. 1987;66:10-1. 465. Angst J. Neue Aspekte zur Epidemiologie der Depression. Int Symposium "Lofepramine in the treatment of depressive disorders: Review of the past 10 years and future prospects" Lugano; 1987: Brain Tribune; 1987. 466. Angst J. Begriff der affektiven Erkrankungen. In: Kisker KP, Lauter H, Meyer JE, Müller C, Strömgren E, editors. Affektive Psychosen. 5 ed. Berlin Heidelberg New York London Paris Tokyo: Springer- Verlag; 1987. p. 1-50. 467. Angst J. Epidemiologie der affektiven Psychosen. In: Kisker KP, Lauter H, Meyer JE, Müller C, Strömgren E, editors. Affektive Psychosen. 5 ed. Berlin Heidelberg New York Paris Tokyo: Springer- Verlag; 1987. p. 51-66. 468. Angst J. Verlauf der affektiven Psychosen. In: Kisker KP, Lauter H, Meyer JE, Müller C, Strömgren E, editors. Affektive Psychosen. 5 ed. Berlin Heidelberg New York Paris Tokyo: Springer-Verlag; 1987. p. 115-33. 469. Angst J. Switch from depression to mania, or from mania to depression: role of psychotropic drugs. Psychopharmacol Bull. 1987;23:66-7. 470. Angst J. Die aktuellen Schwerpunkte der psychiatrischen Forschung in der Schweiz. Psychiatr Psychobiol. 1987;2:91-9.

31 471. Angst J. Epidemiologie der Langzeitbehandlungen mit Psychopharmaka in der Praxis. Probleme und Chancen der Langzeittherapie mit Psychopharmaka 3 Zürcher Psychopharmakotherapie Forum ZPF Zürich 1987; 1987; 1987. p. 2-18. 472. Angst J. Évolution spontanée de la dépression. (Abstract). Congrès "Prévention et traitement de la dépression" Roumanie 1987; 1987; 1987. 473. Angst J. Évolution spontanée de la dépression. Congrès "Prévention et traitement de la dépression" Roumanie 1987; 1987: Epsilon, Magazin d'information psychiatriques; 1987. p. 21-3. 474. Angst J. Langzeitbehandlung mit Psychopharmaka. So behandeln Zürcher Ärzte. Med Tribune. 1987;25:19. 475. Angst J. Zürich und die Psychiatrie. Schlaf - Traum - Depression Trimipramin Report 2; 1987: Panscientia Verlag; 1987. p. 1. 476. Angst J. Epidemiological and clinical research on affective disorders. Past, present, and future. (abstract). Reunion Internacional Conmemorativa "La psiquiatria al filo del siglo XXI", XX Aniversario de la fundacion de la Asociacion Psiquiatrica Mexicana, AC Taxco, Mexico; 1987; 1987. p. 27. 477. Angst J. Investigacion epidemiologica y clinica de los trastornos affectivos: pasado, presente y futuro. Presentacion hecha en la reunion internacional sobre "La psiquiatria en los albores del siglo XXI", en occasion del XX Aniversario de la Asociacion Psiquiatrica Mexicana Taxco, Mexico 1987; 1987: Ciba- Geigy; 1987. 478. Angst J. Schizophrenie-Konzeptionen - Schizophrenie-Diagnostik. (Diskussionsbemerkungen). In: Huber G, editor. Fortschritte in der Psychosenforschung? 7 Weissenauer Schizophrenie-Symposium Bonn 1986; 1987: Schattauer; 1987. p. 37-43. 479. Angst J. Schizophrene und affektive Symptome - Prädikatoren für den Ausgang? (Diskussionsbemerkungen). In: Huber G, editor. Fortschritte in der Psychosenforschung? 7 Weissenauer Schizophrenie-Symposium Bonn 1986; 1987: Schattauer; 1987. p. 85-8. 480. Angst J. Fortschritte in der Psychosenforschung? (Diskussionsbemerkungen). In: Huber G, editor. Fortschritte in der Psychosenforschung? 7 Weissenauer Schizophrenie-Symposium Bonn 1986; 1987: Schattauer; 1987. p. 123-6. 481. Angst J, Gastpar M. Depression - Schlaf - Traum. Neue Ergebnisse aus Forschung und Praxis. 2 Internationales Trimipramin-Symposium, Zürich; 1987: Panscientia; 1987. p. 7-8. 482. Angst J, Stassen HH. Verlaufsaspekte affektiver Psychosen: Suizide, Rückfallrisiko im Alter. In: Huber G, editor. Fortschritte in der Psychosenforschung? 7 Weissenauer Schizophrenie-Symposium Bonn 1986; 1987: Schattauer; 1987. p. 145-64. 483. Dobler-Mikola A, Angst J. Life events and depressive syndromes: results of a prospective panel study over 4 years. In: Angermeyer MC, editor. From social class to social stress. Berlin Heidelberg New York: Springer; 1987. p. 153-65. 484. Stassen HH, Scharfetter C, Angst J. Morbid risks of subgroups of affective disorders: some methodological and empirical results. J Psychiatr Res. 1987;21:347-55. 485. Angst J. European long-term follow-up studies of schizophrenia. Schizophr Bull. 1988;14:501-13.

32 486. Angst J. Risikofaktoren für den Verlauf affektiver Störungen. In: von Zerssen D, Möller HJ, editors. Affektive Störungen Diagnostische, epidemiologische, biologische und therapeutische Aspekte. Berlin Heidelberg New York London Paris Tokyo: Springer-Verlag; 1988. p. 99-110. 487. Angst J. Prämorbide Persönlichkeit - Methodische Probleme. In: Janzarik W, editor. Persönlichkeit und Psychose. Stuttgart: Enke; 1988. p. 72-81. 488. Angst J. Clinical course of affective disorders. In: Helgason T, Daly RJ, editors. Depressive illness: prediction of course and outcome. Berlin Heidelberg New York London Paris Tokyo: Springer-Verlag; 1988. p. 1-44. 489. Angst J. Genetik affektiver Erkrankungen. Münch Med Wschr. 1988;130:161-4. 490. Angst J. Geschlechtsdifferenzen und psychiatrische Morbidität. Heidelberger Universitätshefte. 1988;40:119-24. 491. Angst J. Similarities and differences between unipolar and bipolar disorders: premorbid personality, course, and outcome. (Abstract). APA 141st Annual Meeting Montréal 1988; 1988: CME Syllabus; 1988. p. 40. 492. Angst J. Suicides among depressive and bipolar patients. (Abstract). APA 141st Annual Meeting Montréal 1988; 1988: CME Syllabus; 1988. p. 250. 493. Angst J. Recurrent brief depression. A new concept of mild depression. (Abstract FR 04.05). XVIth CINP Congress Munich 1988; 1988: Psychopharmacology; 1988. p. 123. 494. Angst J, Angst K, Graf-Nold A. Switch rates from depression to mania from 1900-1980. (Abstract WE 09.01). XVIth CINP Congress Munich; 1988: Psychopharmacology; 1988. p. 62. 495. Angst J, Dobler-Mikola A. Depressive Syndrome in einer Kohorte junger Erwachsener im Längsschnitt. In: Olbrich RK, editor. Prospektive Verlaufsforschung in der Psychiatrie. Berlin Heidelberg New York London Paris Tokyo: Springer; 1988. p. 67-81. 496. Angst J, Merikangas KR. Psychopathology and migraine. (Abstract). Annual Meeting of the American College of Neuropsychopharmacology Nashville 1988; 1988; 1988. 497. Angst J, Stassen HH, Woggon B. Effect of neuroleptics on positive and negative symptoms and the deficit state. (Abstract). Clozapine (Leponex/Clozaril) Scientific Update Meeting, Montreux 1988; 1988; Basel: Sandoz Pharmaceuticals; 1988. p. 19. 498. Angst J, Vollrath M, Koch R. Lofepramine in the treatment of depressive disorders. In: Angst J, Woggon B, editors. Review of the past 10 years and future prospects International Symposium organized by the Psychiatric University Hospital Zurich Lugano 1987; 1988: Vieweg-Verlag; 1988. p. 1- 14. 499. Angst J, Woggon B. Editor's introductory remarks. In: Angst J, Woggon B, editors. Review of the past 10 years and future prospects International Symposium organized by the Psychiatric University Hospital Zurich Lugano 1987; 1988: Vieweg-Verlag; 1988. p. III. 500. Stassen HH, Scharfetter C, Winokur G, Angst J. Familial syndrome patterns in schizophrenia, schizoaffective disorder, mania, and depression. Eur Arch Psychiatr Neurol Sci. 1988;237:115-23. 501. Angst J. Perspektiven des dritten Basler Psychiatriegesprächs. Outlook from the third psychiatry rounds in Basel. Schweiz Rundsch Med Prax. 1989;78:788-90.

33 502. Angst J. Genetik affektiver Erkrankungen. In: Helmchen H, Hippius H, editors. Psychiatrie für die Praxis: MMV Medizin Verlag München; 1989. p. 90-6. 503. Angst J. Der Verlauf schizoaffektiver Psychosen. In: Marneros A, editor. Schizoaffektive Psychosen. Berlin Heidelberg New York Tokyo: Springer; 1989. p. 47-54. 504. Angst J. Zum Rücktritt von Prof. Dr. med. Klaus Ernst. Neue Zürcher Zeitung. 1989 13.10.1989;Sect. 54. 505. Angst J. Entwicklung der Forschungsabteilung. Psychiatrische Universitätsklinik Zürich Zwanzig Jahre Forschungsabteilung 1969-1989; 1989. p. 5-9 (engl. 142-5). 506. Angst J. Zum Rücktritt von Prof. Dr. med. Klaus Ernst. Bli-Info. 1989. 507. Angst J, Bech P, Boyer P, Bruinvels J, Engel R, Helmchen H, et al. Consensus conference on the methodology of clinical trials of antidepressants Zurich, march 1988: report of the consensus committee. Pharmakopsychiat. 1989;22:3-7. 508. Angst J, Ernst C. Epidemiologie. Psychiatrische Universitätsklinik Zürich Zwanzig Jahre Forschungsabteilung 1969-1989; 1989. p. 10-8 (engl. 146-52). 509. Angst J, Ernst C, Stassen HH. The effect of marital status and parenthood on depression. Results from a longitudinal study of young males and females. (Abstract). Vth European Symposium on Social Psychiatry, Manchester 1989; 1989; 1989. 510. Angst J, Merikangas K, Scheidegger P. Recurrent brief depression. A new subtype of affective disorder. (Abstract No. 33). British Association for Psychopharmacology (BAP)/ Canadian College of Neuropsychopharmacology (CCNP) Joint Annual Meeting Cambridge 1989; 1989; 1989. p. 9. 511. Angst J, Scharfetter C. Psychosenforschung. Psychiatrische Universitätsklinik Zürich Zwanzig Jahre Forschungsabteilung 1969-1989; 1989. p. 49-63 (engl. 176-87). 512. Angst J, Stassen HH, Woggon B. Effect of neuroleptics on positive and negative symptoms and the deficit state. Psychopharmacology. 1989;99:41-6. 513. Angst J, Vollrath M. Beziehungen zwischen Angst und Depression. In: Kielholz P, Adams C, editors. Die Vielfalt von Angstzuständen. Köln: Deutscher Ärzte-Verlag; 1989. p. 79-100. 514. Angst J, Vollrath M. Relationships between anxiety and depression. In: Kielholz P, Adams C, editors. The kaleidoscope of anxiety states. Köln: Deutscher Ärzte-Verlag; 1989. p. 78-100. 515. Angst J, Vollrath M, Koch R, Dobler-Mikola A. The Zurich Study. VII. : symptoms, classification and prevalence. Eur Arch Psychiatr Neurol Sci. 1989;238:285-93. 516. Dobler-Mikola A, Angst J. Depressive syndromes in field studies: problems of case definition. WPA Bulletin. 1989;1:7-12. 517. Dobler-Mikola A, Binder J, Angst J. Soziale Netzwerke und Krankheitsverhalten: Eine Analyse des Umgangs mit psychischen und psychosomatischen Störungen bei jungen Erwachsenen. In: Angermeyer MC, Klusmann D, editors. Soziales Netzwerk Ein neues Konzept für die Psychiatrie. Berlin Heidelberg New York: Springer Verlag; 1989. p. 164-76. 518. Merikangas KR, Angst J. Validation of recurrent brief depression. (Abstract). American College of Neuropsychopharmacology 28th Annual Meeting Maui Hawai 1989; 1989; 1989. p. 200.

34 519. Meyer JW, Delini-Stula A, Angst J. Levoprotiline - antidepressive and sleep-ameliorating activity? 16th AGNP-Symposium Nürnberg 1989; 1989: Pharmacopsychiatry; 1989. p. 207. 520. Stassen HH, Angst J, Ragaz M, Scharfetter C. Quantitative genetic approaches to affective disorders and schizophrenia. First World Concress on Psychiatric Genetics Cambridge 1989; 1989; 1989. 521. Stassen HH, Kuny S, Woggon B, Angst J. Affective state and voice: results of a pilot study with six depressive patients. Pharmakopsychiat. 1989;22(suppl.):17-22. 522. Vollrath M, Angst J. Panic disorder in the Zurich cohort study: symptoms and course. In: Achte K, Tamminen T, Laaksonen R, editors. Many faces of panic disorder Proceedings of the WPA symposium on the psychopathology of panic disorders Espoo Finland 1988; 1989: Psychiatria Fennica; 1989. p. 74-82. 523. Vollrath M, Angst J. Comorbidity of panic and depression in the Zurich Study of young adults. (Abstract No. 3130). Psychiatry today Accomplishments and promises VIII World Congress of Psychiatry Athens 1989; 1989: Excerpta Medica, International Congress Series 899; 1989. p. 802 (Abstract No 3130). 524. Vollrath M, Angst J. Results of the Zurich cohort study: course of anxiety and depression. Psychiatr Psychobiol. 1989;4:307-13. 525. Vollrath M, Angst J. Outcome of panic and depression in a seven-year follow-up: results of the Zurich study. Acta Psychiatr Scand. 1989;80:591-6. 526. Vollrath M, Wicki W, Angst J. The Zurich Study. VIII. Insomnia: association with depression, anxiety, somatic syndromes, and course of insomnia. Eur Arch Psychiatry Neurol Sci. 1989;239:113-24. 527. Amaducci L, Angst J, Bech P, Benkert O, Bruinvels J, Engel R, et al. Consensus conference on the methodology of clinical trials of "Nootropics", Munich, June 1989. Report of the consensus committee. Pharmacopsychiatry. 1990;23:171-5. 528. Angst J. Depression and anxiety: a review of studies in the community and primary health care. In: Sartorius N, Goldberg D, Costa e Silva J, Lecrubier Y, Wittchen U, editors. Psychological disorders in general medical settings. Toronto Lewiston New York Bern Göttingen Stuttgart: Hogrefe & Huber Publischers; 1990. p. 60-8. 529. Angst J. Course as classifier for depression. (Abstract). Recurrent Mood disorders International Symposium Montecarlo (Monaco) 1990; 1990; 1990. p. 19. 530. Angst J. Recurrent brief depression. A new concept of depression. Pharmacopsychiatry. 1990;23:63-6. 531. Angst J. Epidemiologie und Diagnostik von Angst, Panik und Phobie. Vortrag gehalten anlässlich der 1 Ostschweizer Tagung zur Diagnose und Behandlung der Angst- und Panikerkrankung in der Praxis; 1990; 1990. 532. Angst J. The course of affective disorders: implications for psychopharmacology. In: Yamashita I, Toru M, Coppen AJ, editors. Proceedings of the 17th Collegium Internationale Neuro- Psychopharmacologicum Congress; 1990: Clin Neuropharmacol; 1990. p. 3-4. 533. Angst J. Guidelines for investigating antidysthymic and antidepressant drugs must take epidemiological data into account. In: Yamashita I, Toru M, Coppen AJ, editors. Proceedings of the 17th Collegium Internationale Neuro-Psychopharmacologicum Congress; 1990: Clin Neuropharmacol; 1990. p. 657-8.

35 534. Angst J. Depression in population studies: prevalence, symptoms, risk factors, and course. Depresiones y otros trastornos animicos Cursos de Verano, El Escorial 1989. Madrid: Universidad Complutense de Madrid; 1990. p. 33-52. 535. Angst J. Moclobemide: clincal efficacy. (Abstract). Association of European Psychiatrists AEP Recent advances in psychiatric research and their applications to diagnosis and treatment in psychiatry Fifth European Congress Strasbourg 1990; 1990; 1990. 536. Angst J. Epidemiology of schizophrenia: discussion. In: Häfner H, Gattaz WF, editors. Search for the causes of schizophrenia. Berlin Heidelberg New York: Springer-Verlag; 1990. p. 48-53. 537. Angst J. Sexuelle Ausbeutung von Kindern. Neue Zürcher Zeitung. 1990 18.10.1990;Sect. 90. 538. Angst J. Natural history and epidemiology of depression. Results of community studies. In: Cobb J, Goeting LM, editors. Current approaches Prediction and treatment of recurrent depression; 1990. p. 1- 11. 539. Angst J. Preface. In: Angst J, editor. Use of reversible inhibitors of monoamine oxidase-A in major depression and other psychiatric disorders Symposium held during the VIII World Congress of Psychiatry, Athens 1989; 1990: Acta Psychiatr Scand; 1990. p. 82. 540. Angst J, Ernst C. Geschlechtsunterschiede in der Psychiatrie. Weibliche Identität im Wandel Studium Generale, Wintersemester 1989/90: Ruprecht-Karls-Universität Heidelberg; 1990. p. 69-84. 541. Angst J, Merikangas KR, Scheidegger P, Wicki W. Recurrent brief depression: a new subtype of affective disorder. J Affect Disord. 1990;19:87-98. 542. Angst J, Scharfetter C. Schizoaffektive Psychosen - ein nosologisches Ärgernis. In: Lungershausen E, Kaschka WP, Witkowski RJ, editors. Affektive Psychosen. Stuttgart New York: Schattauer; 1990. p. 23- 31. 543. Angst J, Stassen HH, Gross G, Huber G, Stone MH. Suicide in affective and schizoaffective disorders. In: Marneros A, Tsuang MT, editors. Affective and schizoaffective disorders. Berlin Heidelberg New York: Springer; 1990. p. 168-85. 544. Angst J, Vollrath M, Merikangas KR, Ernst C. Comorbidity of anxiety and depression in the Zurich cohort study of young adults. In: Maser JD, Cloninger CR, editors. Comorbidity of mood and anxiety disorders. Washington D.C.: American Psychiatric Press; 1990. p. 123-37. 545. Angst J, Wicki W. Recurrent brief depression. The Royal College of Psychiatrists Annual Meeting Birmingham 1990; 1990; 1990. p. 8. 546. Angst J, Wicki W. The Zurich Study: panic, agoraphobia, and generalized anxiety disorder. J Psychiatr Res. 1990;24(suppl. 1):21-2. 547. Merikangas K, Wicki W, Angst J. Combined depression. (Abstract). The Royal College of Psychiatrists Annual Meeting Birmingham 1990; 1990; 1990. p. 8. 548. Merikangas KR, Angst J. Comorbidity of migraine and psychiatric disorders. (Abstract). 5th Congress of the International Federation of Psychiatric Epidemiology Montréal CA 1990; 1990; 1990. p. 54. 549. Merikangas KR, Angst J. Depression and migraine. In: Sandler M, Collins GM, editors. Migraine: a spectrum of ideas. Oxford New York Tokyo: Oxford University Press; 1990. p. 248-58. 550. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatr. 1990;47:849-53.

36 551. Merikangas KR, Wicki W, Angst J. Course of depression in untreated samples: implications for diagnostic nomenclature. (Abstract). American College of Neuropsychopharmacology 29th Annual Meeting San Juan, Puerto Rico 1990; 1990; 1990. p. 143. 552. Preisig M, Angst J. Course of affective : males versus females. (Abstract). 5th Congress of the International Federation of Psychiatric Epidemiology Montréal 1990; 1990; 1990. p. 61. 553. Sieber MF, Angst J. Alcohol, tobacco, and cannabis: 12-year longitudinal associations with antecedent social context and personality. Drug Alcohol Depend. 1990;25:281-92. 554. Stassen HH, Schmid GB, Gross G, Angst J, Huber G. Prädiktoren des langfristigen Verlaufs schizophrener Erkrankungen. In: Huber G, editor. Idiopathische Psychosen Psychopathologie Neurobiologie Therapie 8 Weissenauer Schizophrenie-Symposium Bonn 1990; 1990: Schattauer; 1990. p. 95-104. 555. Vollrath M, Koch R, Angst J. The Zurich Study IX.Panic disorder and sporadic panic: symptoms, diagnosis, prevalence, and overlap with depression. Eur Arch Psychiatr Neurol Sci. 1990;239:221-30. 556. Angst J. Epidemiology. (Abstract). 2nd International Symposium on Moclobemide RIMA: a new concept in the treatment of depression Davos 1991; 1991; 1991. p. 15. 557. Angst J. Efficacy of Moclobemide in different patient groups. (Abstract). 2nd International Symposium on Moclobemide RIMA: a new concept in the treatment of depression Davos 1991; 1991; 1991. p. 22. 558. Angst J. Is schizophrenia disappearing? Introductory remarks of the chief-editor. Eur Arch Psychiatr Neurol Sci. 1991;240:373-8. 559. Angst J. Moclobémide: revue des études cliniques internationales. Nervure. 1991;4:22-5. 560. Angst J. Depression and hypomania in primary care. (Abstract PL-11-1). In: Racagni G, Fukuda T, Brunello N, editors. World Federation of Societies of Biological Psychiatry 5th World Congress Florence 1991; 1991: Biol Psychiatry; 1991. p. S3 (Abstract PL-11-1). 561. Angst J. Psychiatrische Epidemiologie als Basis der klinischen Forschung. Psychische Krankheiten: Äussere und innere Faktoren Schweizerische Akademie der Medizinischen Wissenschaften Symposium Basel 1991; 1991; 1991. p. 7-9. 562. Angst J. Epidemiologie von "recurrent brief" und "major depression" - Resultate der Zürich-Studie. In: Hippius H, Pöldinger W, editors. Phantasie und Wirklichkeit - Fluvoxamin. Berlin Heidelberg New York: Springer-Verlag; 1991. p. 83-7. 563. Angst J. The epidemiology of recurrent depression. (Abstract S-2-1). IVth Congress of the European College of Neurpsychopharmacology Monte Carlo 1991; 1991: Eur Neuropsychopharmacol; 1991. p. 212-3. 564. Angst J. 6. Basler Psychiatriegespräch "Panik". Epidemiologie von Panikerkrankungen und Panikattacken. Der informierte Arzt. 1991;9:853-9. 565. Angst J, Angst K, Baruffol I, Meinherz-Surbeck R. ECT-induced and drug-induced hypomania. (Abstract). International congress on schizophrenia and affective psychoses Nosology in contemporary psychiatry Geneva 1991; 1991; Geneva; 1991. p. 56. 566. Angst J, Baumgarten HG, Halla R, Heimann H, Hippius H, Hohagen F, et al. Plenardiskussion. In: Hippius H, Pöldinger W, editors. Phantasie und Wirklichkeit - Fluvoxamin; 1991. p. 113-26.

37 567. Angst J, Bech P, Bobon D, Engel R, Hippius H, Janzen GJ, et al. Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs. 1991;24:149-52. 568. Angst J, Degonda M. Suicidal thoughts and attempts in the normal population. Results of the prospective Zurich cohort study from age 20 to 30. (Abstract). International congress on schizophrenia and affective psychoses Nosology in contemporary psychiatry Geneva 1991; 1991; 1991. p. 70. 569. Angst J, Hippius H, Hohagen F, Kasper S, Kuehne GE, Martinius J, et al. Podiumsdiskussion. In: Hippius H, Pöldinger W, editors. Phantasie und Wirklichkeit - Fluvoxamin: Springer-Verlag; 1991. p. 88- 111. 570. Angst J, Koch R. Neurasthenia in young adults. In: Gastpar M, Kielholz P, editors. Problems of psychiatry in general practice Neurasthenia Obsessive-compulsive disorder Advances in treatment of depression Teaching and training of the GP. Lewinston Toronto Bern Göttingen: Hofgrefe & Huber Publishers; 1991. p. 37-48. 571. Angst J, Vollrath M. The natural history of anxiety disorders. Acta Psychiatr Scand. 1991;84:446-52. 572. Angst J, Wicki W. The Zurich Study. XI. Is a separate form of depression? Results of the Zurich cohort study. Eur Arch Psychiatry Clin Neurosci. 1991;240:349-54. 573. Isler H, Merikangas KR, Angst J. Treatment patterns of migraine in the community: results of the Zurich cohort study of young adults. Proceedings 5th International Headache Congress Washington DC 1991; 1991: Cephalalgia; 1991. p. 110. 574. Merikangas KR, Angst J. Comorbidity of alcoholism and anxiety: evidence from epidemiologic and family study data. (Abstract). American College of Neuropsychopharmacology 30th Annual Meeting San Juan, Puerto Rico 1991; 1991; 1991. p. 147. 575. Merikangas KR, Isler H, Angst J. Comorbidity of migraine and psychiatric disorders: results of a prospective epidemiologic study. Proceedings 5th International Headache Congress Washington DC 1991; 1991: Cephalalgia; 1991. p. 308-9. 576. Merikangas KR, Wicki W, Angst J. Course of depression in untreated samples: implications for diagnostic nomenclature. (Abstract). American Psychiatric Association, Annual Meeting New Orleans 1991; 1991; 1991. 577. Preisig M, Angst J. Maladies dépressives. Facteurs du risque de récidive. Encephale. 1991;17:365-72. 578. Schmid GB, Stassen HH, Gross G, Huber G, Angst J. Longterm prognosis of schizophrenia. Psychopathology. 1991;24:130-40. 579. Wicki W, Angst J. The Zurich Study. X. Hypomania in a 28- to 30-year-old cohort. Eur Arch Psychiatry Clin Neurosci. 1991;240:339-48. 580. Angst J. L'hypomanie. A propos d'une cohorte de jeunes. Encephale. 1992;18:23-9. 581. Angst J. Drug-induced affective syndromes. In: Keshavan MS, Kennedy JS, editors. Drug-induced dysfunction in psychiatry. New York Washington Philadelphia London: Hemisphere Publishing Corporation; 1992. p. 181-90. 582. Angst J. Epidemiology of depression. Psychopharmacology. 1992;106(suppl.):S71-S4. 583. Angst J. Minor depression and recurrent brief depression. Chronic depressive conditions Spoleto 1992; 1992; 1992.

38 584. Angst J. Chairman's introduction. Third International Symposium on moclobemide Management of subtypes of depression and the role of RIMAs Vienna 1992; 1992; 1992. 585. Angst J. How recurrent is depression? (Abstract No. 9A). American Psychiatric Association 145th Annual Meeting Human values and biopsychosocial integration CME Syllabus and Proceedings Summary Wahington DC 1992; 1992; 1992. p. 26. 586. Angst J. Comorbidity of recurrent brief depression. (Abstract). Proceedings of the 18th Collegium Internationale Neuro-Psychopharmacologicum Congress; 1992: Clin Neuropharmacol; 1992. p. 9A- 10A. 587. Angst J. Comorbidity of panic disorder in a community sample. (Abstract). Proceedings of the 18th Collegium Internationale Neuro-Psychopharmacologicum Congress; 1992: Clin Neuropharmacol; 1992. p. 176A-7A. 588. Angst J. Course of mood disorders: a challenge to psychopharmacology. (Abstract). 1992: Clin Neuropharmacol; 1992. p. 444A-5A. 589. Angst J. How recurrent and predictable is depressive illness? In: Montgomery SA, Rouillon F, editors. Long-term treatment of depression. Chichester New York: John Wiley & Sons; 1992. p. 1-13. 590. Angst J. Recurrent brief psychiatric syndromes of depression, hypomania, neurasthenia, and anxiety from an epidemiological point of view. Neurology, Psychiatry and Brain Research. 1992;1:5-12. 591. Angst J. Recurrent brief depressions - A hereto unrecognised handicap. Depression Briefing. 1992;3:101-3. 592. Angst J. A critical appraisal of the clinical utility of moclobemide, the first reversible MAOi. (Abstract). British Association for Psychopharmacology and European Behavioural Pharmacology Society Joint meeting Cambridge 1992; 1992: J Psychopharmacol; 1992. 593. Angst J. Epidemiologia de los trastornos afectivos. Salud Mental. 1992;5:1-5. 594. Angst J. Current issues in the classification and epidemiology of mood disorders. Inaugural workshop and inaugural session of the European Decade of Brain Research New Pharmacological approaches in the therapy od depressive disorders Brussels 1992; 1992; 1992. 595. Angst J. Klinische Psychiatrie: gestern, heute, morgen. Vortrag anlässlich der Feier "125 Jahre Klinik Rheinau" Klinik Rheinau 1992; 1992: Intercura; 1992. p. 30-9. 596. Angst J. Co-morbidity of recurrent brief depression (RBD) with other psychiatric syndromes. (Abstract). 1992: Anales Psiquiatria; 1992. p. 11. 597. Angst J. Epidemiology of anxiety disorders and their interrelationships. (Abstract). 1992: Anales Psiquiatria; 1992. p. 4-5. 598. Angst J. Epidemiologie affektiver Störungen. ZNS Journal. 1992;1:2-8. 599. Angst J. Epidemiologie der Zwangssyndrome. Zwangserkrankungen: Erkenntnisse, Trends, Therapeutische Lösungen Symposium Luzern 1992; 1992: Ciba-Geigy; 1992. 600. Angst J. Epidemiological aspects of dysthymia. 5th Congress European College of Neuropsychopharmcology, Symposium: New approaches in the treatment of dysthymia Marbella 1992; 1992: Spotlight; 1992. p. 5. 601. Angst J. Recurrent brief depression. (Chairman: J. Angst). 1992: Psychopharmacology; 1992. p. 463.

39 602. Angst J. Depression research brings new results. Int Med News. 1992(November):1. 603. Angst J. Epidemiology of depression. (Reprint). Depression in panic disorder Third International Symposium on Moclobemide: RIMAs in subtypes of depression Vienna 1992; 1992: Focus on Depression; 1992. p. 89-90. 604. Angst J. Kraepelins Nosologie endogener Psychosen aus heutiger Sicht. (Vortrag anlässlich der Verleihung der Goldenen Kraepelin-Medaille). . München; 1992. 605. Angst J, Angst K, Baruffol I, Meinherz-Surbeck R. ECT-induced and drug-induced hypomania. Convuls Ther. 1992;8:179-85. 606. Angst J, Degonda M, Ernst C. The Zurich Study: XV. Suicide attempts in a cohort from age 20 to 30. Eur Arch Psychiatr Neurol Sci. 1992;242:135-41. 607. Angst J, Ernst C. Age and sex as risk factors for affective disorders. (Abstract). AEP Association of European Psychiatrists, Section Committee, Psychiatric Epidemiology and Social Psychiatry, 5th European Symposium Zurich 1992; 1992; 1992. p. 1. 608. Angst J, Gachoud JP, Gasser UE. Multicenter study evaluating the efficacy and tolerance of moclobemide in depressed patients treated by general practitioners. (Abstract). Proceedings of the 18th Collegium Internationale Neuro-Psychopharmacologicum Congress; 1992: Clin Neuropharmacol; 1992. p. 146B. 609. Angst J, Merikangas KR. Headache and personality. (Abstract). Proceedings of the 18th Collegium Internationale Neuro-Psychopharmacologicum Congress; 1992: Clin Neuropharmacol; 1992. p. 273A- 4A. 610. Angst J, Scheidegger P, Stabl M. Efficacy of moclobemide in different patient groups. Psychopharmacology. 1992;106(suppl.):S109-S13. 611. Angst J, Stabl M. Efficacy of moclobemide in different patient groups: a meta- analysis of studies. (Abstract). XVIIIth CINP Congress Symposium on MAOIs: new development Nice; 1992: Psychopharmacology; 1992. 612. Angst J, Wicki W. The Zurich Study: XIII. Recurrent brief anxiety. Eur Arch Psychiatry Clin Neurosci. 1992;241:296-300. 613. Ernst C, Angst J. The Zurich Study: XII. Sex differences in depression. Evidence from longitudinal epidemiological data. Eur Arch Psychiatry Clin Neurosci. 1992;241:222-30. 614. Ernst C, Schmid GB, Angst J. The Zurich Study: XVI. Early antecedents of depression. A longitudinal prospective study on incidence in young adults. Eur Arch Psychiatry Clin Neurosci. 1992;242:142-51. 615. Merikangas KR, Angst J. Dysthymia, minor depression and recurrent brief depression: epidemiology and course. (Abstract). Management of subtypes of depression and the role of RIMAs Vienna 1992; 1992; 1992. p. 4. 616. Merikangas KR, Angst J. Migraine and psychopathology: epidemiologic and genetic aspects. (Abstract). Migraine: the interface between Neurology and Psychiatry, 18th Collegium Internationale Neuro-Psychopharmacologicum Congress; 1992: Clin Neuropharmacol; 1992. p. 275A-6A. 617. Reitzle M, Steinhausen HC, Angst J. The Zurich longitudinal study of child psychiatric disorders. II. Childhood antecedents of maladjustment in adulthood. (Abstract). AEP Association of European

40 Psychiatrists, Section Committee, 'Psychiatric epidemiology and social psychiatry' 6th European Symposium Zurich 1992; 1992; 1992. p. 40. 618. Stassen HH, Angst J, Delini-Stula A. Onset of improvement under antidepressant treatment: a survival- analytical approach. (Abstract). 5th Congress of the European College of Neuropsychopharmacology Marbella 1992; 1992: Eur Neuropsychopharmacol; 1992. p. 319. 619. Steinhausen HC, Reitzle M, Angst J. The Zurich longitudinal study of child psychiatric disorders. 1. Child psychiatric disorders and outcome in adulthood. (Abstract). AEP, Association of European Psychiatrists, Section Committee 'Psychiatric epidemiology and social psychiatry' 6th European Symposium Zurich 1992; 1992; 1992. p. 49. 620. Vollenweider FX, Antonini A, Angst J, Leenders KL. Effekt von Amphetamin und Ketamin auf den zerebralen Energiemetabolismus bei gesunden Probanden, gemessen mittels PET und 18F-FDG. (Abstract). Schweiz Med Wochenschr. 1992;122(suppl. 45):25. 621. Vollenweider FX, Antonini A, Scharfetter C, Angst J. Zerebraler Energiemetabolismus während akut induzierter Ketamin-Modell-Psychose bei gesunden Probanden, gemessen mittels PET (Positronen- Emissions-Tomographie) und (18F)-Fluorodeoxyglukose. (Abstract). Fortschr Neurol Psychiatr. 1992;60(suppl. 1):43. 622. Vollenweider FX, Antonini A, Scharfetter C, Leenders KL, Angst J. Zerebraler Energiemetabolismus (PET, FDG) bei gesunden Probanden während Ketamin und Psilocybin induzierten Modell-Psychosen. (Abstract). Fortschr Neurol Psychiatr. 1992;60(suppl. 1):103. 623. Vollrath M, Koch R, Angst J. Binge eating and weight concerns among young adults. Results from the Zurich cohort study. Br J Psychiatry. 1992;160:498-503. 624. Wicki W, Angst J. Funktionelle Magen- und Darmbeschwerden bei jungen Erwachsenen: Vorkommen, Verlauf, Persönlichkeit und psychosoziale Faktoren. Psychother Psychosom Med Psychol. 1992;42:371-80. 625. Wicki W, Angst J, Merikangas KR. The Zurich Study: XIV. Epidemiology of seasonal depression. Eur Arch Psychiatry Clin Neurosci. 1992;241:301-6. 626. Altamura A, Angst J, Behnke K, Bridges K, Dilling H, Faravelli C, et al. Syndromal subgroups in depression.; 1993: Int Clin Psychopharmacol; 1993. p. 203-4. 627. Angst J. Efficacy of moclobemide in subtypes of depression: a meta-analysis. The UK Launch of Moclobemide (Manerix) Hanbury Manor, Ware 1993; 1993; 1993. 628. Angst J. Komorbidität von Angst, Phobie, Zwang und Depression. Angst, Zwang, Depression Aspekte der funktionalen Klassifikation, Konsequenzen für die Psychopharmakotherapie Mainz 1993; 1993: duphar med communication; 1993. p. 3. 629. Angst J. Epidemiology of bipolar disorders, major and minor depression, recurrent brief depression, and suicide attempts. II International Bakirköy Days Istanbul 1993; 1993; 1993. p. 18. 630. Angst J. Resistant depression and its treatment. II International Bakirköy Days Istanbul 1993; 1993. p. 19. 631. Angst J. Il prototipo della depressione da Kraepelin al DSM-III-R e all'ICD-10. In: Faravelli C, Gnocchi G, Monteleone P, editors. I disturbi depressivi. Napoli: Idelson Liviana; 1993. p. 1-10.

41 632. Angst J. Prädiktoren des Spontanverlaufs affektiver Psychosen. In: Heinrich K, Klieser E, Lehmann E, editors. Prädiktoren des Therapieverlaufs endogener Psychosen 9 Düsseldorfer Psychiatrie- Symposion 1990; 1993: Schattauer; 1993. p. 51-61. 633. Angst J. Epidemiologie der Depression. Resultate aus der Zürich-Studie. In: Pöldinger W, Reimer C, editors. Depressionen Therapiekonzepte im Vergleich. Berlin Heidelberg New York: Springer; 1993. p. 3-12. 634. Angst J. Recurrent brief depression: a new disorder. (abstract No. 820). 9th World Congress of Psychiatry World Psychiatric Association Rio de Janeireo, Brazil 1993; 1993; 1993. p. 209. 635. Angst J. Die depressive Verstimmung als Schaltstelle psychiatrischer Störungen. In: Hell D, editor. Ethologie der Depression Familientherapeutische Möglichkeiten. Stuttgart Jena: Gustav Fischer; 1993. p. 3-15. 636. Angst J. Efficacy of reversible MAOIs in severely depressed and suicidal patients. VIth Congress of the European College of Neuropsychopharmacology Budapest, Hungary 1993; 1993: Eur Neuropsychopharmacol; 1993. p. 241-2. 637. Angst J. Epidemiologie affektiver Erkrankungen unter Berücksichtigung der leichteren Formen. In: Berger M, Möller HJ, Wittchen HU, editors. Psychiatrie als empirische Wissenschaft. München Bern Wien New York: Zuckerschwerdt Verlag; 1993. p. 51-6. 638. Angst J. Current issues in the classification and epidemiology of mood disorders. Int Acad Biomed Drug Res. 1993;5:1-7. 639. Angst J. Course as classifier for depression. In: Placidi GF, Dell'Osso L, Nisticò G, Akiskal HS, editors. Recurrent mood disorders New perspectives in therapy. Berlin Heidelberg New York: Springer; 1993. p. 69-78. 640. Angst J. Mixed anxiety depression: comorbidity or diagnostic entity? (abstract). Recent advances in the treatment of depression Department of Biological Psychiatry, Academic Hospital Utrecht 1993; 1993; 1993. 641. Angst J. Recent development in the classification of depression. (abstract). Therapeutic implications Symposium Oslo 1993; 1993; 1993. 642. Angst J. Comorbidity of anxiety, phobia, compulsion and depression. Int Clin Psychopharmacol. 1993;8(suppl. 1):S21-S5. 643. Angst J. Today's perspective on Kraepelin's nosology of endogenous psychoses. Eur Arch Psychiatry Clin Neurosci. 1993(243):164-70. 644. Angst J. Epidemiologie affektiver Erkrankungen unter Berücksichtigung leichterer Formen. In: Berger M, Möller HJ, Wittchen HU, editors. Psychiatrie als empirische Wissenschaft. München Berlin Wien New York: Zuckerschwerdt Verlag; 1993. p. 51-6. 645. Angst J. Vorwort. Funktionelle somatische Symptome und ihre Beziehung zu Angst und Depression Zürich 1993; 1993; 1993. p. 1. 646. Angst J. Severity of depression and benzodiazepine co-medication in relationship to efficacy of antidepressants in acute trials. A meta-analysis of moclobemide trials. Hum Psychopharmacol. 1993;8:401-7.

42 647. Angst J, Ansseau M, Bech P, Engel R, Hippius H, Lader M, et al. Report on the fourth consensus conference on the methodology of clinical trials with anxiolytic drugs. Pharmacopsychiat. 1993;26:1-5. 648. Angst J, Delini-Stula A, Stabl M, Stassen HH. Is a cut-off score a suitable measure of treatment outcome in short-term trials in depression? A methodological meta-analysis. Hum Psychopharmacol. 1993;8:311-7. 649. Angst J, Ernst C. Prevalence of affective disorder among the elderly. (abstract). Sixth Congress of the International Psychogeriatric Association Berlin 1993; 1993; 1993. p. 40. 650. Angst J, Ernst C. Prevalence of affective disorder among the elderly. In: Gottfries CG, editor. Affective disorders in the elderly Proceedings from a Lundbeck Symposium held in Berlin 1993 within the 6th Congress of the International Psychogeriatric Association; 1993; 1993. 651. Angst J, Ernst C. Current concepts of the classification of affective disorders. Int Clin Psychopharmacol. 1993;8:211-5. 652. Angst J, Gachoud JP, Gasser UE, Koehler M. Antidepressant therapy with moclobemide in primary care practice. Hum Psychopharmacol. 1993;8:319-25. 653. Angst J, Scheidegger P, Stabl M. Efficacy of moclobemide in different patients groups. Results of new subscales of the Hamilton Depression Rating Scale. Clin Neuropharmacol. 1993;16(suppl. 2):S55-S62. 654. Angst J, Wicki W. The epidemiology of frequent and less frequent panic attacks. In: Montgomery SA, editor. Psychopharmacology of panic: Oxford University Press; 1993. p. 7-24. 655. Crow TJ, Angst J. Is the Kraepelinian binary system dead? 9th World Congress of Psychiatry World Psychiatric Association Rio de Janeiro, Brazil; 1993; 1993. p. 109. 656. Degonda M, Angst J. The Zurich Study. XX. Social phobia and agoraphobia. Eur Arch Psychiatry Clin Neurosci. 1993;243:95-102. 657. Degonda M, Wyss M, Angst J. The Zurich Study. XVIII. Obsessive-compulsive disorders and syndromes in the general population. Eur Arch Psychiatry Clin Neurosci. 1993;243:16-22. 658. Ernst C, Angst J. Further commentary on Hollister's article (Response: Hollister LE). Integrat Psychiatry. 1993;8:157-9. 659. Ernst C, Angst J, Foeldenyi M. The Zurich Study. XVII. Sexual abuse in childhood. Frequency and relevance for adult morbidity. Data of a longitudinal epidemiological study. Eur Arch Psychiatry Clin Neurosci. 1993;242:293-300. 660. Ernst C, Foeldenyi M, Angst J. The Zurich Study: XXI. Sexual dysfunctions and disturbances in young adults. Eur Arch Psychiatry Clin Neurosci. 1993;243:179-86. 661. Hochstrasser B, Angst J. Recurrence of depressive disorders - epidemiological and follow-up data. 18th Symposium of AGNP Nuremberg; 1993: Pharmacopsychiat; 1993. p. 162. 662. Hochstrasser B, Angst J. The association of insomnia with depressive disorders - an epidemiological viewpoint. 18th Symposium of AGNP Nuremberg; 1993: Pharmacopsychiat; 1993. p. 162. 663. Merikangas KR, Angst J. Neurasthenia in a longitudinal community study. Changig the course and outcome of mental disorder The contribution of epidemiology World Psychiatric Association, Section Epidemiology and Community Psychiatry Symposium Groningen; 1993; 1993. p. 98.

43 664. Merikangas KR, Angst J. Comorbidity and social phobia: evidence from epidemiologic and genetic studies. VIth Congress of the European College of Neuropsychopharmacology Budapest, Hungary; 1993: Eur Neuropsychopharmacology; 1993. p. 188-9. 665. Merikangas KR, Cheng SH, Whitaker A, Angst J. Validation of the diagnostic criteria for migraine in the Zurich longitudinal cohort study. Cephalalgia. 1993;13(suppl. 12):47-53. 666. Merikangas KR, Foeldenyi M, Angst J. The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich cohort study. Eur Arch Psychiatry Clin Neurosci. 1993;143:23-32. 667. Merikangas KR, Merikangas JR, Angst J. Headache syndromes and psychiatric disorders: association and familial transmission. J Psychiatr Res. 1993;27:197-210. 668. Merikangas KR, Stevens DE, Angst J. Headache and personality: results of a community sample of young adults. J Psychiatr Res. 1993;27:187-96. 669. Merikangas KR, Whitaker A, Angst J. Validation of diagnostic criteria for migraine. (abstract). Thirty- fifth Annual Scientific Meeting The American Association for the Study of Headache San Fransico, California; 1993; 1993. 670. Stassen HH, Delini-Stula A, Angst J. Time course or improvement under antidepreassant treatment: a survival analytical approach. Eur Neuropsychopharmacol. 1993;3:127-35. 671. Vollenweider FX, Antonini A, Leenders KL, Angst J. Evidence for a cortial subcortical dysbalance in the ketamine model of schizophrenia using PET. (abstract). 9th World Congress of Psychiatry World Psychiatric Association Rio de Janeiro, Brazil; 1993; 1993. p. 199. 672. Vollenweider FX, Antonini A, Scharfetter C, Angst J, Leenders KL. Psychopathologie und kortikale Aktivitätsmuster im PET (FDG) bei Ketamine und Psilocybin induzierten Modell-Psychosen. (abstract). Topographische Diagnostik des Gehirns Deutsch-Oesterreichischer Neurologenkongress: Topographische Diagnostik des Gehirns Klinik, Neurophysiologie, Neuropsychologie, Morphologie Wien; 1993; 1993. p. 1993. 673. Vollenweider FX, Antonini A, Scharfetter C, Angst J, Leenders KL. Zerebraler Energiemetabolismus während akut induzierter Ketamin-Modell-Psychose bei gesunden Probanden, gemessen mittels PET (Positronen-Emmissions-Tomographie) und (18F)-Fluordeoxyglukose. In: Baumann P, editor. 3 Drei- Länder-Symposium für Biologische Psychiatrie Lausanne, 1992; 1993: Springer; 1993. p. 497-9. 674. Vollrath M, Angst J. Coping and illness behavior among young adults with panic. J Nerv Ment Dis. 1993;181:303-8. 675. Waser PG, Angst J, Scharfetter C. Manfred Bleuler 90jährig: Ein Leben für die Psychiatrie. Zürichsee- Zeitung. 1993 04. Januar 1993;Sect. 5. 676. Angst J. Comorbidity of mood disorders: a longitudinal perspective. Collegium Internationale Neuro- Psychopharmacologicum, Regional Workshop: Critical issues in the treatment of affective disorders Under the Patronage of the Commission of the European Community European Decade of Brain Research Paris; 1994; 1994. 677. Angst J. Epidemiology of subthreshold syndromes of anxiety and depression. First Scientific Meeting of the Swiss Society of Psychiatric Epidemiology Clinique Psychiatrique Universitaire Prilly-Lausanne; 1994; 1994.

44 678. Angst J. Epidemiology of depressive disorders. International symposium on biological and therapeutic aspects of major psychoses Chairmen: AC Altamura, N Rudas, Institute of Psychiatry, University of Cagliari, Italy; 1994; 1994. 679. Angst J. Begrüssung. In: Gross G, editor. Perspektiven psychiatrischer Forschung und Praxis 9 Weissenauer Schizophrenie-Symposion aus Anlass des 70 Geburtstages von Prof Dr med Gerd Huber mit Verleihung des Kurt-Schneider-Preises Bonn 1992; 1994: Schattauer; 1994. p. 11-2. 680. Angst J. Efficacy of moclobemide, a reversible MAO-A inhibitor (R.I.M.A.), in agitated depression. Selective enzyme inhibition, RIMA - a pathway through the maze BAP Satellite Symposium Cambridge; 1994; 1994. p. 8-9. 681. Angst J. The history and epidemiology of panic disorders. Controversies and conventions in panic disorder; 1994; Copenhagen: AEP Satellite Symposium; 1994. p. 4-6. 682. Angst J. Strategies of research: combatting current convictions. 7th Congress, Association of European Psychiatrists, General lectures Copenhagen, ; 1994; 1994. p. S3-S4. 683. Angst J. Comorbidity of affective and anxiety disorders. 7th Congress, Association of European Psychiatrists, New perspectives in psychiatric epidemiology Copenhagen, Denmark; 1994; 1994. p. S32-S3. 684. Angst J. Verlauf unipolar depressiver, bipolar manisch-depressiver und schizo-affektiver Erkrankungen und Psychosen. Ergebnisse einer prospektiven Studie. (Japanisch) (Original: Fortschr Neurol Psychiatr (1980) 48: 3-30). Arch Psychiatr Diagnostics Clin Evaluation. 1994;5:365-8. 685. Angst J. The epidemiology of dysthymia. Abstracts of the VIIth Congress of the European College of Neuropsychopharmacvology Jerusalem, Israel; 1994: Eur Neuropsychopharmacology; 1994. p. 203. 686. Angst J. Moclamine: la meta analyse des études cliniques. Revue scientifique trimestrielle Roche. 1994;Numero special moclamine (moclobemide):20-2. 687. Angst J. La efficacia de moclobemida en el tratamiento de la depresion. Curso tematico RIMA. Unidad de Congresos Centro Medico National Siglo XXI Mexico, DF; 1994; 1994. p. 8-9. 688. Angst J. The history and concept of recurrent brief depression. (editorial). Eur Arch Psychiatry Clin Neurosci. 1994;244(Special issue No 4):171-3. 689. Angst J. The epidemiology of obsessive compulsive disorder. In: Hollander E, Zohar J, Marazziti D, Olivier B, editors. Current insights in obsessive compulsive disorder. Chichester New York Brisbane: John Wiley & Sons; 1994. p. 93-104. 690. Angst J. Dank von Prof. J. Angst. Punktuell. 1994(92):4. 691. Angst J. Bipolar disorder: epidemiology, comorbidity, premorbid personality. First International Conference on Bipolar Disorder University of Pittsburgh, June 1994, An official satellite of the XIXth CINP Congress to be held June 27 through July 1 1994, in Washington, DC, Pittsburgh, Pennsylvania, Translation: Trouble bipolaire: épidémipologie, comorbidité et personalité prémorbide Première Conférence Internationale sur les troubles Bipolaires, Pittsburg, Juin 1994 Rapport des Congrès; 1994; 1994. p. 11. 692. Angst J. Das Komorbiditätskonzept in der psychiatrischen Diagnostik. In: Dilling H, Schulte-Markwort E, Freyberger.H.J., editors. Von der ICD-9 zur ICD-10 Neue Ansätze der Diagnostik psychischer

45 Störungen in der Psychiatrie, Psychosomatik und Kinder- und Jugendpsychiatrie. Bern Göttingen Toronto Seattle: Verlag Hans Huber; 1994. p. 41-8. 693. Angst J. Comorbidity of mood disorders. A longitudinal prospective study. In: Langner SZ, Brunello N, Racagni G, Mendlewicz J, editors. Critical issues in the treatment of affective disorders Paris; 1994: Int Acad Biomed Drug Res; 1994. p. 158-61. 694. Angst J. Bipolar disorder: epidemiology, comorbidity, premorbid personality. First International Conference on Bipolar Disorder Pittsburgh, Pennsylvania; 1994; 1994. p. 182-4. 695. Angst J, Bech P, Bruinvels J, Engel RR, Ferner U, Guelfi JD, et al. Report on the fifth Consensus Conference: Methodology of long-term clinical trials. Pharmacopsychiatry. 1994;27:101-7. 696. Angst J, Delini-Stula A, Koehler M, Mikkelsen H. Comparative Efficacy of SSRI and moclobemide (RIMA) in major depressive disorder. Meta-analysis of studies. 7th Congress, Association of European Psychiatrists, Reversible inhibitors of MAO-A New clinical findings Copenhagen, Denmark; 1994: Eur Psychiatry; 1994. p. 47s-8s. 697. Angst J, Delini-Stula A, Mikkelsen H. Therapeutic efficacy of antidepressants in agitated and non- agitated depressives: meta-analysis of studies with moclobemide.(abstract). Neuropsychopharmacology. 1994;10(suppl. 3):76s. 698. Angst J, Ernst C. Praemorbide und postmorbide Persönlichkeit bei affektiv Erkrankten. In: Huber G, editor. 10 Weissenauer Schizophrenie-Symposion, Dresden 1994, veranstaltet von der Weissenauer Arbeitsgemeinschaft für Psychosenforschung eV in Zusammenarbeit mit der Sächsischen Wissenschaftlichen Gesellschaft für Nervenheilkunde; 1994; 1994. 699. Angst J, Gachoud JP, Gasser UE, Koehler M. Antidepressant therapy with moclobemide in primary care practice. 7th Congress, Association of European Psychiatrists, Depression, mood disorders: treatment Copenhagen, Denmark; 1994; 1994. p. S163. 700. Angst J, Hochstrasser B. Recurrent brief depression: The Zurich Study. J Clin Psychiatry. 1994;55(suppl. 4):3-9. 701. Angst J, Johnson FN. Moclobemide in special sub-groups of depression. Rev Contemp Pharmacother. 1994:45-55. 702. Angst J, Neuenschwander M, Preisig M. Lifetime prognosis of depression is often poor. CINP Satellite Symposium: Recovery from depression: risk or reality? Washington DC; 1994 June 28 1994; 1994. p. 51. 703. Angst J, Stablm. Rimas in severe depression: Meta-analysis and prospective studies. (abstract). XIX Collegium InternationaleNeuro-Psychpharmacologicum Congress Washington, DC; 1994: Neuropsychopharmacology; 1994. p. S414. 704. Angst J, Stassen HH. Methodische Aspekte von Studien zur antidepressive Wirksamkeit. In: Steinberg R, Philipp M, Möller HJ, editors. Spezielle Aspekte der antidepressiven Therapie Neuere Ergebnisse zu Moclobemid. München: MMV Medizin Verlag GmbH; 1994. p. 147-66. 705. Angst J, Stassen HH, Angst F. Excess mortality in psychiatric populations: methodological issues and empirical results. XIXth Collegium Internationale Congress Washington, DC; 1994: Neuropsychopharmacology; 1994. p. S583.

46 706. Clayton-P.J., Ernst C, Angst J. Premorbid personality traits of men who develop unipolar or bipolar disorders. Eur Arch Psychiatry Clin Neurosci. 1994;243:340-6. 707. Delini-Stula A, Mikkelsen H, Angst J. Comparative efficacy of moclobemide (RIMA) and imipramine (TCA) in agitated and retarded major depressive disorder patients. Collegium Internationale Neuro- Psychopharmacologicum, Regional Workshop, Paris, March 1994: Critical issues in the treatment of affective disorders Under the Patronage of the Commission of the European Community European Decade of the Brain; 1994; 1994. 708. Delini-Stula A, Mikkelsen H, Angst J. Comparative efficacy of moclobemide (RIMA) and imipramine (TCA) in agitated and retarded depression. (abstract). Collegium Internationale Neuro- Psychopharmacologicum, Regional Workshop, Paris, March 1994: Critical issues in the treatment of affective disordrer Under the Patronage of the Commission of the European Community Europen Decade of Brain Research; 1994; 1994. 709. Ernst C, Angst J. Eugen Bleuler's "Schizophrenias". Am J Psychiatry. 1994;151:914. 710. Merikangas KR, Angst J. Validity sub-threshold anxiety and depression: results of the Zurich cohort study. Neuropsychopharmacology. 1994;10(suppl. 3):S543. 711. Merikangas KR, Angst J. Neurasthenia in a longitudinal cohort study of young adults. Psychol Med. 1994;24:1013-24. 712. Merikangas KR, Dartigues JF, Whitaker A, Angst J. Diagnostic criteria for migraine. A validity study. Neurology. 1994;44(suppl. 4):S11-S6. 713. Merikangas KR, Whitaker AE, Isler H, Angst JA. The Zurich Study. XXIII. Epidemiology of headache syndromes in the Zurich cohort study of young adults. Eur Arch Psychiatry Clin Neurosci. 1994;244:145-52. 714. Merikangas KR, Wicki W, Angst J. Heterogeneity of depression. Classification of depressive subtypes by longitudinal course. Br J Psychiatry. 1994;164:342-8. 715. Stassen HH, Angst J. Methods of estimating onset of improvement. Abstracts of the VIIth Congresss of the European College of Neuropsychopharmacology Jerusalem, Israel; 1994: Eur Neuropsychopharmacology; 1994. p. 284. 716. Stassen HH, Angst J, Delini-Stula A. Severity at baseline and onset of improvement in depression. Meta-analysiss of imipramine and moclobemide versus placebo. Eur Psychiatry. 1994;9:129-36. 717. Vollenweider FX, Antonini A, Scharfetter C, Angst J, Leenders KL. Hyperfrontality and psychopathology in the acute ketamine and psilocybin model of schizophrenia using PET and FDG. In: Lang W, Deecke L, editors. Joint Meeting of the German Society of Neurology (LXVI Annual Meeting) and the Section of Neurology, Austrian Society of Neurologists and Psychiatrists Topic of the Meeting: Topographic diagnostic of the brain Vienna; 1994: J Neurol; 1994. p. 262. 718. Vollenweider FX, Scharfetter C, Leenders KL, Angst J. Hyperfrontality and psychopathology in the ketamine and psilocybin model of schizophrenia using PET and FDG. First Swiss Poster Meeting on Basic and Clinical Neuroscience in conjunction with the annual meetings of the Swiss chapter of IBRO and the Swiss Society for Biological Psychiatry Basel; 1994; 1994. p. 24. 719. Vollenweider FX, Scharfetter C, Leenders KL, Angst J. Ketamine and psilocybin model psychoses: psychopathology and FDG-PET. XIXth Collegium Internationale Neuro-Psychopharmacologidum Congress Washington, DC; 1994: Neuropsychopharmacology; 1994. p. S771.

47 720. Vollenweider FX, Scharfetter C, Leenders KL, Angst J. Disturbance of serotonergic or glutamatergic neurotransmission results in hyperfrontality as measured by PET and FDG in acute human model psychoses. Abstracts of the VIIth Congress of the European College of Neuropsychopharmacology Jerusalem, Israel; 1994: Eur Neuropsychopharmacology; 1994. p. 367. 721. Angst J. Special issue: Social phobia. Eur Arch Psychiatry Clin Neurosci. 1995;244:289. 722. Angst J. Dépressions brèves récurrentes. In: Olié JP, Poirier MF, Lôo H, editors. Les maladies dépressives. Paris: Médecine-Sciences Flammarion; 1995. p. 223-33. 723. Angst J. Methods of estimating onset of improvement. VIe Internationale Symposium Psychiatrie Luxembourg; 1995; 1995. 724. Angst J. 25 Jahre Zürich-Studie. Depressive haben eine schlechte Prognose. Die Kurzzeittherapie ist out. Med Tribune. 1995(11):7. 725. Angst J. Psychotic continuum or distinct entities: discussion. In: Marneros A, Andreasen NC, Tsuang MT, editors. Psychotic continuum. Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona Budapest: Springer; 1995. p. 87-8. 726. Angst J. Clinical course and risk factors in unipolar depression. (abstract). American Psychiatric Association 148th Annual Meeting Miami, Florida; 1995: Syllabus and Proceedings; 1995. p. 262. 727. Angst J. Lifetime risk of depression and duration of treatment. Managing depression with the whole patient in mind An interactive focus conference Paris; 1995; 1995. p. 2. 728. Angst J. Recurrent brief psychiatric syndromes: hypomania, depression, anxiety, neurasthenia, and insomnia. (abstract). Collegium Internationale Neuropsychopharmacologicum CINP Regional Conference: Neuroscience and Neuropsychopharmacology, East and West at the Beginning of the European Decade of Brain Research Vienna - Prague; 1995: Homeostasis; 1995. p. 9. 729. Angst J. The efficacy of moclobemide (1977-1994). A meta-analysis. Farmakoterapia w Psychiatrii I Neurologii: I-MAO, RIMA w Leczeniu depresji; 1995. p. 31-48. 730. Angst J. The diagnosis and epidemiology of recurrent brief depression. (abstract). 2nd International Conference in New Directions in Affective Disorders Jerusalem; 1995; 1995. 731. Angst J. History and epidemiology of panic. Eur Psychiatry. 1995;10(suppl. 2):S57-S9. 732. Angst J. Depressionbehandlung heute. Le traitement de la dépression aujourdhui.. Frage & Antwort Journal / Questions et Réponse (Beilage zu Der informierte Arzt / Gazette médicale). 1995(September):16. 733. Angst J. Die klinische Forschung im Bereich affektiver Erkrankungen. Eine persönliche Sicht. Pharmacopsychiatry. 1995;28(suppl. 1):38-41. 734. Angst J. Psychopathology of depression and spectrum of activity of moclobemide, a reversible MAO-A inhibitor (RIMA). 19th Symposium of AGNP Nürnberg; 1995: Pharmacopsychiatry; 1995. p. 160. 735. Angst J. Epidémiologie du spectre bipolaire. In: Akiskal H, Darcourt G, Hantouche E, Fraud JPS, editors. Mieux identifier les troubles bipolaires Symposium international organisé par Sanofi Wintrop Paris; 1995: Encéphale; 1995. p. 37-42. 736. Angst J. Epidémiologie des troubles bipolaires,. In: Bourgeois ML, Verdoux H, editors. Les troubles bipolaires de l'humeur. Paris Milan Barcelone: Masson Médecine et Psychothérapie.; 1995. p. 29-42.

48 737. Angst J. The epidemiology of dysthymia. Perspect Depr. 1995;3:1-5. 738. Angst J. The epidemiology of depressive disorders. Eur Neuropsychopharmacol. 1995;5(suppl.):95-8. 739. Angst J. La eficacia del moclobemide en el tratamiento de la depresion. Distimia Informacion Reciente (Roche). 1995:10-1. 740. Angst J, Amrein R, Stabl M. Moclobemide and tricyclic antidepressants in severe depression: meta- analysis and prospective studies. J Clin Psychopharmacol. 1995;15(suppl. 2):S16-S23. 741. Angst J, Amrein R, Stabl M. Moclobemide: a paradigm of research in clinical psychophamracology. (abstract). IVth International Symposium on Moclobemide "Understanding Social Phobia" Oslo, Norway; 1995; 1995. 742. Angst J, Borbely A, Engel RR, Ferner U, Hippius H, Lader M, et al. Report on the sixth Consensus Conference on the methodology of clinical trials with hypnotic drugs. Pharmacopsychiatry. 1995;28:2-7. 743. Angst J, Merikangas KR, Preisig M. Epidemiology of mixed anxiety depression. Second Scientific Meeting of the Swiss Society of Psychiatric Epdiemiology Basel; 1995 June 23; 1995. 744. Angst J, Preisig M. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr. 1995;146(1):5-16. 745. Angst J, Preisig M. Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr. 1995;146(1):17-23. 746. Angst J, Preisig M, Merikangas KR. Depression and beyond: different psychopharmacology of subtypes. (abstract S-14-1). Abstracts of the VIIIth Congress of the European College of Neuropsychopharmacology Venice, Italy; 1995: Eur Neuropsychopharmacol; 1995. p. 197. 747. Angst J, Stabl M, Delini-Stula A. The efficacy of moclobemide in different sub-types and syndromal forms of depression. (poster). IVth International Symposium on Moclobemide "Understanding Social Phobia" Oslo, Norway; 1995; 1995. 748. Angst J, Stassen HH. Wie sinnvoll sind Doppelblindstudien? TW Neurol Psychiatr. 1995;9:106-8. 749. Costa e Silva JA, Angst J, Davidson J, Keller M, Lépine JP, Liebowitz M, et al. Social phobia,. A clinical review. World Psychiatric Association Social Phobia Task Force. 1995. 750. Costa e Silva JA, Angst J, Davidson J, Keller M, Lépine JP, Liebowitz M, et al. Pocket reference to social phobia. World Psychiatric Assoication Social Phobia Task Force Supported by an educational grant from F Hoffmann-La Roche, Basel, Science Press London. 1995. 751. Delini-Stula A, Angst J. The efficacy of moclobemide in agitated-anxious subgroups of depressed patients. A meta-analysis of double-blind, controlled studies. (poster). IVth International Symposium on Moclobemide "Understanding Social Phobia" Oslo, Norway; 1995; 1995. 752. Delini-Stula A, Angst J. Comparative efficacy of moclobemide (RIMA) and (SSRI) in major depression. A meta-analysis of double-bind, controlled studies. (poster). IVth International Symptosium on Moclobemide "Understanding Social Phobia" Oslo, Norway; 1995; 1995. 753. Delini-Stula A, Köhler M, Mikkelsen H, Angst J. Comparative efficacy of selective 5-HT-uptake (SSRI) and MAO-A (RIMA) inhibitors in major depression - a meta-analysis of fluoxetine and moclobemide trials. (poster). Swiss Biological Psychiatry Meeting Geneva; 1995; 1995.

49 754. Delini-Stula A, Mikkelsen H, Angst J. Therapeutic efficacy of antidepressants in agitated anxious depression - a meta-analysis of moclobemide studies. J Affect Disord. 1995;35:21-30. 755. Delini-Stula A, Mikkelsen H, Angst JA. Side-effects and drug-interaction profiles of moclobemide (RIMA) and fluoxetine. 19th Symposium of AGNP, Nuremberg; 1995: Pharmacopsychiatry; 1995. p. 171. 756. Ernst C, Angst J. Manfred Bleuler, 103-1994: In memoriam. World Psychiatry (Newsletter of the World Psychiatric Association). 1995;3:2. 757. Ernst C, Angst J. Depression in old age. Is there a real decrease in prevalence? A review. Eur Arch Psychiatry Clin Neurosci. 1995;245:272-87. 758. Ernst C, Angst JA. Images in Psychiatry: Manfred Bleuler 1903-1994. Am J Psychiatry. 1995;152:609. 759. Gattaz WF, Vogel P, Kick H, Delini-Stula A, Köhler M, Mikkelsen H, et al. Comparative efficacy and tolerability of moclobemide and fluoxetine in major depression. 19th Symposium of AGNP Nuremberg; 1995: Pharmacopsychiatry; 1995. p. 179. 760. Merikangas KR, Angst J. Comorbidity and social phobia: evidence from clinical, epidemiologic, and genetic studies. Eur Arch Psychiatry Clin Neurosci. 1995;244:297-303. 761. Merikangas KR, Angst J. Comorbidity of alcoholism and anxiety disorders. Search for the causes of psychiatric disorders: epidemiological approaches World Psychiatric Association, Section of Epidemiology & Community Psychiatry in Association with College of Physicians and Surgeons, Department of Psychiatry and the School of Public Health, New York; 1995; 1995. p. 275. 762. Stabl M, Amrein R, Angst J. In-patient studies with moclobemide and clomiparmine: severity, dose and antidepressant efficacy. (poster). IVth International Symposium on Moclobemide "Understanding Social Phobia" Oslo, Norway; 1995; 1995. 763. Steinberg R, Philipp M, Angst J, A. K, editors. Depressionsbehandlung heute. Von der Diagnose zur wirksamen Therapie. München: MMV Medizin Verlag GmbH; 1995. 764. Vollenweider FX, Leenders KL, Oye I, Scharfetter C, Angst J. Differential effects of S-ketamine and R- ketamine on psychopathology and brain energy metabolism measured by FDG-PET in humans. Abstracts of the VIIIth Congress of the European College of Neuropsychopharmacology Venice, Italy; 1995; 1995. 765. Angst J. Comorbidity of mood disorders: a longitudinal prospective study. Br J Psychiatry. 1996;168(suppl. 30):31-7. 766. Angst J. Manfred Eugen Bleuler (1903-1994): in memoriam. Nervenarzt. 1996;67:1-2. 767. Angst J. The myths of psychopharmacology. In: Healy D, editor. The Psychopharmacologists. London: Chapman & Hall; 1996. p. 287-307. 768. Angst J. The course of psychiatric disorders as a diagnostic tool. In: Ackenheil M, Bondy B, Engel R, Ermann M, Nedopil N, editors. Implications of psychopharmacology to psychiatry. Berlin Heidelberg New York: Springer; 1996. p. 56-65. 769. Angst J. Wie rasch wirken Antidepressiva? (abstract). Fortschritte der Antidepressiven Therapie, Zürich; 1996; 1996. 770. Angst J. Comorbidity of anxiety disorders with mood disorders and substance abuse. Second Tryptich Workshop in Psychiatry Anxiety and its comorbidity Maastrich; 1996; 1996. p. 12-3.

50 771. Angst J. Historical perspectives and current problems in the classification diagnosis and treatment of mood disorders: new critical specifiers. In: Ayhan IH, Palaoglu Ö, Gögüs A, Akarsu ES, Ulusahin A, editors. Current aspects in the psychopharmacology of mood disorders ENCP Regional Metting, Istanbul; 1996; 1996. 772. Angst J. SSRIs: a decade of progress. Symposium SSRIs: a decade of experience Brussels, Belgium; 1996; 1996. 773. Angst J. The epidemiology of dysthymia. In: Fahy TA, Joughin NA, Kent A, Treasure J, editors. Psychiatry Peer selected citations 1996; 1996; 1996. p. 6-11. 774. Angst J. Dysthymia and personality disturbances. (abstract). In: Norman T, Burrows G, Maguire K, editors. Abstracts of the XXth Collegium Internationale Neuro-Psychopharmacologicum Congress Melbourne, Australia; 1996: Europ Neuropsychopharmacol; 1996. p. 222-3. 775. Angst J. Quality of life in anxiety. 8th Congress of Association of European Psychiatrists London; 1996: Eur Psychiatry; 1996. p. 228s. 776. Angst J. Nosologo-mania and comorbidity in psychiatry. 8th Congress of Association of European Psychiatrists London; 1996: Eur Psychiatry; 1996. p. 256s. 777. Angst J. Epidemiology of bipolar disorders: new data. 8th Congress of Association of European Psychiatrists London; 1996: Eur Psychiatry; 1996. p. 302s-3s. 778. Angst J. Panic disorder: history and epidemiology. (abstract). 8th Congress of AEP Satellite Symposium Panic & Depression not all SSRIs are the same; 1996 11 July 1996; London; 1996. 779. Angst J. Boundaries of unhappiness and depression. (abstract). X World Congress of Psychiatry Madrid; 1996; 1996. p. 5. 780. Angst J. Outcome of treated vs. non-treated depressive episodes. (abstract). X World Congress of Psychiatry Madrid; 1996; 1996. p. 142. 781. Angst J. Begrüssung, Einleitung und Schlussdisskussion. Symposium: Therapiresistente Depressionen Ein Leitfaden für die Praxis Zürich; 1996; 1996. 782. Angst J. Persönlichkeitszüge von psychosomatisch und somatisch Erkrankten. Im Spannungsfeld zwischen Spezialisierung und Integration - Perspektiven der Psychiatrie, Psychotherapie und Nervenheilkunde Düsseldorf; 1996: Nervenarzt; 1996. p. 75. 783. Angst J. Diagnose und Epidemiologie der Depression. 5 Jahrestagung zum Thema Depression KPK Waldhaus Chur; 1996; 1996. p. 11-2. 784. Angst J. Epidemiology of depression - results of the Zurich cohort study. (abstract). VIIth Pan-Arab Congress of Psychiatry Lebanon; 1996; 1996. p. 25-6. 785. Angst J. Problem areas in the management of schizophrenia. (abstract). VIIth Pan-Arab Congress of Psychiatry Lebanon; 1996; 1996. p. 34. 786. Angst J. The course of depression. (abstract). VIIth Pan-Arab Congress of Psychiatry Lebanon; 1996; 1996. p. 42. 787. Angst J. Methodische Probleme der Prüfung von Antidepressiva. (abstract). AMDP-Tagung Berlin; 1996; 1996. p. 2. 788. Angst J. The epidemiology of dysthymia. Psychiatr Rev. 1996;1:5-9.

51 789. Angst J. Man müsste optimistisch bleiben. (Interview). Geriatrie Praxis. 1996;5:20-2. 790. Angst J. Soziale Phobie. Lebensqualität stark beeinträchtigt! TW Neurol Psychiatr. 1996;10:3. 791. Angst J, Amrein R, Stabl M. Moclobemide: a paradigm of research in clinical psychopharmacology. 8th Congress of Association of European Psychiatrists London; 1996: Eur Psychiatry; 1996. p. 219s. 792. Angst J, Amrein R, Stabl M. Moclobemide: a paradigm of research in clinical psychopharmacology. Int Clin Psychopharmacol. 1996;11(suppl. 3):3-7. 793. Angst J, Angst F. Terapia e esito a lungo termine di pazienti bipolari gravi e schizo-maniacali. - Treatment and lifetime outcome of severe bipolar and schizo-manic patients. L'influenza dei trattamenti antidepressivi e profilattici sul decorso della malattia maniaco-depressiva Roma; 1996; 1996. p. 9. 794. Angst J, Angst F. Treatment and lifetime outcome of severe bipolar and schizo-manic patients. L'influenza dei trattamenti antidepressivi e profilattici sul decorso della malattia maniaco-depressiva Convegno in occasione del 20o Anniversario del Centro Lucio Bini Roma; 1996 25.-26. Ottobre 1996; 1996. p. 9. 795. Angst J, Degonda M. Epidemiology of sexual problems and dysfunctions in the community. (abstract). 8th Congress of Association of European Psychiatrists London; 1996: Eur Psychiatry; 1996. p. 233s. 796. Angst J, Ernst C. Prämorbide und postmorbide Persönlichkeit bei affektiv Erkrankten. In: Gross G, Huber G, Morgner J, editors. Persönlichkeit, Persönlichkeitsstörung, Psychose 10 Weissenauer Schizophrenie-Symposium Dresden; 1996: Schattauer; 1996. p. 119-32. 797. Angst J, Hochstrasser B. Zurich Study (abstract). In: Trier ZfPIuDU, editor. Inventory of European Longitudinal Studies in the Behavioral and Medical Sciences Update 1990 - 1994. Trier: ZPD; 1996. p. 140. 798. Angst J, Kupfer DJ, Rosenbaum JF. Recovery from depression: risk or reality? Acta Psychiatr Scand. 1996;93:413-9. 799. Angst J, Merikangas K. The depressive spectrum: diagnostic classification and course. 1996 CINP President's Workshop Unipolar major depression: one primary disease or multiple, discrete related disorders and subtypes? Implications for the life course and management of unipolar disorders La Jolla, California, USA; 1996; 1996. p. 16-7. 800. Angst J, Merikangas KR. Affective disorders and headache syndromes in the community (abstract S- 11-2). In: Norman T, Burrows G, Maguire K, editors. XXth Collegium Internationale Neuro- Psychopharmacologicum Congress Melbourne, Australia; 1996: Eur Neuropsychopharmacol; 1996. p. 26-7. 801. Bech P, Angst J. Quality of life in anxiety and social phobia. Int Clin Psychopharmacol. 1996;11(suppl. 3):97-100. 802. Delini-Stula A, Angst J, Stassen HH. Methodologische Aspekte der Erfassung des Wirkungseintritts von Antidepressiva. 4 Drei-Länder-Symposium für Biologische Psychiatrie Würzburg; 1996: Fortsch Neurol Psychiatr; 1996. p. 57. 803. Ernst C, Angst J. Images in psychiatry: the Burghölzli clinic. Am J Psychiatry. 1996;153:816. 804. Ernst C, Angst J, Klesse R, Zuberbühler HU. Unipolar and bipolar disorder: premorbid personality in patients and in community samples. In: Mundt C, Goldstein MJ, Hahlweg K, Fiedler P, editors.

52 Interpersonal factors in the origin and course of affective disorder. London: The Dorset Press; 1996. p. 89-100. 805. Hochstrasser B, Angst J. The Zurich Study: XXII. Epidemiology of gastrointestinal complaints and comorbidity with anxiety and depression. Eur Arch Psychiatr Neurol Sci. 1996;246:261-72. 806. Merikangas KR, Angst J. Post-traumatic headache in the Swiss male cohort study. Schweiz Arch Neurol Neurochir Psychiat. 1996;147:105-8. 807. Merikangas KR, Angst J, Eaton W, Canino G, Rubio-Stipec M, Wacker H, et al. Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force. Br J Psychiatry. 1996;168(suppl. 30):58-67. 808. Merikangas KR, Ernst C, Maier W, Hoyer EB, Angst J. Minor depression. In: Widiger TA, Frances AJ, Pincus HA, Ross R, First MB, Davis WW, editors. DSM-IV Sourcebook. Washington D.C.: American Psychiatric Association; 1996. p. 97-110. 809. Merikangas KR, Hoyer EB, Angst J. Recurrent brief depression. In: Widiger TA, Frances AJ, Pincus HA, Ross R, First MB, Davis WW, editors. DSM-IV Sourcebook. Washington D.C.: American Psychiatric Association; 1996. p. 111-26. 810. Stassen HH, Angst J, Delini-Stula A. Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses. Pharmacopsychiat. 1996;29:87-96. 811. Thompson C, Wilkinson G, Angst J, Kind P, Wade A. Effective management of depression today: report from an interactive workshop. Int Clin Psychopharmacol. 1996;11(suppl. 1):45-50. 812. Angst J. The prevalence of depression. Antidepressant therapy at the dawn of 3rd millenium Back to the future of the monoamine hypothesis Castres; 1997 19th-21th March 1997; 1997. p. 23. 813. Angst J. Die klinische Forschung im Bereich affektiver Erkrankungen. Eine persönliche Sicht. - The clinical research of affective disorders. A personal perspective. Anna Monika Stiftung Jubiläumsschrift 1965-1995; 1997. p. 48-59. 814. Angst J. Minor and recurrent brief depression. In: Akiskal HS, Cassano GB, editors. Dysthymia and the spectrum of chronic depressions. New York London: The Guilford Press; 1997. p. 183-90. 815. Angst J. Epidemiologie der Angststörungen. In: Rockstroh B, Elbert T, Watzl H, editors. Impulse für die Klinische Psychologie Rudolf Cohen zum 1361997. Göttingen Bern Toronto: Hogrefe Verlag für Psychologie; 1997. p. 81-90. 816. Angst J. Depression and anxiety: implications for nosology, course, and treatment. J Clin Psychiatry. 1997;58(suppl. 8):3-5. 817. Angst J. Future trends of psychiatric epidemiology. International Congress on "The State of the Art in Psychiatry", Basle, Switzerland; 1997; 1997. p. 8. 818. Angst J. Recurrent brief psychiatric syndromes: hypomania, depression, anxiety and neurasthenia. In: Judd LL, Saletu B, Filip V, editors. Basic and clinical science of mental and addictive disorders. Basel Freiburg Paris: Karger; 1997. p. 33-8. 819. Angst J. Epidemiology of social phobia. Xth Congress of the European College of Neuropsychopharmacology Vienna; 1997: Eur Neuropsychopharmacol; 1997. p. S84-S5. 820. Angst J. Epidemiology of depression. In: Honig A, Van Praag HM, editors. Depression: neurobiological, psychological and therapeutic advances. Chichester: John Wiley & Sons; 1997. p. 17-29.

53 821. Angst J. Epidémiologie moderne des troubles bipolaires. (abstract). Symposiums Internationaux sur les Troubles Bipolaires de l'Humeur Strassbourg; 1997; 1997. p. 12. 822. Angst J. Psychotherapie und Pharmakotherapie der Depressionen im Vergleich zu Plazebos. Symposium Psychotherapie und Pharmakotherapie der Depression Zürich; 1997; 1997. p. 6-7. 823. Angst J. How common is depression? Serotonin Summit Amsterdam; 1997; 1997. p. 1-E. 824. Angst J. Psychiatric diagnoses - where next? Curr Opin Psychiatry. 1997;10:427-8. 825. Angst J. Nosologische Konzepte in der Psychiatrie. In: Gaebel W, Falkai P, Lehmann E, editors. Psychiatrie heute - Perspektiven für morgen Kurt Heinrich zum 70 Geburtstag. Paderborn München Wien Zürich: Ferdinand Schöningh; 1997. p. 51-64. 826. Angst J. Epidemiology and psychopathology of depression and hypomania. 2 Congresso Nazionale della Società Italiana die Psicopaologia Pisa; 1997: G Italiano Psicopatol; 1997. p. 28. 827. Angst J. Fortnightly review. A regular review of the long term follow up of depression. BMJ. 1997;315:1143-6. 828. Angst J. The prevalence of depression. In: Briley M, Montgomery SA, editors. Antidepressant therapy at the dawn of the third millenium. London: Martin Dunitz; 1997. p. 191-212. 829. Angst J, Angst F. Treatment and lifetime outcome of severe bipolar and schizomanic patients. 2 Congresso Nazionale della Sodietà Italiana di Psicopatologia Pisa; 1997: G Italiano Psicopatol; 1997. p. 29. 830. Angst J, Angst F, Sellaro R. Prognose und Prophylaxe depressiver und schizo-depressiver Erkranklungen. In: Marneros A, Brieger P, editors. Psychiatrie als Therapiefach. Regensburg: Roderer; 1997. p. 105-11. 831. Angst J, Merikangas KR. The depressive spectrum: diagnostic classification and course. J Affect Disord. 1997;45:31-40. 832. Angst J, Merikangas KR, Preisig M. Subthreshold syndromes of depression and anxiety in the community. J Clin Psychiatry. 1997;58(suppl. 8):6-10. 833. Angst J, Sellaro R, Angst F. Long-term outcome and mortality of treated versus untreated bipolar patients. Bipolar Disorder: From Origin to Outcome10th ECNP Congress, Satellite Symposium Vienna; 1997; 1997. p. 8-10. 834. Angst J, Stassen HH. Delayed onset of antidepressant action. Metaanalysis of moclobemide vs fluoxetine studies. Issues of concern in the standardisation and harmonisation of psychotropic drug trials in EuropeVII ECST Strasbourg Forum, 2-3 June; 1997; 1997. 835. Angst J, Stassen HH. Definitions for early onset of antidepressant action. Issues of concern in the standardisation and harmonisation of psychotropic drug trials in EuropeVII ECST Strasbourg Forum; 1997; 1997. 836. Ernst C, Angst J. The Zurich Study XXIV. Structural and emotional aspects of childhood and later psychopathology. Eur Arch Psychiatry Clin Neurosci. 1997;247:81-6. 837. Stassen HH, Angst J, Delini-Stula A. Onset of action under antidepressant treatment. Eur Psychiatry. 1997;12:163-5.

54 838. Stassen HH, Angst J, Delini-Stula A. Delayed onset of action of antidepressant drugs? Survey of recent results. Eur Psychiatry. 1997;12:166-76. 839. Vollenweider FX, Leenders KL, Oye I, Hell D, Angst J. Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol. 1997;7:25-38. 840. Vollenweider FX, Leenders KL, Scharfetter C, Antonini A, Maguire A, Maguire P, et al. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and (18F)fluordeoxyglucose (FDG). Eur Neuropsychopharmacol. 1997;7:9-24. 841. Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J. Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology. 1997;16:357-72. 842. Angst F, Angst J. Suicides among hospitalised patients with mood disorders followed up over 35 to 38 years. (abstract 0-37). The suicidal process challenges for treatment and prevention 7th European Symposium on Suide and Suicidal Behaviour Gent, Belgium; 1998; 1998. 843. Angst F, Sellaro R, Angst J. The natural history of bipolar disorder. (abstract). Paper presented at the Summer Meeting of the British Association for Psychopharmacology Cambridge; 1998: J Psychopharmacol; 1998. 844. Angst J. A brief history of bipolar disorder. J Bipolar Disord. 1998;1:31-6. 845. Angst J. Epidemiology, course and mortality of mood disorders. Symposium on Tailoring Antidepressant Treatment Stockholm, January 20th; 1998; 1998. 846. Angst J. Sexual problems in healthy and depressed persons. Sexual Dysfunction & Depression Bern; 1998 13.03.1998; 1998. p. 1. 847. Angst J. Is dysthymia separate form from major depression? (abstract S.1.3). Abstracts of the 3rd ECNP Regional Meeting, Athens, Greece, April 2-4, 1998; 1998: Eur Neuropsychopharmacol; 1998. 848. Angst J. Modern epidemiology of anxiety states. (abstract). Second International Symposium in Anxiety "Psychopharmacology, Cognition and Treatment" London, March 20-21, 1998; 1998; 1998. 849. Angst J. Epidemiology, clinical features and comorbidiy of : results of the Zurich Cohort Study. Abstracts of the 9th European Symposium, Association of European Psychiatrists, Section Committee Psychiatric Epidemioloy and Social Psychiatry "Epidemiology of Mental Disorders Toward Integration of Biological and Psychosocial Factors" Beaune, France; 1998 16-18.04.1998; 1998. p. 32. 850. Angst J. Klassifikation der Depression aus historischer Sicht. Symposium zu Ehren von Professor Paul Kielholz in der Psychiatrischen Universitätsklinik Basel "Paul Kielholz und die Depressionstherapie - Rückblick und Ausblick". Jatros Neurol Psychiatr Psychother. 1998;14(suppl. 3):S6-S11. 851. Angst J. Panic disorder: history and epidemiology. 20th Congress of the Collegium Internationale Neuro-Psychopharmacologicum, 23 June 1996, Melbourne, Australia and the 8th Congress of the Association of European Psychiatrists, 7 July 1996, London, UK; 1998: Eur Psychiatry; 1998. p. 51s- 5s.

55 852. Angst J. Prevalence, validity and comorbidity of mood disorders. (Epidemiologia zaburzen afektywynch.). XXXIXth Congress of Polish Psychiatrists, Bydgoszcz-Torun, 3-6 June 1998; 1998: Psychiatria Polska; 1998. p. 2-9. 853. Angst J. Persönlichkeitszüge von psychosomatisch und somatisch erkrankten jungen Männern aus der Normalbevölkerung. In: Gaebel W, Falkai P, editors. Zwischen Spezialisierung und Integration - Perspektiven der Psychiatrie und Psychotherapie. Wien New York: Springer; 1998. p. 204-9. 854. Angst J. Dysthymia and personality. Eur Psychiatry. 1998;13:188-97. 855. Angst J. Libidoveränderungen und sexuelle Funktionsstörungen in der Allgemeinpraxis. (abstract). Symposium Restaurant Casino Zürichhorn, Zürich, 18101998: Das Spektrum depressiver Erkrankungen Spezielle Syndrome und Symptome in ihren Konsequenzen für die Therapie; 1998; 1998. 856. Angst J. Can long-term medication reduce the mortality associated with mood disorders. Abstracts of the 53th Annual Meeting Society of Neurology, Psychiatry and Neurosurgery Noviembre 18-21, Vina del Mar, Chile; 1998: Rev Chilena de Neuro-Psiquiatr; 1998. p. 3. 857. Angst J. Subtypes of mood disorders classification, prevalence and validity. Abstracts of the 53th Annual Meeting Society of Neurology, Psychiatry and Neurosurgery Noviembre 18-21, Vina del Mar, Chile; 1998: Rev Chilena de Neuro-Psiquiatr; 1998. p. 15-6. 858. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord. 1998;50:143-51. 859. Angst J. Prévalence, mortalité et devenir au long cours des troubles de l'humeur. (2ème partie). Neurone. 1998;3:158-63. 860. Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol. 1998;13(suppl. 6):S1-S4. 861. Angst J. Treated versus untreated major depressive episodes. Psychopathology. 1998;31:37-44. 862. Angst J, Angst F. Long-term outcome and mortality of bipolar disorder. (abstract). XXIst CINP Congress, 12-16 July, 1998 Glasgow, Scotland; 1998; 1998. p. 13-6. 863. Angst J, Angst F. Prévalence, mortalité et devenir au long cours des troubles de l'humeur (1ère partie). Neurone. 1998;3:137-9. 864. Angst J, Clayton PJ. Personality, smoking and suicide: a prospective study. J Affect Disord. 1998;51:55-62. 865. Angst J, Merikangas KR. Mixed anxiety depression. Psychiatr Hung. 1998;13:263-8. 866. Angst J, Sellaro R, Angst F. Long-term outcome and mortality of treated versus untreated bipolar and depressed patients: a preliminary report. Int J Psychiatry Clin Pract. 1998;2:115-9. 867. Angst J, Stassen HH. Methodische Probleme der Prüfung von Antidepressiva. In: Stieglitz RD, Fähndrich E, Möller H-J, editors. Syndromale Diagnostik psychischer Störungen. Göttingen Bern Toronto Seattle: Hogrefe - Verlag für Psychologie; 1998. p. 5-12. 868. Eichenberger A, Eich D, Angst J. Socioeconomic status, standard of living, and neurotic disorder. (Letter to the editor). Lancet. 1998;352:1706-7.

56 869. Preisig M, Fenton BT, Merikangas KR, Angst J. Comorbidity of mood and anxiety disorders. Abstracts of the 9th European Symposium, Association of European Psychiatrists, Section Committee Psychiatric Epidemiology and Social Psychiatry, "Epidemiology of Mental Disorders Towards Inegration of biological and Psychosocial Factors" Beaune, France, 16-18 April 1998; 1998; 1998. 870. Stassen H, H., Angst J. Delayed onset of action of antidepressants. Fact or fiction? CNS Drugs. 1998;9:177-84. 871. Stassen HH, Angst J, Delini-Stula A. Onset of improvement under fluoxetine and moclobemide. Eur Psychiatry. 1998;13:128-33. 872. Steinhausen H-C, Meier M, Angst J. The Zurich long-term outcome study of child and adolescent psychiatric disorders in males. Psychol Med. 1998;28:375-83. 873. Swendsen JD, Merikangas KR, Canino G, Kessler RC, Rubio-Stipec M, Angst J. The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities. Compr Psychiatry. 1998;39:176-84. 874. Vollenweider FX, Maguire RP, Leenders KL, Mathys K, Angst J. Effects of high amphetamine dose on mood and cerebral glucose metabolism in normals using positron emission tomography (PET). Psychiatry Res: Neuroimaging Section. 1998;83:149-62. 875. Angst J. A dimensional view of today's classification of depressive and anxiety states. Salud Mental. 1999;22(Numero Especial):42-7. 876. Angst J. Personality features of bipolar versus depressive patients. Psicopatologia: neuroscienze e umanesimo 4o Congresso Nazionale della Società Italiana de Psicopatologia Firenze; 1999 March 3-7 1999; 1999. 877. Angst J. Verlauf psychotischer und nichtpsychotischer affektiver Erkrankungen. In: Gross G, Klosterkötter J, Schüttler R, editors. 50 Jahre Psychiatrie Symposion am 13 Dezember 1996 in Bonn Veranstaltet von der Weissenauer Arbeitsgemeinschaft für Psychosenforschung eV, Bonn aus Anlass des 75 Geburtstages von Professor Dr med Dr hc Gerd Huber. Stuttgart New York: Schattauer; 1999. p. 146-56. 878. Angst J. TOC, épidémie invisible. Symposium Paris 8.5.99 "Le TOC: une maladie a découvrir". Président: Prof. P. Pichot. (abstracts 10-11). 1999; 1999. 879. Angst J. Placebo-controlled trials: a meta-analysis. Abstracts VIII ECST Strasbourg Forum, 9-10 June 1999; 1999; 1999. 880. Angst J. Late-onset depression: long-term course and outcome. In: Marneros A, editor. Late onset mental disorders The Potsdam Conference. London: The Royal College of Psychiatrists, Gaskell; 1999. p. 47-58. 881. Angst J. Laudatio Ambros Uchtenhagen. Eur Addict Res. 1999;5:97-101. 882. Angst J. Epidemiology of bipolar spectrum disorder in community-based studies. Third International Conference on Bipolar disorder June 17-19 1999, Pittsburg, Pennsylvania; 1999; 1999. 883. Angst J. Major depression in 1998: are we providing optimal therapy? J Clin Psychiatry. 1999;60(suppl. 6):5-9.

57 884. Angst J. Geleitwort. In: Marneros A, editor. Handbuch der unipolaren und bipolaren Erkrankungen Gewidmet Herrn Professor Dr med Jules Angst für sein Lebenswerk. Stuttgart New York: Georg Thieme Verlag; 1999. p. XXXVI-XL. 885. Angst J. Categorical and dimensional perspectives of depression. In: Maj M, Sartorius N, editors. Depressive disorders. Chichester New York Weinheim: John Wiley & Sons; 1999. p. 54-6. 886. Angst J. Subthreshold psychiatric syndromes. (abstract P-01-1). In: Lopez-Ibor JJ, Sartorius N, Gaebel W, Haasen C, editors. Psychiatry on new thresholds Abstracts of the XI World Congress of Psychiatry Hamburg, Germany 6-11 August 1999; 1999; 1999. p. 1. 887. Angst J. Course, outcome and mortality of bipolar and schizo-bipolar disorders. (abstract S-31-3). In: Lopez-Ibor JJ, Sartorius N, Gaebel W, Haasen C, editors. Psychiatry on new thresholds Abstracts of the XI World Congress of Psychiatry Hamburg, Germany, 6-11 August 1999; 1999; 1999. p. 88. 888. Angst J. Personality features of bipolar and depressive patients. (abstract S-43-3). In: Lopez-Ibor JJ, Sartorius N, Gaebel W, Haasen C, editors. Psychiatry on new thresholds Abstracts of the XI World Congress of Psychiatry Hamburg, Germany, 6-11 August 1999; 1999; 1999. p. 109. 889. Angst J. Perimenstrual symptoms in the community: prevalence, stability, comorbidity. Eur Neuropsychopharmacol. 1999;9(suppl. 5):S144-S5. 890. Angst J. Angst, Phobie, Zwang und Geschlecht. ZNS Journal. 1999;19:26-33. 891. Angst J. Zum Abschied von Herrn Prof. Dr. med. Christian Scharfetter. Punktuell. 1999(113):14. 892. Angst J. Spektrum zaburzen depresyinch. Nowe moziwosci terapii - efectin. Gdansk, 4 Oktober, Warszawa, 6 Oktober, Krakow, 8 Oktober; 1999; 1999. 893. Angst J. Modern epidemiology of anxiety. UCB Pharma Sector. 1999;1. 894. Angst J. Depression screening and suicide risk. (discussion). 1999: J Clin Psychiatry; 1999. p. 51-2. 895. Angst J. Suicide risk in different patient populations. (discussion). 1999: J Clin Psychiatry; 1999. p. 75- 6. 896. Angst J. Modern epidemiology of anxiety: results of the Zurich Cohort Study. Hum Psychopharmacol Clin Exp. 1999;14:S29-S37. 897. Angst J. Modern epidemiology of anxiety.; 1999. 898. Angst J, Angst F, Stassen HH. Suicide risk in patients with major depressive disorder. J Clin Psychiatry. 1999;60(suppl. 2):57-62. 899. Angst J, et al. Medical intervention and suicide risk. (discussion). J Clin Psychiatry; 1999; 1999. p. 111-2. 900. Angst J, Ferrero F. State of the art in psychiatry. (abstract). Symposium state of the art in psychiatry 26 June 1999 Berne; 1999; 1999. p. 3. 901. Angst J, Sellaro R. Personality and antecedents of bipolar, depressive, and anxiety syndromes in young adults. Retrospective data from the Zurich Cohort Study. (abstract S-96-4). In: Lopez-Ibor JJ, Sartorius N, Gaebel W, Haasen C, editors. Psychiatry on new thresholds Abstracts of the XI World Congress of Psychiatry Hamburg, Germany, 6-11 August, 1999; 1999; 1999. p. 207. 902. Hendin H, Angst J, et al. Medical intervention and suicide risk. (discussion). J Clin Psychiatry; 1999; 1999. p. 111-2.

58 903. Jamison KR, Angst J, al. e. Consensus discussion.; 1999: J Clin Psychiatry; 1999. p. 113-6. 904. Jamison KR, Angst J, et al. Suicide risk in different patient populations. (discussion). 1999: J Clin Psychiatry; 1999. p. 75-6. 905. Marneros A, Crow T, Tsuang MT, Maj M, Angst J. Schizoaffective disorders: the state of the art. (abstract S-31-1). In: Lopez-Ibor JJ, Sartorius N, Gaebel W, Haasen C, editors. Psychiatry on new thresholds Abstracts of the XI World Congress of Psychiatry Hamburg, Germany, 6-11 August 1999; 1999. p. 87. 906. Stassen HH, Angst J. The timing of recovery from depression. (abstract S-172-4). In: Lopez-Ibor JJ, Sartorius N, Gaebel W, Haasen C, editors. Psychiatry on new thresholds Abstracts of the XI World Congresss of Psychiatry Hamburg, Germany, 6-11 August 1999; 1999. p. 349. 907. Stassen HH, Angst J, Delini-Stula A. Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement. Pharmacopsychiatry. 1999;32:56-60. 908. Stotz G, Woggon B, Angst J. Psychostimulants in the therapy of treatment-resistant depression. Review of the literature and findings from a retrospective study in 65 depressed patients. Dialogues in Clinical Neuroscience. 1999;1:165-74. 909. Akiskal H, Bourgeois ML, Angst J, Post R, Möller HJ, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord. 2000;59(suppl. 1):S5-S30. 910. Angst J. Threshold and subthreshold affective syndrome: epidemiology and clinical relevance. 5 Congresso Nazionale della Società Italiana di Psicopatologia: La mente e il suo cervello tra ordine, disordine e intervento terapeutico Roma 23-27 Febraio 2000; 2000; 2000. p. 10. 911. Angst J. Associations between psychosomatic and affective syndromes. Abstracts of the 23rd European Congress of Psychosomatic Research June 17-21, Oslo, Norway; 2000: J Psychosom Res; 2000. 912. Angst J. Bipolar disorder: importance in correct diagnosis and initial treatment. Satellite Symposium: New options to optimise treatment outcomes in bipolar disorder, XXIInd CINP Congress, Brussels, July 9 to 13, 2000. Programme and Abstract Book, p 4-5. 2000; 2000. 913. Angst J. Recurrent brief depression: past and future. Abstracts from the XXIInd CINP Congress, Brussels, July 9-13, 2000.; 2000: Neuropsychopharmacology; 2000. p. S 42.3. 914. Angst J. Bipolare Erkrankungen: Epidemiologie und Verlauf. Symposium Bipolare Störungen Aktuelle Behandlungskonzepte in der Akut- und Langzeittherapie 9 November 2000; 2000; Basel: Psychiatrische Universitätsklinik; 2000. 915. Angst J. Longterm observation of depression. La depresion a largo plazo. Como afrontar la depresion en el siglo XXI 23 de noviembre de 2000; 2000; Barcelona: Lundbeck; 2000. 916. Angst J. TOC: une épidémie invisible. Rev Prat Med Gen. 2000;Numéro spécial (Novembre):3-5. 917. Angst J. Temperament and personality types in bipolar patients: a historical review. In: Marneros A, Angst J, editors. Bipolar disorders 100 years after manic-depressive insanity. Dordrecht, Boston, London: Kluwer Academic Publishers; 2000. p. 175-99. 918. Angst J. Course and prognosis of mood disorders. In: Gelder MG, Lopez-Ibor (Jr) JJ, Andreasen NC, editors. New Oxford Textbook of Psychiatry. Oxford: Oxford University Press; 2000. p. 719-24.

59 919. Angst J. Epidemiologie der Angststörungen. 2 Symposium Privatklinik Meiringen Diagnose und Therapie von Angststörungen - Der heutige Stand (State of the art in diagnosis and treatment of anxiety disorders); 2000 June 30th 2000; Meiringen; 2000. 920. Angst J, Angst F, Sellaro R, Zhang H. Longterm course of bipolar disorder. Eur Psychiatry. 2000;15(suppl. 2):S27.01. 921. Angst J, Angst F, Stassen HH, Clayton P. Prevention of suicides by long-term treatment with anti- depressant. Eur Psychiatry. 2000;15(suppl. 2):S39.04. 922. Angst J, Merikangas KR. Migraine: what does comorbidity tell us? Abstracts from the XXIInd CINP Congress Brussels, July 9-13, 2000; 2000: Neuropsychopharmacology; 2000. p. EW.11.1. 923. Angst J, Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry. 2000;48:445-57. 924. Angst J, Sellaro R. Epidemiology, course and comorbidity of insomnia. IV Zjazd Polskiego towarzystwa Badan nad Snem. 2000. 925. Angst J, Sellaro R. Epidemiologie der Angststörungen. 2 Symposium, 30 Juli 2000, Privatklinik Meiringen Diagnose und Thrapie von Angststörungen - Der heutige Stand - Epidemiology of anxiety disorders - State of the art in diagnosis and treatment of anxiety disorders; 2000; 2000. 926. Angst J, Sellaro R, Merikangas KR. Depressive spectrum diagnoses. Compr Psychiatry. 2000;41(suppl. 1):S39-S47. 927. Angst J, Sellaro R, Zhang H, Merikangas K. Die atypische Depression - eine Frauenkrankheit? Psychiatrie und Psychosomatik in der Gynäkologie. 4 Kongress: Psychiatrische Erkrankungen bei Frauen, 16 - 18 November 2000; 2000; Bonn: Universitäts-Frauenklinik; 2000. 928. Angst J, Stassen H, H. Delayed onset of action of antidepressants: fact or fiction? In: Palmer KJ, editor. Controversies in depression management: Adis International; 2000. p. 1-9. 929. Angst J, Stassen HH. Früher Wirkungseintritt von Antidepressiva. Tagung der Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie eV (AMDP) Bonn, 2 - 4 November 2000; 2000; 2000. 930. Delini-Stula A, Cameron A, Angst J. Comparative efficacy of antidepressants on anxiety features in depression: a meta-analysis of double-blind studies of imipramine and moclobemide against placebo. Int J Psychiatry Clin Pract. 2000;4:111-7. 931. Marneros A, Angst J, editors. Bipolar Disorders. 100 years after manic-depressive insanity. Dordrecht, NL: Kluwer Academic Publisher B.V.; 2000. 932. Marneros A, Angst J. Preface. In: Marneros A, Angst J, editors. Bipolar disorders 100 years after manic-depressive insanity. Dordrecht, Boston, London: Kluwer Academic Publishers; 2000. p. xv-xvii. 933. Marneros A, Angst J. Bipolar disorders: roots and evolution. In: Marneros A, Angst J, editors. Bipolar disorders 100 years after manic-depressive insanity. Dordrecht Boston London: Kluwer Academic Publishers; 2000. p. 1-36. 934. Ajdacic-Gross V, Huber H, Eich D, Angst J, Rössler W. The Zurich Study: changing factors characterizing drop-outs in 5 follow-ups within 20 years. IEA-Kongress; 2001; Oxford; 2001. 935. Angst J. Prevalence of subthreshold mood disorders in young adults. Giornale Italiano di Psicopatologia. 2001;7(suppl.):61.

60 936. Angst J. TOC: une épidémie invisible. Rev Prat Med Gen. 2001(Numéro special):4-6. 937. Angst J. Prophylaxis in depression. Long-term treatment of affective disorders - what has recently changed? 7th WCBP, Berlin 2001 Abstract book; 2001; Berlin (1-6 July); 2001. p. 14-5. 938. Angst J. Vulnerability to bipolar and depressives syndromes: results from a prospective cohort study of a community sample. World J Biol Psychiatry. 2001;2(suppl. 1):S106. 939. Angst J. Zur Epidemiologie von Schlafstörungen bei jungen Erwachsenen. In: Rüther E, Gruber-Rüther A, Heuser MP, e.V. DDGfKuPdA, editors. Träume. Innsbruck: Verlag Integrative Psychiatrie; 2001. p. 1-7. 940. Angst J. The bipolar spectrum: epidemiology and clinical validity. Bipolar spectrum: therapeutic advances International Academy for Biological and Drug Research, Florence, Italy 2001; 2001 November 16-17, 2001; Florence, Italy, November 16-17 2001; 2001. p. 17-9. 941. Angst J. Editorial. Psychiatric Networks. 2001;4:5-9. 942. Angst J, Gamma A. The long-term course of anxiety spectrum: complex panic, panic, GAD and subthreshold recurrent brief anxiety (RBA). Eur Neuropsychopharmacol. 2001;11(suppl. 2):S32. 943. Angst J, Gamma A, Sellaro R, Zhang H, Merikangas K. The validity of atypical depression in the community: results of the Zurich Cohort Study. J Affect Disord. 2001;in print. 944. Angst J, Marneros A. Bipolarity from ancient to modern times: conception, birth and rebirth. J Affect Disord. 2001;67:3-19. 945. Angst J, Merikangas KR. Multi-dimensional criteria for the diagnosis of depression. J Affect Disord. 2001;62:7-15. 946. Angst J, Sartorius N, (eds.). Suicide: the differences in ages and gender. Int Clin Psychopharmacol. 2001;16(suppl. 2). 947. Angst J, Scharfetter C. Gedanken zum schizophrenen Spektrum aus epidemiologischer Sicht. Fortschr Neurol Psychiat. 2001;69(Sonderheft 2):S92-S4. 948. Angst J, Sellaro R. Geschlecht und Angsterkrankung, Phobien und Zwangsstörungen. In: Riecher- Roessler A, Rohde-Dachser C, editors. Psychische Erkrankungen bei Frauen Für eine geschlechtersensible Psychiatrie und Psychotherapie. Basel: Karger; 2001. p. 62-72. 949. Angst J, Sellaro R, Gamma A. Insomnien: Definition, Epidemiologie, Symptomatik, Persönlichkeit, Verlauf und Komorbidität. Neue Therapiewege bei Depression, Angst und Schlafstörung 2 Regionaltreffen der AGNP, Dresden 2001; 2001; Dresden, 28.-29.Juli; 2001. p. 29. 950. Angst J, Sellaro R, Stolar M, Merikangas KR, Endicott J. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand. 2001;104:110-6. 951. Angst J, Stassen H, H. Do antidepressants really take several weeks to show effect? In: Leonard BE, editor. Antidepressants. Basel / Switzerland: Birkhäuser Verlag; 2001. p. 21-30. 952. Angst J, Stassen HH, Angst F. Suicide prevention and mood disorders. World Psychiatric Association SEP-AEN-SEPB, International Congress Madrid, September 30 - October 4, 2001, Abstracts book. Actas Esp Psiquiatr; 2001; 2001. p. 14. 953. Gamma A, Angst J. Concurrent psychiatric comorbidity and multimorbidity in a community study: gender differences and quality of life. Eur Arch Psychiatry Clin Neurosci. 2001;251(suppl. 2):II/43-II/6.

61 954. Hantouche E, Angst J, Lancrenon S, Hamel NH, Errieau G, Deleuze MP. Dépistage du TOC en médecine générale. Résultats de l'étude "AR-TOC". Rev Prat Med Gen. 2001;15:931-6. 955. Hasler G, Schnyder U, Klaghofer R, Angst J. A naturalistic retrospective study on treatment of depressive disorders with and without psychotropic medication. World J Biol Psychiatry. 2001;2(suppl.):141S. 956. Montgomery S, Van Zwietenboot B, Angst J, Bowden CL, Calabrese JR, al. e. ECNP Consensus Meeting March 2000 Nice. Guidelines for investigating efficacy in bipolar disorder. Eur Neuropsychopharmacol. 2001;11:79-88. 957. Preisig M, Merikangas KR, Angst J. Clinical signifiance and comorbidity of subthreshold depression and anxiety in the community. Acta Psychiatr Scand. 2001;104:96-103. 958. Sartorius N, Angst J. Preface: suicide in population subgroups. Clin Psychopharmacol. 2001;16(suppl. 2):i-ii. 959. Ajdacic-Gross V, Eich D, Schönauer I, Huber H, Angst J, Rössler W. Early practice of sport is associated with lesss complaints and higher life satisfaction in adulthood (Zurich Study). (abstract 168). 2002: Acta Psychiatr Scand; 2002. p. 52. 960. Akiskal HS, Brieger P, Mundt C, Angst J, Marneros A. Temperament und affektive Störungen. Die TEMPS-A-Skala als Konvergenz europäischer und US-amerikanischer Konzepte. Nervenarzt. 2002;73:262-71. 961. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34- 38 years. J Affect Disord. 2002;68(2-3):167-81. 962. Angst J. Foreword. In: Vieta E, editor. Bipolar disorders Clinical and therapeutic progress. Madrid: Editorial Medica Panamericana; 2002. p. XVII-XVIII. 963. Angst J. Atypical depression: a common, clinically relevant disorder. Italian J Psychopathology. 2002;8(suppl.):74 (S35). 964. Angst J. Terminology, history and definition of bipolar spectrum. In: Maj M, Akiskal HS, López-Ibor JJ, Sartorius N, editors. Bipolar disorders. Chichester: Wiley & Sons, LTD; 2002. p. 53-5. 965. Angst J. Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia. Schizophr Res. 2002;57:5-13. 966. Angst J. Epidemiology of bipolar disorder. Bipolar disorders: clinical challenges and treatment choices; 2002; Geneva, 9-10 September 2002: Lilly; 2002. 967. Angst J. Evolution naturelle au long cours du TOC. Iceberg des syndromes obsessionnels compulsifs. Le Nouvel Obsessionnel. 2002;38(numéro special):5-6. 968. Angst J. Chronicity of depression. Optimising the treatment of mood and anxiety disorders; 2002 30th November - 1st December 2002; Versailles: Lundbeck; 2002. p. 5-8. 969. Angst J. Questionnaire d'hypomanie. In: Hantouche, E.G. Les troubles bipolaires de l'humeur. Quotidien médecin. 2002;7089:3. 970. Angst J. Epidemiological changes in bipolar disorders. 2nd international expert review of bipolar disorders; 2002 21.-23.03.2002; Maastricht: RPA Communications; 2002. p. 3.

62 971. Angst J. Künftige Forschungsperspektiven aus klinisch-epidemiologischer Sicht. In: Schreiber W, Lautenbacher S, editors. Zukunftsperspektiven der Psychiatrie (Festschrift zum 60 Geburtstag von Prof Dr Jürgen-Christian Krieg). Marburg; 2002. p. 8-9. 972. Angst J, Angst F, Gamma A, Ajdacic-Gross V, Eich D, Rössler W. Course and outcome of bipolar disorder. Nya behandlingsmöjligheter vid bipolar sjukdom; 2002; Stockholm, 5 september 2002: Lilly; 2002. p. no. 3. 973. Angst J, Angst F, Gamma A, Ajdacic-Gross V, Eich D, Rössler W. Course and outcome of bipolar disorder. Troubles bipolaires: stratégie de traitement Ce que l'on sait déjà, ce qui est nouveau; 2002; Genève, 24 octobre 2002: Lilly; 2002. p. No. 1. 974. Angst J, Endrass J, Gamma A, Ajdacic V, Eich D, Rössler W. Risk factors for mood disorders. In: Van der Meer E, Hafgendorf H, et al., editors. 43 Kongress, 22bis 26 September 2002; 2002 22. - 26. September 2002; Humboldt-Universität, Berlin: Deutsche Gesellschaft für Psychologie.; 2002. p. 208. 975. Angst J, Gamma A. Prevalence of bipolar disorders: traditional and novel approaches. Clin Appr Bipol Disord. 2002;1:10-4. 976. Angst J, Gamma A. A new bipolar spectrum concept: a brief review. Bipolar Disord. 2002;4(suppl. 1):S11-S4. 977. Angst J, Gamma A. Diagnostic issues in bipolar disorder. Update on maintenance treatments for bipolar disorder A data given approach; 2002; Barcelona Spain, 6th October 2002; 2002. p. 4-5. 978. Angst J, Gamma A. History, epidemiology and costs of bipolar disorders. New appraoches in the management of bipolar disorders; 2002; Brussels, November 16, 2002; 2002. p. No. 2. 979. Angst J, Gamma A. The evolving epidemiology of bipolar disorder. World Psychiatry. 2002;1:146-8. 980. Angst J, Gamma A, Ajdacic-Gross V, Eich D, Rössler W. The iceberg of obsessive-compulsive syndromes. (abstract S27.1). Eur Psychiatry; 2002; 2002. p. S45. 981. Angst J, Gamma A, Ajdacic-Gross V, Eich D, Rössler W. Gender differences in the prevalence of affective disorders. (abstract SES05.1). Eur Psychiatry; 2002; 2002. p. S27. 982. Angst J, Gamma A, Endrass J, Angst F. Affective spectra: a new bipolar concept and new clinical perspectives. Italian J Psychopathology. 2002;8(suppl.):10. 983. Angst J, Gamma A, Gastpar M, Lépine J-P, Mendlewicz J, Tylee A. Gender diffferences in depression. Epidemiological findings from European DEPRES I and II studies. Eur Arch Psychiatry Clin Neurosci. 2002;252:201-9. 984. Angst J, Gamma A, Sellaro R, Zhang H, Merikangas K. Toward validation of atypical depression in the community: results of the Zurich cohort study. J Affect Disord. 2002;72:125-38. 985. Angst J, Hantouche E. Epidemiología del trastorno bipolar menor y de la hipomanía: un territorio nuevo. In: Vieta E, editor. Hipomanía. Madrid: Aula Médica; 2002. p. 13-31. 986. Angst J, Hantouche EG. The epidemiology of minor bipolar disorder and hypomania: new territory. (manuscript). In: Vieta E, Angst J, editors. Hypomania. Madrid: Grupo Aula Medica; 2002. p. 13-31. 987. Angst J, Sellaro R, Merikangas KR. Multimorbidity of psychiatric disorders as an indicator of clinical severity. Eur Arch Psychiatry Clin Neurosci. 2002;252:147-54.

63 988. Bauer M, Whybrow PC, Angst J, Versiani M, Möller H-J. World Federation of Societies od Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 2: maintenance treatment of major depressive disorders and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry. 2002;3:69-86. 989. Bauer M, Whybrow PC, Angst J, Versiani M, Möller H-J, Force WT. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatry. 2002;3:5-43. 990. Eich D, Huber H, Ajdacic-Gross V, Angst J, Rössler HW. Heart complaints in the Zurich study: associations with depressive complaints. (abstract 142). Acta Psychiatr Scand; 2002; 2002. p. S46. 991. Eriksson E, Endicott J, Andersch B, Angst J, Demyttenaere F, Facchinetti F, et al. New perspectives on the treatment of premenstrual syndrome and premenstrual dysphoric disorder. Arch Womens Ment Health. 2002;4:111-9. 992. Hantouche EG, Angst J, Kochmann FJ, Lancrenon S, Deleuze MP, Allilaire JF. Structure factorielle des obsessions-compulsions: résultats dans une population de 3500 patients dépistés en médecine générale. Ann Méd Psychol. 2002;160:25-33. 993. Hantouche EG, Demonfaucon C, Angst J, Perugi G, Allilaire JF, Akiskal HS. Trouble obsessionnel compulsif cyclothymique. Caractéristiques cliniques d'une entité négligée et non reconnue. Presse Med. 2002;31:644-8. 994. Hasler G, Schnyder U, Klaghofer R, Angst J. Treatment of depressive disorders with and without medication - a naturalistic study. Pharmacopsychiatry. 2002;35:235-8. 995. Merikangas KR, Avenevoli S, Acharyya S, Zhang H, Angst J. The spectrum of social phobia in the Zurich cohort study of young adults. Biol Psychiatry. 2002;51:81-91. 996. Stassen HH, Angst J. Wirkung und Wirkungseintritt in der Antidepressiva-Behandlung. In: Böker H, Hell D, editors. Therapie der affektiven Störungen Psychosoziale und neurobiologische Perspektiven. Stuttgart New York: Schattauer; 2002. p. 141-65. 997. Tohen M, Angst J. Epidemiology of bipolar disorder. In: Tsuang MT, Tohen M, editors. Textbook in psychiatric epidemiology. New York: John Wiley & Sons, Inc., Publication; 2002. p. 427-44. 998. Angst J. General aspects of the concepts on transnosography and syndromal spectra. Ital J Psychopathology. 2003;9:26. 999. Angst J. Lifelong course and prognosis of bipolar disorder. Integrating science and medicine for superior outcomes in bipolar disease; 2003 12-15 March 2003; London: Lilly; 2003. 1000. Angst J. Epidemiologie bipolarer Erkrankungen. Behandlungsstrategien bei bipolaren Störungen - ein Überblick über atypische Antipsychotika, Stimmungsstabilisatoren und anderes; 2003 20.03.03; Zurich: Lilly; 2003. p. 1-9. 1001. Angst J. Risk factors for depression and bipolar disorders. 6th Scientific Meeting; 2003 September 24th; Zurich; 2003. 1002. Angst J. Diagnose und Verlauf bipolarer Erkrankungen. In: Lilly ZO, editor. Bipolaren Patienten Perspektiven für das Leben geben; 2003; Wattens (A); 2003. 1003. Angst J. Phänomenologie und Epidemiologie Bipolar-Affektiver Störungen. Internationales Marburger Bipolar-Symposium; 2003 29.11.2003; Marburg; 2003. p. 5-15.

64 1004. Angst J. Epidemiology and course of bipolar disorders. Long-term treatment of affective disorders; 2003 November 14-15 2003; Modena; 2003. 1005. Angst J. Bipolare Erkrankungen - unterschätzte Prävalenz und Komplexität. Krankenpflege. 2003;41:224. 1006. Angst J, Angst F, Gamma A, Ajdacic-Gross V, Eich D, Rössler HW. Epidemiology, course and outcome of bipolar disorders. Nord J Psychiatry. 2003;57:5. 1007. Angst J, Gamma A. Diagnose und Verlauf bipolarer Erkrankungen. Diagnose und Verlauf bipolarer Erkrankungen; 2003; Wien 9. Mai 2003: Lilly; 2003. p. 1-17. 1008. Angst J, Gamma A. The switch from depression to hypomania and mania: fact or fiction? (abstract S0103). 2003: Int J Psychiatry Clin Pract; 2003. p. 291. 1009. Angst J, Gamma A, Ajdacic V, Eich D, Rössler W, Stassen HH. The spectrum approach to psychiatric nosology: application of longitudinal community study data to define psychiatric phenotypes. Theory, evidence and psychiatric epidemiology; 2003 9.-11.07.2003; Paris: Europa Organisation; 2003. 1010. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rössler HW. Diagnostic issues in bipolar disorder. Eur Neuropsychopharmacol. 2003;13:S43-S50. 1011. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rössler W. Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord. 2003;73:133-46. 1012. Angst J, Gamma A, Endrass J. Risk factors for the bipolar and depression spectra. Acta Psychiatr Scand. 2003;108(suppl. 418):S15-S9. 1013. Angst J, Gamma A, Gastpar M, Lépine J-P, Mendlewicz J, Tylee A. Age and gender differences in depression. Epidemiological findings from the European DEPRES I study. Eur Arch Psychiatr Neurol Sci. 2003;in preparation. 1014. Angst J, Gamma A, Neuenschwander M, Ajdacic V, Eich D, Rössler W. Syndrom-Spektren im Längsschnitt: Angst, Depression, Hypomanie und Alkohol. In: Soyka M, Möller H-J, Wittchen H-U, editors. Psychopathologie im Längsschnitt Methoden - Analyse - Bewertung. Landsberg/Lerch: Ecomed; 2003. p. 15-27. 1015. Angst J, Gamma A, Sellaro R, Lavori P, Zhang H. Recurrence of bipolar disorders and major depression. A life-long perspective. Eur Arch Psychiatry Clin Neurosci. 2003;253:236-40. 1016. Angst J, Gamma A, Stassen HH, Ajdacic V, Eich D, Rössler W. A longitudinal syndrome-oriented approach to phenotypic heterogeneity. (abstract 7). 2003: Pharmacopsychiatry; 2003. p. 211. 1017. Angst J, Pezawas L, Gamma A, Ajdacic-Gross V, Eich D. Dépressions brèves, récurrentes. In: Olié J- P, Poirier MF, Lôo H, editors. Les maladies dépressives. 2e ed. Paris: Médecine-Sciences Flammarion; 2003. p. 291-305. 1018. Burns T, Eichenberger A, Eich D, Ajdacic-Gross V, Angst J, Rössler W. Which individuals with affective sympoms seek help? Results from the Zurich epidemiological study. Acta Psychiatr Scand. 2003;108:419-26. 1019. Carta MG, Altamura AC, Hardoy MC, Pinna F, Medda S, Dell'Osso L, et al. Is recurrent brief depression an expression of mood spectrum disorders in young people? Arch Psychiatry Clin Neurosci. 2003;253:149-53.

65 1020. Carta MG, Hardoy MC, Usai P, Carpiniello B, Angst J. Recurrent brief depression in celiac disease. J Psychosom Res. 2003;55:573-4. 1021. Eich D, Ajdacic-Gross V, Condrau M, Huber H, Gamma A, Angst J, et al. The Zurich study: participation patterns and symptom checklist 90-R scores in six interviews, 1979-99. Acta Psychiatr Scand. 2003;108(suppl. 418):S11-S4. 1022. Endrass J, Angst J, Gamma A, Gallo WT, Ajdacic-Gross V, Eich D, et al. Premorbid personality in bipolar II disorders, with reference to family genetics. Results of a prospective epidemiological study. Neurol Psychiatry Brain Res. 2003;10:121-4. 1023. Hantouche EG, Angst J, Akiskal HS. Factor structure of hypomania: interrelationships with and the soft bipolar spectrum. J Affect Disord. 2003;73:39-47. 1024. Hantouche EG, Angst J, Demonfaucon C, Perugi G, Lancrenon S, Akiskal HS. Cyclothymic OCD: a distinct form? J Affect Disord. 2003;75:1-10. 1025. Haro JM, Goetz I, Reed C, Nolen WA, Van Os J, Vieta E, et al. European mania in bipolar longitudinal evaluation of medication (EMBLEM) study: study design and recruitment of a 2-year, Pan-European, observational health outcomes study in bipolar disorder. 5th International Conference on bipolar disorder; 2003; Pittsburgh (USA); 2003. p. 52-3. 1026. Hasler G, Lissek S, Milos G, Gamma A, Ajdacic V, Eich D, et al. Mental health, health habits, and body weight variability.(Poster). 7th annual intramural research program's scientific retreat; 2003 September 22-23; National Institute of Mental Health, Bethesda USA; 2003. 1027. Merikangas KR, Zhang H, Avenevoli S, Acharyya S, Angst J. Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich cohort study. Arch Gen Psychiatry. 2003;60:993-1000. 1028. Pezawas L, Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Recurrent brief depression - past and future. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:75-83. 1029. Pezawas L, Wittchen H-U, Pfister H, Angst J, Lieb R, Kasper S. Recurrent brief depressive disorder reinvestigated: a community sample of adolescents and young adults. Psychol Med. 2003;33:407-18. 1030. Stassen HH, Angst J, Szegedi A. How to assess the onset of antidepressant effect: empirical data on 2788 patients. (abstract 278). 2003: Pharmacopsychiatry; 2003. p. 265. 1031. Szegedi A, Angst J. Wann beginnen Antidepressiva zu wirken? Symposium: Neue Prädiktoren eine Therapieresponse bei depressiven Störungen 21112003; 2003: Nervenarzt; 2003. p. S211-S2. 1032. Szegedi A, Angst J, Stassen HH. Time course of response to antidepressant drug treatment: Are there gender differences? (abstract 282). 2003: Pharmacopsychiatry; 2003. p. 266. 1033. Wang PS, Tohen M, Bromet E, Angst J. Psychiatric Epidemiology. In: Tasman A, Kay J, Lieberman JA, editors. Psychiatry Second Edition. Chichester: John Wiley & Sons Ltd.; 2003. p. 211-33. 1034. Ajdacic-Gross V, Eich D, Horvath S, Gamma A, Angst J, Rössler W. Filter questions related to psychic and somatic complaints in the Zurich Study: convergence or divergence? Acta Psychiatr Scand. 2004;110(Suppl):33. 1035. Ajdacic-Gross V, Lauber C, Eich D, Gamma A, Angst J, Rössler W. Wie oft kommen Heilpraktiker und Alternativmediziner bei der Behandlung von psychischen Beschwerden zum Zug? Epidemiologische Daten aus der Zürich-Studie.; 2004: Nervenarzt; 2004. p. S373 (abstract 1072).

66 1036. Angst J. 50 years of psychiatric pharmacotherapy: A clinician's view. Eur Psychatry. 2004;19(Suppl 1):28s. 1037. Angst J. Hypomania: definition, assessment, prevalence and clinical significance. IX Congresso Nazionale della Società Italiana di Psicopatologia; 2004 April 1-4 2004; Rome; 2004. p. 57-69. 1038. Angst J. Bipolar disorder. A seriously underestimated health burden. Eur Arch Psychiatry Clin Neurosci. 2004;254:59-60. 1039. Angst J. Neurasthenie: Konzept und Epidemiologie. Psychiatrie der Stress-Erkrankungen; 2004 June 17, 2004; Meiringen; 2004. 1040. Angst J. Bipolar disorder. Workshop Bipolar; 2004 May 15, 2004; Lissabon; 2004. 1041. Angst J. Painting a portrait of accurate diagnosis for the best patient outcome. XXIVth CINP Congress; 2004 June 20-24, 2004; Paris; 2004. 1042. Angst J. Painting a portrait of accurate diagnosis for the best patient outcome. Int J Neuropsychopharmacol. 2004;7(Suppl 1):S104. 1043. Angst J. Fifty years in psychiatry: from psychotherapy to pharmacotherapy and long-term follow-up studies. In: Ban TA, Healy D, Shorter E, editors. Reflections on twentieth-century psycho- pharmacology. Budapest: Animula Publishing House; 2004. p. 195-201. 1044. Angst J. Bipolare Erkrankungen: Prävalenz und Komorbidität. Neue Ansätze bei der Therapie der Bipolaren Erkrankung; 2004 30.01-1.02.2004; Palma de Mallorca; 2004. p. 7-9. 1045. Angst J. Mood disorders: myth and fact.; 2004: Europ Arch Psychiat Neurol Sci; 2004. p. S5 (abstract 1). 1046. Angst J. Pharmakotherapie im wechselnden politischen Umfeld.; 2004: Nervenarzt; 2004. p. S400 (abstract 0687). 1047. Angst J. The mood spectrum: improving the diagnosis of bipolar disorder. Towards the reconstruction of the depressive phenotype. (dias). 17th Congress of the European College of Neuropsychopharmacology; 2004; Stockholm, Sweden; 2004. p. 1-4. 1048. Angst J. Bipolar II disorder facilitates progression of alcoholism. (abstract). The Life Course Epidemiology of Mental Disorders; 2004; Bristol and Bath, England: International Federation of Psychiatric Epidemiology; 2004. p. 20. 1049. Angst J. Drug use trajectories in a probability sample of young adults. (abstract). The Life Course Epidemiology of Mental Disorders; 2004; Bristol and Bath: International Federation of Psychiatric Epidemiology; 2004. p. 20-1. 1050. Angst J. Dinge zu bezweifeln... an jeder Sache ewas zu sehen suchen...: Ein Geleitwort. In: Marneros A, editor. Das Neue Handbuch der Bipolaren und Depressiven Erkrankungen. Stuttgart: Georg Thieme; 2004. p. XXXIII-XXXVI. 1051. Angst J, Angst F, Gamma A, Eich D, Ajdacic V, Rössler W. Bipolar disorder: epidemiology, diagnosis and long-term treatment. Lilly Club of Psychopharmacology Switzerland (LCPS); 2004 16.-17.12.2004; Zürich; 2004. 1052. Angst J, Angst F, Gerber-Werder R, Gamma A. Mortality and affective disorders: A prospective life- long patient study. Eur Psychiatry. 2004;19(suppl. 1):12s.

67 1053. Angst J, Angst F, Gerber-Werder R, Gamma A. Mortality in mood-disorder patients with and without long-term medication.; 2004: Europ Neuropsychopharmacol; 2004. p. S144-S5 (abstract S.18.01). 1054. Angst J, Gamma A. Unipolar mania: clinical characteristics and validity of the concept. Ital J Psychopathol. 2004;10(Suppl 1):19. 1055. Angst J, Gamma A. Gender differences in affective disorders: a brief review. In: Genazzani AR, editor. Hormone replacement therapy and the brain The current status of research and practice. London: Parthenon Publishing; 2004. p. 100-6. 1056. Angst J, Gamma A. Bipolare Störungen als lebenslanges Schicksal. (abstract). Leben mit Manie und Depression; 2004; Hamburg: Deutsche Gesellschaft für Bipolare Störungen e.V.; 2004. p. 3. 1057. Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Prevalence and clinical significance of subthreshold mood disorders. Int J Neuropsychopharmacol. 2004;7(Suppl 1):S50. 1058. Angst J, Gamma A, Endrass J, Goodwin R, Ajdacic V, Eich D, et al. Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course. Eur Arch Psychiatry Clin Neurosci. 2004;254:156-64. 1059. Angst J, Gamma A, Stassen HH. The clinical action of drugs. Lilly Club of Psychopharmacology Switzerland (LCPS); 2004 16.-17.12.2004; Zürich; 2004. 1060. Angst J, Gerber-Werder R, Zuberbühler H-U, Gamma A. Is heterogeneous? Eur Arch Psychiatry Clin Neurosci. 2004;254:82-91. 1061. Angst J, Hantouche EG, Akiskal HS, Lancrenon S, Chatenet-Duchene L, Gérard DA. Is the hypomania checklist suitable for screening bipolar II disorder? ; 2004: Europ Neuropsychopharmacol; 2004. p. S216-S7 (abstract P.1.098). 1062. Angst J, Hantouche EG, Akiskal HS, Lancrenon S, Châtenet-Duchêne L, Gérard DA. Is the hypomania checklist suitable for screening bipolar II disorder? (poster). 17th Congress of the European College of Neuropsychopharmacology; 2004; Stockholm, Sweden; 2004. 1063. Bauer M, Whybrow P, Angst J, Versiani M, Möller H-J. Biologische Behandlung unipolarer depressiver Störungen. Behandlungsleitlinien der World Federation of Societies of Biological Psychiatry (WFSBP). Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2004. 1064. Eich-Höchli D, Bosca A, Ajdacic-Gross V, Gamma A, Angst J, Rössler W. The Zurich-Study: ADHD- scale and psychiatric disorders? Eur Psychatry. 2004;19(Suppl 1):238-9s. 1065. Eich-Höchli D, Bosca A, Ajdacic-Gross V, Gamma A, Angst J, Rössler W. The Zurich-Study: ADHD- subscale and psychiatric disorders? Preliminary ADHD-Subscale derived from SCL. 12th AEP Congress; 2004 April 14-18 2004; Geneva; 2004. 1066. Eich-Höchli D, Bosca A, Ajdacic-Gross V, Gamma A, Angst J, Rössler W. Preliminary ADHD-subscale derived from SCL: longitudinal aspects. (abstract). 2004: Acta Psychiatr Scand; 2004. p. 11. 1067. Hasler G, Buysse DJ, Klaghofer R, Gamma A, Ajdacic V, Eich D, et al. The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep. 2004;27:661-6. 1068. Hasler G, Gregen PJ, Gamma A, Ajdacic V, Eich D, Rössler W, et al. The longitudinal assocations between panic and asthma. The Zurich cohort study. Neuropsychopharmacology. 2004;29(suppl. 1):S146.

68 1069. Hasler G, Pine DS, Gamma A, Milos G, Ajdacic V, Eich D, et al. The associations between psychopathology and being overweight: a 20-year prospective study. Psychol Med. 2004;34:1047-57. 1070. Hepp U, Gamma A, Schnyder U, Eich-Höchli D, Ajdacic-Gross V, Angst J. Wie zuverlässig sind Angaben zu traumatischen Erfahrungen im zeitlichen Verlauf? ; 2004: Nervenarzt; 2004. p. S206 (abstract 0778). 1071. Hepp U, Gamma A, Schnyder U, Eich-Höchli D, Ajdacic-Gross V, Rössler W, et al. Prävalenz posttraumatischer Belastungsstörungen in der Schweiz.; 2004: Nervenarzt; 2004. p. S201-S2 (abstract 0398). 1072. Horvath S, Ajdacic-Gross V, Eich D, Gamma A, Angst J, Rössler W. Is one question enough? Identifying cases with serious depressive symptoms in the Swiss Household Panel.(Poster). 2004 June 23-26, 2004; Mannheim; 2004. 1073. Horvath S, Ajdacic-Gross V, Eich D, Gamma A, Angst J, Rössler W. Is one question enough? Identifying cases with serious depressive symptoms in the Swiss Household Panel.(Abstract). 2004 June 23-26, 2004: Acta Psychiatr Scand; 2004. p. 13. 1074. Kessing LV, Hansen MG, Andersen PK, Angst J. The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders - a life-long perspective. Acta Psychiatr Scand. 2004;109:339-44. 1075. Lavergne F, Gamma A, Delini-Stula A, Angst J. Mirtazapine reduces quickly emotional pain in depression. Int J Neuropsychopharmacol. 2004;7(Suppl 1):S353. 1076. Lavergne F, Gamma A, Delini-Stula A, Angst J. Mirtazapine reduces quickly emotional pain in depression. (Poster). XXIV CINP Congress; 2004; Paris: Cambridge University Press; 2004. 1077. Lavergne F, Gamma A, Delini-Stula A, Angst J. Mirtazapine reduces quickly "emotional pain" in depression.; 2004: Europ Arch Psychiat Neurol Sci; 2004. p. S26-S7 (abstract 94). 1078. Merikangas KR, Low NCP, Herrell R, Angst J. Familial and longitudinal patterns of comorbidity of migraine and mental disorders. Int J Neuropsychopharmacol. 2004;7(Suppl 1):S33. 1079. Stassen HH, Angst J. Wirkung und Wirkungseintritt in der Antidepressiva-Behandlung. Medizinspektrum. 2004;April:15-7. 1080. Stassen HH, Angst J, Dahmen N, Szegedi A. Do antidepressants really take several weeks to show Effect? (Abstract). 2004: Int J Neuropsychopharmacol; 2004. p. S18-S9. 1081. Szegedi A, Sander T, Dahmen N, Giegling I, Nürnberg P, Rujescu D, et al. A molecular-genetic approach to modelling the onset of action of psychotropic drugs. (Abstract). 2004: Int J Neuropsychopharmacol; 2004. p. S19-S20. 1082. Angst J. Changing nosological perspectives in a changing world. (abstract). In: Cassano GB, Panchieri P, editors. La psichiatria che cambia in un mondo in trasformazione X Congresso Nazionale della Società Italiana di Psicopatologia; 2005; Rom: Pacini Editore; 2005. p. 9. 1083. Angst J. The bipolar spectrum: an overview. (abstract). In: Cassano GB, Panchieri P, editors. La psichiatria che cambia in un mondo in trasformazione X Congresso Nazionale della Società Italiana di Psicopatologia; 2005; Rom: Pacini Editore; 2005. p. 19. 1084. Angst J. Prólogo. In: Vázquez-Barquero J-L, Artal J, Crespo Facorro B, editors. Las fases tempranas de los trastornos bipolares. Barcelona: Masson Publisher; 2005. p. XV-XVI.

69 1085. Angst J. Geleitwort. In: Bauer M, Berghöfer A, Adli M, editors. Akute und therapieresistente Depressionen Pharmakotherapie - Psychotherapie - Innovationen. Heidelberg: Springer; 2005. p. V-VI. 1086. Angst J. Mortality in mood-disorder patients with and without long-term medication. (poster KL07.2). In: Okasha A, Mezzich J, Haasen C, editors. Abstract Book of the XIII World congress of Psychiatry, 5000 Years of Science and Care, Building the Future of Psychiatry Cairo, September 10-15, 2005 Egypt; 2005; 2005. p. 27. 1087. Angst J. Forty years with Paul Grof. [http://groups.msn.com/PaulGrofsFestschrift/documents.msnw]. [Festschrift] 2005 [cited; Available from: http://groups.msn.com/PaulGrofsFestschrift/documents.msnw 1088. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD, et al. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord. 2005;88:217-33. 1089. Angst J, Angst F, Gerber-Werder R, Gamma A. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch Suicide Res. 2005;9(3):279-300. 1090. Angst J, Angst F, Gerber-Werder R, Gamma A. Affective disorder: longitudinal course and impact of long-term medication. (abstract). Pfizer Neuroscience Specialist's Symposium; 2005 4. - 5. März 2005; Oslo: Pfizer Norge; 2005. p. 28. 1091. Angst J, Angst F, Gerber-Werder R, Gamma A. Predictors and prevention of suicide. (abstract). 5th International Forum on Mood and Anxiety Disorders Vienna 9 - 11 November 2005; 2005: Int J Psychiatry Clin Pract; 2005. p. 302. 1092. Angst J, Angst F, Gerber-Werder R, Gamma A, Kessing L. Course of bipolar disorders. (abstract S- 025.01). World Federation of Societies of Biological Psychiatry 8th World Congress of Biological Psychiatry Vienna, Austria; 2005: World J Biol Psychiatry; 2005. p. 10. 1093. Angst J, Benazzi F, Ajdacic-Gross V, Eich-Höchli D, Rössler W, Gamma A. Neurasthenia and atypical depression. (Abstract). In: Sass H, Ackenheil M, Möller HJ, editors. 13th AEP Congress Munich 2005; 2005: European Psychiatry; 2005. p. S117. 1094. Angst J, Cassano G. The mood spectrum: improving the diagnosis of bipolar disorder. Bipolar Disord. 2005;7(suppl. 4):4-12. 1095. Angst J, Gamma A. Mortality of bipolar disorder. (abstract). In: Cassano GB, Panchieri P, editors. La psichiatria che cambia in un mondo in trasformazione X Congresso Nazionale della Società Italiana di Psicopatologia; 2005; Rom: Pacini Editore; 2005. p. 113. 1096. Angst J, Gamma A, Ajdacic V, Eich D, Pezawas L, Rössler W. Recurrent brief depression as an indicator of severe mood disorders. In: Marneros A, Goodwin FK, editors. Bipolar disorders Mixed states, rapid cycling and atypical forms. Cambridge New York Melbourne Madrid Cape Town Singapore São Paulo: Cambridge University Press; 2005. p. 109-30. 1097. Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. 20 years of the Zurich Study: lessons learnt for the screening and understanding of bipolar spectrum disorder. The Fifth International Review of Bipolard Disorders Lyon 2005; 2005: IRBD; 2005. p. 7. 1098. Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Epidemiology of the bipolar spectrum. (abstract). Burden and treatment of bipolar depression Brussels 2005; 2005: GlaxoSmithKline; 2005. p. 6-7. 1099. Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. The contemporary epidemiology of bipolar disorders and the bipolar spectrum. (poster SY130.1). In: Okasha A, Mezzich J, Haasen C, editors. Abstract

70 Book of the XIII World congress of Psychiatry, 5000 Years of Science and Care, Building the Future of Psychiatry Cairo, September 10-15, 2005 Egypt; 2005; 2005. p. 322. 1100. Angst J, Gamma A, Ajdacic V, Eich D, Rössler W, Merikangas KR. The bipolar spectrum: epidemiology and clinical perspectives. (abstract 8). Sixth International Conference on Bipolar Disorder; 2005: Bipol Disord; 2005. p. 18. 1101. Angst J, Gamma A, Ajdacic-Gross V, Eich D, Rössler W. Recurrent brief depression (RBD): epidemiological and clinical characteristics. (abstract S-062.01). World Federation of Societies of Biological Psychiatry 8th World Congress of Biological Psychiatry Vienna, Austria; 2005: World J Biol Psychiatry; 2005. p. 20. 1102. Angst J, Gamma A, Ajdacic-Gross V, Eich D, Rössler W. Recurrent brief depression (RBD): epidemiological and clinical characteristics. XXV CINP Congress, Chicago, 9-13 July 2006; 2005: Int J Neuropsychopharmacol; 2005. p. S63. 1103. Angst J, Gamma A, Ajdacic-Gross V, Eich D, Rössler W, Altamura C. Epidemiology of brief and recurrent brief depression. (abstract). 5th International Forum on Mood and Anxiety Disorders Vienna 9 - 11 November 2005; 2005: Int J Psychiatry Clin Pract; 2005. p. 304. 1104. Angst J, Gamma A, Angst F, Gerber-Werder R, Ajdacic V, Eich D, et al. Is unipolar depression still the most relevant group of affective disorder? (abstract S-043.01). World Federation of Societies of Biological Psychiatry 8th World Congress of Biological Psychiatry Vienna, Austria; 2005: World J Biol Psychiatry; 2005. p. 18. 1105. Angst J, Gamma A, Endrass J, Hantouche E, Goodwin R, Ajdacic V, et al. Obsessive-compulsive syndromes and disorders: significance of comorbidity with bipolar and anxiety syndromes. Eur Arch Psychiatry Clin Neurosci. 2005;255:65-71. 1106. Angst J, Gamma A, Hantouche E, Benazzi F, Ajdacic V, Eich D, et al. 20 years of the Zurich Study: lessons for screening and understanding the bipolar spectrum. Aspects of Affect. 2005;1:109-15. 1107. Angst J, Gamma A, Neuenschwander M, Ajdacic-Gross V, Eich D, Rössler W, et al. Prevalence of mental disorders in the Zurich cohort study: a twenty year prospective study. Epidemiol Psichiatr Soc. 2005;14:68-76. 1108. Angst J, Hantouche E, Akiskal H, Lancrenon S, Châtenet-Duchêne L, Gerard DA. Is the hypomania checklist suitable for screening bipolar II disorder? (Abstract). The Fith International Review of Bipolard Disorders Lyon 2005; 2005: IRBD; 2005. p. 23-4. 1109. Angst J, Hantouche E, Akiskal H, Lancrenon S, Châtenet-Duchêne L, Gerard DA. Is the hypomania checklist suitable for screening bipolar II disorder? Aspects of Affect. 2005;1:117-8. 1110. Angst J, Preisig M. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. (reprint). In: Hartwich P, Barocka A, editors. Schizoaffektive Psychosen Diagnostik und Therapie. Sternenfels: Verlag Wissenschaft & Praxis; 2005. p. 77-102. 1111. Angst J, Preisig M. Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. (reprint). In: Hartwich P, Barocka A, editors. Schizoaffektive Psychosen Diagnostik und Therapie. Sternenfels: Verlag Wissenschaft & Parxis; 2005. p. 103-20.

71 1112. Angst J, Sellaro R, Stassen HH, Gamma A. Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J Affect Disord. 2005;84:149-57. 1113. Carta MG, Angst J. Epidemiological and clinical aspects of bipolar disorders: controversies or a common need to redefine the aims and methodological aspects of surveys. Clin Pract Epidem Mental Health. 2005;1. 1114. Eich-Höchli D, Ajdacic-Gross V, Gamma A, Angst J, Rössler W. The Zurich-Study: ADHD-subscale derived from SCL and psychopathological associations. (poster). 13th AEP Congress Munich; 2005; 2005. 1115. Hajek T, Alda M, Grof P, Angst J. Periodicity of spontaneous course of illness in patients with mood disorders. (abstract PO-039.03). World Federation of Societies of Biological Psychiatry 8th World Congress of Biological Psychiatry Vienna, Austria; 2005: World J Biol Psychiatry; 2005. p. 368. 1116. Hajek T, Alda M, Grof P, Angst J. Periodicity of the spontaneous course of illness in patients with mood disorders. (poster). World Federation of Societies of Biological Psychiatry 8th World Congress of Biological Psychiatry Vienna, Austria; 2005; 2005. 1117. Hardoy MC, Carta MG, Cadeddu M, Campus A, Murru A, Carpiniello B, et al. L'accuratezza dell' "Hypomania Check List-32" (HCL-32) in un campione di individui afferenti ad un servizio psichiatrico universitario. (poster no 147). In: Cassano GB, Panchieri P, editors. La psichiatria che cambia in un mondo in trasformazione X Congresso Nazionale della Società Italiana di Psicopatologia; 2005; Rom: Pacini Editore; 2005. p. 255. 1118. Hasler G, Buysse DJ, Gamma A, Ajdacic V, Eich D, Rössler W, et al. Excessive daytime sleepiness in young adults: a 20-year prospective community study. J Clin Psychiatry. 2005;66:521-9. 1119. Hasler G, Gergen PJ, Kleinbaum DG, Ajdacic V, Gamma A, Eich D, et al. Asthma and panic in young adults. A 20-year prospective community study. Am J Respir Crit Care Med. 2005;171:1224-30. 1120. Hasler G, Lissek S, Ajdacic V, Milos G, Gamma A, Eich D, et al. Major depression predicts an increase in long-term body weight variability in young adults. Obes Res. 2005;13:1991-8. 1121. Hasler G, Pine DS, Kleinbaum DG, Gamma A, Luckenbaugh D, Ajdacic V, et al. Depressive symptoms during childhood and adult obesity: the Zurich Cohort Study. Mol Psychiatry. 2005;10:842-50. 1122. Intilla G, Garofalo A, Carpiniello B, Carta MG, Angst J. La depressione ricorrente breve nell'epatite cronica virale sotto trattamento interferonico. In: Cassano GB, Panchieri P, editors. La psichiatria che cambia in un mondo in trasformazione X Congresso Nazionale della Società Italiana di Psicopatologia; 2005; Rom: Pacini Editore; 2005. p. 258. 1123. Intilla G, Garofalo A, Hardoy MC, Carpiniello B, Carta MG, Angst J. L'elevata frequenza della depressione ricorrente breve nell'epatite cronica virale sotto trattamento interferonico. (poster). La psichiatria che cambia in un mondo in trasformazione X Congresso Nazionale della Società Italiana di Psicopatologia; 2005; Rom; 2005. 1124. Kasper S, Spadone C, Verpillat P, Angst J. is a fast-acting antidepressant: results of a meta-analysis. (Poster). 18th ECNP Congress Amsterdam 2005; 2005; 2005. 1125. Kasper S, Spadone C, Verpillat P, Angst J. Onset of action of escitalopram: results of a pooled analysis. (abstract). 5th International Forum on Mood and Anxiety Disorders Vienna 9 - 11 November 2005; 2005: Int J Psychiatry Clin Pract; 2005. p. 326.

72 1126. Kessler RC, Akiskal HS, Angst J, Fava M, Hirschfeld R, Walters E. Prevalence and effects of mood disorders on role performance in the United States. (abstract 8). Sixth International Conference on Bipolar Disorder; 2005: Bipol Disord; 2005. p. 18. 1127. Lavergne F, Berlin I, Gamma A, Stassen H, Angst J. Onset of improvement and response to mirtazapine in depression: a multicenter naturalistic study of 4771 patients. Neuropsychiatr Dis Treat. 2005;1:59-68. 1128. Oedegaard KJ, Angst J, Neckelmann D, Fasmer OB. Migraine aura without headache compared to migraine with aura in patients with affective disorders. J Headache Pain. 2005;6:378-86. 1129. Pezawas L, Angst J, Kasper S. Recurrent brief depression revisited. Int Rev Psychiatry. 2005;17:63-70. 1130. Pini S, de Queiroz V, Pagnin D, Pezawas L, Angst J, Wittchen HU. Prevalence and burden of bipolar disorders in European countries. Europ Neuropsychopharmacol. 2005;15:425-34. 1131. Rihmer Z, Angst J. Epidemiology of bipolar disorder. In: Kasper S, Hirschfeld RMA, editors. Handbook of bipolar disorder Diagnosis and therapeutic approaches. New York London: Taylor & Francis; 2005. p. 21-35. 1132. Rihmer Z, Angst J. Mood disorders: epidemiology. In: Sadock BJ, Sadock VA, editors. Comprehensive textbook of psychiatry. Philadelphia Baltimore New York London Buenos Aires Hong Kong Sydney Tokyo: Lippincott Williams & Williams; 2005. p. 1575-82. 1133. Stassen HH, Angst J, Dahmen N, Giegling I, Hell D, Rujescu D, et al. Assessment of the onset of action with psychotropic drugs: implications for pharmacogenetics. (abstract S-096-04). World Federation of Societies of Biological Psychiatry 8th World Congress of Biological Psychiatry Vienna, Austria; 2005: World J Biol Psychiatry; 2005. p. 104. 1134. Stassen HH, Angst J, Dahmen N, Gieling I, Rujescu D, Sander T, et al. Can genes control antidepressant response? (abstract). 18th ECNP Congress, 22-26 October 2005, Amsterdam; 2005: European Neuropsychopharmacology; 2005. p. S349. 1135. Stassen HH, Angst J, Scharfetter C. Genetik affektiver Störungen - der quantitative Ansatz Syndrom- orientierter Modelle. In: Deserno H, editor. Depression - Pluralismus in Praxis und Forschung. Göttingen: Vandenhoeck & Ruprecht; 2005. p. 219-57. 1136. Stassen HH, Angst J, Scharfetter C. Therapie mit Antidepressiva. Erfolg von genetischen Faktoren abhängig? Leading Opinions Neurologie Psychiatrie. 2005;6:25-7. 1137. Szegedi A, Angst J, Stassen H. Early improvement as a predictor of treatment outcome with antidepressanst: why the first 2 weeks of treatment really matter. (abstract S-096-02). World Federation of Societies of Biological Psychiatry 8th World Congress of Biological Psychiatry Vienna, Austria; 2005: World J Biol Psychiatry; 2005. p. 103. 1138. von Salis T, Christen L, Christen S, Angst J, Neuenschwander M, Meister U, et al. Liegen dem Wunsch nach Militärdienst-Befreiung psychische Auffälligkeiten zugrunde? Ein Vergleich zwischen Gesuchstellern und einer neutralen männlichen Kontrollstichprobe in Zürich. Schweiz Arch Neurol Psychiat. 2005;156:20-8. 1139. Kozak S, Gantenbein AR, Isler H, Merikangas KR, Angst J, Gamma A, et al. Nosology and treatment of primary headache in a Swiss headache clinic. J Headache Pain. 2005 6:121-7.

73 1140. Ajdacic-Gross V, Horvath S, Canjuga M, Gamma A, Angst J, Rössler W, et al. How ubiquitous are physical and psychological complaints in young and middle adulthood? A longitudinal perspective. Soc Psychiatry Psychiatr Epidemiol. 2006;41:881-8. 1141. Ajdacic-Gross V, Rössler W, Eich D, Gamma A, Angst J. Psychotic experiences in the general population: longitudinal patterns (poster). 14th European Congress of Psychiatry 4-8 March 2006, Nice; 2006; 2006. 1142. Ajdacic-Gross V, Rössler W, Eich D, Gamma A, Angst J. Psychotic experiences in the general population: results from a twenty-year prospective community study (abstract WC6B). In: Birchwood M, McGorry P, editors. 5th International Conference on Early Psychosis 4 - 6 October 2006 Birmingham UK; 2006: Schizophrenia Research; 2006. p. S15. 1143. Angst J. Bipolar schizophrenia overlap 1: has the Kraepelinian dychotomy gone? XIIIth Biennial Winter Workshop on Schizophrenia Research 4-10 February 2006 Davos, Switzerland; 2006: Schizophrenia Research; 2006. p. 3. 1144. Angst J. Detection of hypomania: the hidden highway to correct diagnosis and treatment (abstract). The 6th International Review of Bipolar Disorders London 5-7 April 2006; 2006; 2006. p. 18. 1145. Angst J. Das Spektrum affektiver Störungen: Ein brauchbares Modell? Die Psychiatrie. 2006;2:92-3. 1146. Angst J. Treating mood disorders with long-term outcome in mind: introduction. International Neuroscience Conference, 28-29 April 2006, Paris; 2006; 2006. p. 44-7. 1147. Angst J. Do many patients with depression suffer from bipolar disorder? Can J Psychiatry. 2006;51:3-5. 1148. Angst J. Comment on: Screening for bipolarity: a brief review of available measures and recommendations for future research. E. Youngstrom et al. Aspects of Affect Vol. 1 (2):85-91.; 2006. Report No.: AoA Vol. 1 (2): 85-91. 1149. Angst J. Bipolar bozukluk: dünü, bugünü ve yarını. (abstract). MSS Günleri VI, 28 September - 1 October 2006, Antalya, Turkey; 2006: Pfizer Turkey; 2006. p. 35. 1150. Angst J. The William Sargent Lecture (abstract). The Royal College of Psychiatrists Faculties of General Psychiatry and Rehabilitation & Social Psychiatry Annual Residential Conference 19th - 20th October 2006 Southampton; 2006; 2006. 1151. Angst J. Diagnossystemens validitet. In: Sjöstedt C, editor. Hur giltiga är de psykiatriska diagnoserna? Helsingborg: Lunbeck; 2006. p. 15-26. 1152. Angst J. Geleitwort. In: Greil W, Giersch D, editors. Stimmungsstabilisierende Therapien bei manisch- depressiven (bipolaren) Erkrankungen Ein Fachbuch für Betroffene, Angehörige und Therapeuten. Stuttgart New York: Georg Thieme Verlag; 2006. p. VII-VIII. 1153. Angst J, Angst F, Gerber-Werder R, Gamma A. Epidemiologie und klinische Aspekte von Suiziden. Mental Health Forum, 16 November 2006, Bern; 2006; 2006. 1154. Angst J, Benazzi F, Gamma A, Ajdacic V, Eich D, Rössler W. The gradient of bipolarity between DSM- IV bipolar-II and major depressive disorder (abstract). In: Panchieri P, editor. XI Congresso Nationale della Società Italiana di Psicopatologia Terapia psichiatrica un problema di libertà Roma 21-25 Febbraio 2006; 2006: Giornale Italiano di Psicopatologia; 2006. p. 42. 1155. Angst J, Benazzi F, Gamma A, Ajdacic V, Eich D, Rössler W. The gradient of bipolarity between DSM- IV bipolar-II and majord depressive disorder (abstract). XI Congresso Nazionale della Società Italiana

74 di Psicopatologia Terapia psichiatrica un problema die libertà 21-25 Febbraio 2006, Roma; 2006: Pacini Editore; 2006. p. 42. 1156. Angst J, Gamma A. Verlauf und Ausgang bipolarer Störungen. In: Assion H-J, Vollmoeller W, editors. Handbuch bipolare Störungen Grundlagen - Diagnostik - Therapie. Stuttgart: W. Kohlhammer; 2006. p. 186-94. 1157. Angst J, Gamma A. Bipolare Störungen: Diagnostik, Differentialdiagnostik und Komorbidität. (abstract). 3 Jahrestagung der SGBS (Schweizerische Gesellschaft für bipolare Störungen), 14 September 2006; 2006: SGBS; 2006. 1158. Angst J, Gamma A. Depression, Angst, Bipolar-II-Störung. (abstract). 6 Jahrestagung Deutsche Gesellschaft für Bipolare Störungen eV, Manie und Depression Die soziale Dimension bipolarer Störungen 15-16 September 2006 Nürnberg; 2006: DGBS; 2006. p. 6-7. 1159. Angst J, Gamma A. Die soziale Dimension bipolarer Erkrankungen. Eröffnungsreferat. (abstract). 6 Jahrestagung Deutsche Gesellschaft für Bipolare Störungen eV, Manie und Depression Die soziale Dimension bipolarer Störungen 15-16 September 2006 Nürnberg; 2006: DGBS; 2006. p. 3. 1160. Angst J, Gamma A. Differenzialdiagnostik und Therapie depressiver Syndrome - Möglichkeiten und Grenzen. (Dias). 10 Bad Homburger ZNS-Gespräche Therapie in der Psychiatrie und Neurologie Vergangenheit und Zukunft 9-10 September 2006 Bad Homburg; 2006: Lilly 2006. p. 26-9. 1161. Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. The contemporary epidemiology of bipolar disorders and the bipolar spectrum (abstract). Première Journée du Forum Bipolaire Tunisien Le Forum Bipolaire Tunisien & La Société Tunisienne de Psychiatrie 11 février 2006, Tunis; 2006; 2006. 1162. Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Melancholic, atypical and unspecific major depression: a longitudinal perspective from the Zurich Study. Melancholia: Beyond DSM, Beyond Neurotransmitter? May 1-5, 2006 Copenhagen; 2006; 2006. 1163. Angst J, Gamma A, Ajdacic-Gross V, Rössler W. Neues zur Epidemiologie und Diagnostik bipolarer Erkrankungen. (abstract). DGPPN-Kongress 22 - 25 November 2006 Berlin; 2006; 2006. 1164. Angst J, Gamma A, Ajdacic-Gross V, Rössler W. Welche Umweltfaktoren sind relevant für den Ausbuch von affektiven Erkrankungen? (abstract). DGPPN-Kongress 22 - 25 November 2006 Berlin; 2006; 2006. 1165. Angst J, Gamma A, Ajdacic-Gross V, Rössler W. Dagnosis, long-term course, and outcome of GAD. 6th International Forum on Mood and Anxiety Disorders Treatment of GAD 30 November 2006, Vienna; 2006; 2006. 1166. Angst J, Gamma A, Ajdacic-Gross V, Rössler W. Die klinische Bedeutung von kurzen depressiven und hypomanischen Episoden. Aktuelle Resulatate aus der Zürich-Studie und eine neue Therapieoption der Depression Münsterlingen, 4 Dezember 2006; 2006; 2006. 1167. Angst J, Gamma A, Benazzi F, Silverstein B, Ajdacic-Gross V, Eich D, et al. Atypical depressive syndromes in varying definitions. Eur Arch Psychiatry Clin Neurosci. 2006;256:44-54. 1168. Angst J, Gamma A, Bienvenu OJ, Eaton WW, Ajdacic V, Eich D, et al. Varying temporal criteria for generalized anxiety disorder: prevalence and clinical charactersitics in a young age cohort. Psychol Med. 2006;36:1283-92.

75 1169. Angst J, Gamma A, Endrass J, Rössler W, Ajdacic-Gross V, Eich D, et al. Is the association of alcohol use disorders with major depressive disorder a consequence of undiagnosed bipolar-II disorder? Eur Arch Psychiatry Clin Neurosci. 2006;256:452-7. 1170. Angst J, Hantouche E, Akiskal H, Lancrenon S, Châtenet-Duchêne L, Gerard DA. Is the Hypomania Checklist suitable for screening bipolar II disorder? (abstract). Aspects of Affect. 2006;1:117-8. 1171. Angst J, Hantouche EG, Lancrenon S, Gury C, Gérard D. Dépistage de l'hypomanie au sein des dépressions récurrentes (poster). 4e Congrès de l'Encéphale 11-13 January 2006, Paris; 2006; 2006. 1172. Angst J, Stassen HH. Clinical action of antidepressants. DUAG Symposium 2006 3 November 2006, Fredensborg, Dänemark; 2006; 2006. p. 1. 1173. Borges G, Angst J, Nock MK, Meron Ruscio A, Walters EE, Kessler RC. A risk index for 12-month suicide attempts in the National Comorbidity Survey Replication (NCS-R). Psychol Med. 2006;36:1747- 57. 1174. Carta MG, Hardoy MC, Cadeddu M, Murru A, Campus A, Morosini P, et al. The accuracy of the Italian version of the Hypomania Checklist (HCL-32) for the screening of bipolar disorders and comparison with the Questionnaire (MDQ) in a clinical sample. Clin Pract Epidemiol Ment Health; 2006. 1175. Hantouche E, Angst J, Lancrenon S, Gérard D, Allilaire J-F. Faisabilité de l'autoévaluation dans le dépistage de l'hypomanie. Feasibility of auto-evaluation in the detection of hypomania. Annales Médico Psychologiques. 2006;164:721-5. 1176. Hantouche EG, Angst J, Lancrenon S, Gury C, Gérard D. Dépistage de l'hypomanie au sein des dépressions résistantes (poster). 4e Congrès de l'Encéphale 11-13 January 2006, Paris; 2006; 2006. 1177. Hantouche EG, Angst J, Lancrenon S, Gury C, Gérard D. Faisablilité de l'autoévaluation dans le dépistage de l'hypomanie (poster). 4e Congrès de l'Encéphale 11-13 January 2006, Paris; 2006; 2006. 1178. Hantouche EG, Angst J, Lancrenon S, Gury C, Gérard D. Dépistage du trouble BP-II au sein des dépressions récurrentes en médecin générale (poster). 4e Congrès de l'Encéphale 11-13 January 2006, Paris; 2006; 2006. 1179. Hasler G, Gergen PJ, Ajdacic V, Gamma A, Eich D, Rössler W, et al. Asthma and body weight change: a 20-year prospective community study of young adults. Int J Obes. 2006;30:1111-8. 1180. Hepp U, Gamma A, Milos G, Eich D, Ajdacic-Gross V, Rössler W, et al. Prevalence of exposure to potentially traumatic events and PTSD: The Zurich Cohort Study. Eur Arch Psychiatry Clin Neurosci. 2006;256:151-8. 1181. Hepp U, Gamma A, Milos G, Eich D, Ajdacic-Gross V, Rössler W, et al. Inconsistency in reporting potentially traumatic events. Br J Psychiatry. 2006;188:278-83. 1182. Kasper S, Spadone C, Verpillat P, Angst J. Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis. Int Clin Psychopharmacol. 2006;21:105-10. 1183. Kessler RC, Akiskal HS, Angst J, Guyer M, Hirschfeld RMA, Merikangas KR, et al. Validity of the assessment of bipolar spectrum disorders in the WHO CIDI 3.0. J Affect Disord. 2006;96:259-69.

76 1184. Kessler RC, Akiskal HS, Angst J, Hirschfeld RMA, Merikangas KR, Wang PS, et al. The workplace costs of mood disorders: bringing bipolar spectrum disorders into the equation. Journal of Health and Productivity. 2006;1:3-8. 1185. Rössler W, Eich D, Gamma A, Angst J, Ajdacic-Gross V. Longitudinal analyses of psychotic experiences in the general population. (abstract 380). XIIIth Biennial Winter Workshop on Schizophrenia Research 4-10 February 2006 Davos, Switzerland; 2006: Schizophrenia Research; 2006. p. 185. 1186. Sobocki P, Jönsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ. 2006;9:87-98. 1187. Ajdacic-Gross V, Landolt K, Angst J, Gamma A, Rössler W. Smoking and mental disorders: association derived from longitudinal data over 20 years. In: Höschl C, López-Ibor JJ, editors. 15th AEP Congress, Madrid 17-21 March 2007; 2007: European Psychiatry; 2007. p. S323-S4. 1188. Alciati A, D'Ambrosio A, Foschi D, Corsi F, Mellado C, Angst J. Bipolar spectrum disorders in severely obese patients seeking surgical treatment. J Affect Disord. 2007;101:131-8. 1189. Angst F, Gamma A, Gerber-Werder R, Angst J. Long-term medication prevents suicide in severe affective disorders. A prospective cohort study over 40-44 years (awarded poster). Mental Health in Public Health Swiss Public Health Conference 2007 21 - 22 Juni 2007 Olten, Switzerland; 2007; 2007. 1190. Angst J. The bipolar spectrum. Br J Psychiatry. 2007;190(3):189-91. 1191. Angst J. Problems in diagnosing bipolar disorder (author's reply). Br J Psychiatry. 2007;190:537. 1192. Angst J. Psychiatric diagnoses: the weak component of modern research. World Psychiatry. 2007;6:30- 1. 1193. Angst J. Over- and under-diagnosis of bipolar disorder. Response to Dr. Prakash S. Gangdev and Dr. Ryan O'Neill (e-letter). [e-letter] 2007 [cited 10.08.2007]; Available from: 1194. Angst J, Angst F, Gamma A. Treating mood disorders with long-term outcome in mind. Regional Neuroscience Conference, Kuala Lumpur, Malaysia January 26 - 27, 2007; 2007; 2007. 1195. Angst J, Gamma A. Suicidality and mortality in subjects with bipolar disorder (abstract). The 7th International Review of Bipolar Disorders 3-5 May 2007, Rome; 2007; 2007. p. 33-4. 1196. Angst J, Gamma A. Misdiagnosis caused by overlapping symptoms in mood disorders (abstract C.04.01). 20th ECNP Congress, 13-17 October 2007, Vienna Austria; 2007: European Neuropsychopharmacology; 2007. p. S598. 1197. Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Gender differences in the symptoms of depression and anxiety. A comparison of interview and self-assessment data. In: Höschl C, López-Ibor JJ, editors. 15th AEP Congress, Madrid 17-21 March 2007; 2007: European Psychiatry; 2007. p. S3-S4. 1198. Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Los estados de ansiedad en el Estudio Zurich: una perspectiva de las fases tempranas. In: Vázquez-Barquero JL, Herrán Gómez A, editors. Las fases tempranas de la ansiedad. Barcelona Madrid México: Masson; 2007. p. 169-79. 1199. Angst J, Gamma A, Ajdacic-Gross V, Rössler W. The with its neglected sub- diagnostic groups (abstract). In: Marneros A, Röttig D, editors. 110 Jahre Mitteldeutsche Psychiatrietage Biogenese und Psychogenese 21-22 September 2007 Halle/Salle, Deutschland; 2007: Pabst Science Publisher; 2007. p. 7.

77 1200. Angst J, Gamma A, Benazzi F, Ajdacic V, Rössler W. Melancholia and atypical drepression in the Zurich Study: epidemiology, clinical characteristics, course, comorbidity and personality. Acta Psychiatr Scand. 2007;115(suppl. 433):72-84. 1201. Angst J, Gamma A, Gerber-Werder R, Zarate (Jr) CA, Manji HK. Does long-term medication with lithium, clozapine or antidepressants prevent or attenuate dementia in bipolar and depressed patients? Int J Psychiatr Clin Pract. 2007;11:2-8. 1202. Angst J, Gamma A, Pezawas L, Ajdacic-Gross V, Eich D, Rössler W, et al. Parsing the clinical phenotype of depression: the need to integrate brief depressive episodes. Acta Psychiatr Scand. 2007;115:221-8. 1203. Angst J, Gamma A, Pezawas L, Ajdacic-Gross V, Eich D, Rössler W, et al. Recurrent brief depression (abstract). In: Altamura AC, editor. INNOPSY 07 Clinical-therapeutic aspects of comorbidity 9-11 May 2007, Milan; 2007: Int J Psych Clin Pract; 2007. p. 10. 1204. Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry. 2007;8:67-104. 1205. Eich D, Neuhaus C, Gamma A, Angst J, Rössler W, Ajdacic-Gross V, et al. Is depression a risk factor for heart complaints? Longitudinal aspects in the Zurich study. Eur Arch Psychiatry Clin Neurosci. 2007;257:396-401. 1206. Endrass J, Vetter S, Gamma A, Gallo WT, Rossegger A, Urbaniok F, et al. Are behavioral problems in childhood and adolescence associated with bipolar disorder in early adulthood? Eur Arch Psychiatry Clin Neurosci. 2007;257:217-21. 1207. Gamma A, Angst J, Ajdacic V, Eich D, Rössler W. The spectra of neurasthenia and depression: course, stability and transitions. Europ Arch Psychiat Neurol Sci. 2007;257:120-7. 1208. Hantouche E, Angst J. Rate and risk factors of hypomania in recurrent and resistant depression (poster 116). 3rd International Congress on Brain and Behaviour, 2811 - 02122007, Theassaloniki, Greece; 2007: Annals of General Psychiatry; 2007. p. S211. 1209. Hantouche EG, Angst J. Enquête nationales bipolact. À la recherche de l'hypomanie dans les dépressions difficiles. Bipolact. 2007;1:4-12. 1210. Hättenschwiler J, Baumann P, Hatzinger M, Höck P, Holsboer-Trachsler E, Jost M, et al. Begünstigen Antidepressiva die Suizidalität und die Suizidrate von Depressiven? Schweiz Med Forum. 2007;7:757- 64. 1211. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RMA, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2007;64:543-52. 1212. Meyer TD, Hammelstein P, Nilsson L-G, Skeppar P, Adolfsson R, Angst J. The Hypomania Checklist (HCL-32): its factorial structure and association to indices of impairment in German and Swedish nonclinical samples. Compr Psychiatry. 2007;48:79-87. 1213. Oedegaard KJ, Angst J, Neckelmann D, Fasmer OB. The complex relationship between migraine and psychiatry. 9th ECNP Regional Meeting, Sofia, Bulgaria 2007; 2007: Eur Neuropsychopharmacol; 2007. p. S133-S4.

78 1214. Perugi G, Sanna Passino MC, Toni C, Maremmani I, Angst J. Is unipolar mania a distinct subtype? Compr Psychiatry. 2007;48:213-7. 1215. Rössler W, Lauber C, Angst J, Haker H, Gamma A, Eich D, et al. The use of complementary and alternative medicine in the general population: results from a longitudinal community study. Psychol Med. 2007;37:73-84. 1216. Rössler W, Riecher-Rössler a, Angst J, Murray R, Gamma A, Eich D, et al. Psychotic experiences in the general population. A twenty-year prospective study. Schizophr Res. 2007;92:1-14. 1217. Stassen H, Angst J, Scharfetter C, Szegedi A. What lets patients under antidepressants get stuck in their recovery after initial improvement (abstract P.2.c.007). 20th ECNP Congress, 13-17 October 2007, Vienna Austria; 2007: European Neuropsychopharmacology; 2007. p. S344. 1218. Stassen HH, Angst J, Hell D, Scharfetter C, Szegedi A. Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients. J Clin Psychiatry. 2007;68:1195-205. 1219. Stassen HH, Scharfetter C, Angst J. Functional psychoses: molecular-genetic evidence for a continuum. In: Marneros A, Akiskal HS, editors. The overlap of affective and schizophrenic spectra. Cambridge New York Melbourne Madrid Cape Town Singapore São Paolo: Cambridge University Press; 2007. p. 55-78. 1220. Urbaniok F, Endrass J, Rossegger A, Noll T, Gallo WT, Angst J. The prediction of criminal recidivism: The implication of sampling in prognostic models. Eur Arch Psychiatry Clin Neurosci. 2007;257:129-34. 1221. Vieta E, Sanchez-Moreno J, Bulbena A, Chamorro K, Ramos JL, Artal J, et al. Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Spanish: the 32 item hypomania symptom check list (HCL-32). J Affect Disord. 2007;101:43-55. 1222. Angst J, Gamma A, Ajdacic-Gross V, Rössler W. Personality traits of subjects attempting suicide: results from the Zurich Study. Aspects of affect. 2007/2008;2:315-21. 1223. Angst F, Verra ML, Lehmann S, Aeschlimann A, Angst J. Refined insights into the pain-depression association in chronic pain patients. Clin J Pain. 2008;24:808-16. 1224. Angst J. Bipolar disorder - methodological problems and future perspectives. Dialogues Clin Neurosci. 2008;10:12--139. 1225. Angst J. Agitated depression (abstract). In: Pancheri P, editor. XII Congresso Nazionale della Società Italiana di Psicopatologia "Psichiatria Le domande senza ancora una risposta" Roma, 19-23 Febbraio 2008; 2008: Giornale Italiano di Psicopatologia; 2008. p. 21. 1226. Angst J. Das Spektrum bipolarer Störungen (abstract). Affektive Erkrankungen - was gibt es Neues?, Symposium 15032008, Schlössli Privatklinik für Psychiatrie Oetwil; 2008; 2008. 1227. Angst J. Commentary on the paper of Smith, et al. J Psychopharmacol. 2008;22:404-5. 1228. Angst J, Benazzi F. HCL-32. The origins and the development of a self-assessment screening tool for hypomania (abstract). In: Pancheri P, editor. XII Congresso Nazionale della Società Italiana di Psicopatologia "Psichiatria Le domande senza ancora una risposta" Roma, 19-23 Febbraio 2008; 2008: Giornale Italiano di Psicopatologia; 2008. p. 182. 1229. Angst J, Gamma A. The two-dimensional bipolar spectrum (abstract). IRBD 2008, 14-16 April 2008, Copenhage, Denmark; 2008; 2008.

79 1230. Angst J, Gamma A. Diagnosis and course of affective psychoses: was Kraepelin right? Eur Arch Psychiatry Clin Neurosci. 2008;258(suppl. 2):107-10. 1231. Angst J, Gamma A. Transcultural stability and variation in hypomania and its measurement. The First International Review of Bipolar Disorders ASIA PACIFIC 2008 24-26 November 2008, Hong Kong; 2008; 2008. p. 14. 1232. Angst J, Gamma A, Ajdacic-Gross V, Rössler W. Psychiatry N.O.S. 9th Scientific Meeting of the Swiss Society of Psychiatric Epidemiology 31 October 2008 Prilly, Lausanne Switzerland; 2008; 2008. 1233. Angst J, Gamma A, Ajdacic-Gross V, Rössler W. Case against merging generalized anxiety disorder with major depression (abstract SO 0102). In: Baldwin D, Kasper S, editors. 8th International Forum on Mood and Anxiety Disorders IFMAD, 12-14 November 2008, Vienna, Austria; 2008: Int J Psychiatry Clin Pract; 2008. p. 316. 1234. Angst J, Gamma A, Ajdacic-Gross V, Rössler W. Childhood adversity as a risk factor for the early onset and chronicity of depression and anxiety disorders (abstract S18.02). 16th European Congress of Psychiatry, 5 - 9 April 2008, Nice, France; 2008: European Psychiatry; 2008. p. S32. 1235. Angst J, Marneros A, Gamma A, Ajdacic-Gross V, Rössler W. The affective spectrum and its neglected sub-diagnostic groups. In: Marneros A, Röttig D, editors. Biogenese und Psychogenese. Regensburg: S. Roderer Verlag; 2008. p. 48-68. 1236. Angst J, Rössler W. Die Legalisierung von Cannabis ist eine Werteentscheidung. Kommentar zum Artikel "Cannabispolitik: weder dämonisieren noch banalisieren". Schweizerische Aerztezeitung. 2008;89:1240-1. 1237. Angst J, Rössler W. Die Legalisierung von Cannabis ist eine Werteentscheidung. Zeit-Fragen. 2008 10.11.2008;Sect. 6. 1238. Angst J, Rössler W. La légalisation du cannabis est une décision axiologique. Horizons et débats. 2008 17.10.2008;Sect. 6. 1239. Angst J, Zimmermann P. The manic wing of the bipolar spectrum. European Psychiatric Review. 2008;1:19-21. 1240. Angst J, Zimmermann P. Debate: Is bipolar disorder overdiagnosed? Contra (abstract SO 06). In: Baldwin D, Kasper S, editors. 8th International Forum on Mood and Anxiety Disorders IFMAD, 12-14 November 2008, Vienna, Austria; 2008: Int J Psychiatry Clin Pract; 2008. p. 322. 1241. Borges G, Angst J, Nock MK, Ruscio AM, Kessler R. Risk factors for the incidence and persistence of suicide-related outcomes: a 10-year follow-up study using the National Comorbidity Surverys. J Affect Disord. 2008;105:25-33. 1242. Buysse DJ, Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep. 2008;31:473-80. 1243. Gamma A, Angst J, Ajdacic-Gross V, Rössler W. Are hypomanics the happier normals? J Affect Disord. 2008;111:235-43. 1244. Hai-Chen Y, Angst J, Chun-Ping L. Preliminary study of the Chinese version of the 32-item hypomania checklist in patients with bipolar I disorder [Chinese]. Chin J Behavioral Med Sci. 2008;17:950-2.

80 1245. Hegerl U, Bottner A-C, Holtschmidt-Täschner B, Born C, Seemüller F, Scheunemann W, et al. Onset of depressive episodes is faster in patients with bipolar versus unipolar depressive disorder: evidence from a retrospectiove comparative study. J Clin Psychiatry. 2008;69:1075-80. 1246. Hegerl U, Bottner A-C, Mergl R, Holtschmidt-Täschner B, Seemüller F, Scheunemann W, et al. Geschwindigkeit des Depressionsbeginns: Ein Unterscheidungsmerkmal hinsichtlich uni- versus bipolarer affektiver Störungen. Neuropsychiatrie. 2008;22:92-9. 1247. Kvist K, Andersen P, Angst J, Kessing LV. Repeated events and total time on test. Statist Med. 2008;27:3817-32. 1248. Landolt K, Ajdacic-Gross V, Angst J, Gamma A, Rössler W. Attribution of psychological symptoms and psychiatric diagnoses (poster). 9th Scientific Meeting of the Swiss society of Psychiatric Epidemiology 27 October 2008, Prilly, Switzerland; 2008; 2008. 1249. Licht R, Gijsman H, Nolen WA, Angst J. Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce mania or cycle acceleration. Acta Psychiatr Scand. 2008;118:337-46. 1250. Merikangas K, Herrell R, Swendsen J, Rössler W, Ajdacic-Gross V, Angst J. Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study. Arch Gen Psychiatry. 2008;65:47-52. 1251. Phelps J, Angst J, Katzow J, Sadler J. Validity and utility of bipolar spectrum models. Bipolar Disord. 2008;10:179-93. 1252. Reed C, Vieta E, Angst J, Bertsch J, Haro JM. Predictors of switching from mania to depression in an observational study - EMBLEM. XIVth Biennial Winter Workshop on Schizophrenia and Bipolar Disorders Montreux, Switzerland February 3-7, 2008; 2008: Schizophrenia Research; 2008. p. 35-6. 1253. Schuepbach D, Novick D, Haro JM, Reed C, Boeker H, Noda S, et al. Determinants of voluntary vs. involuntary admission in bipolar disorder and the impact of adherence. Pharmacopsychiatry. 2008;41:29-36. 1254. Wu YS, Ou CS, Chen HC, Lu RB, Angst J. Validation of the Chinese version of the Hypomania Checklist (HCL-32) as an instrument for detecting hypomania in patients with mood disorders. J Affect Disord. 2008;106:133-43. 1255. Ajdacic-Gross V, Angst J, Gamma A, Rössler W. Concomitant lifetime disorders in two psychosis syndromes. Eur Arch Psychiatry Clin Neurosci. 2009;259(suppl. 1):S61-S2. 1256. Ajdacic-Gross V, Landolt K, Angst J, Gamma A, Merikangas KR, Gutzwiler F, et al. Adult versus adolescent onset of smoking: how are mood disorders and other risk factors involved? Addiction. 2009;104:1411-9. 1257. Angst J. Recurrent brief depression. In: Ingram RE, editor. The International Encyclopedia of Depression. New York: Springer; 2009. p. 106-8. 1258. Angst J. Psychiatry N.O.S. (not otherwise specified). Salud Mental. 2009;32:1-2. 1259. Angst J. From psychoanalysis to epidemiology: autobiographical notes. Acta Psychiatr Scand. 2009;119:87-97. 1260. Angst J. Diagnostic concepts of bipolar disorders: a European perspective. Clin Psychol Sci Prac. 2009;16:161-5.

81 1261. Angst J. Course and prognosis of mood disorders. In: Gelder MG, Andreasen NC, López-Ibor J, Geddes JR, editors. New Oxford textbook of psychiatry. Oxford: Oxford University Press; 2009. p. 665- 9. 1262. Angst J. Severity and subtypes of depression (commentary 1.4). In: Herrman H, Maj M, Sartorius N, editors. Depressive disorders. Chichester: Wiley-Blackwell; 2009. 1263. Angst J. Neue Erkenntnisse in der Diagnostik und Epidemiologie der bipolaren Störung (abstract). Bipolar Symposium Sanatorium Kilchberg, 29 Oktober 2009; 2009; 2009. 1264. Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Young AH. Detecting bipolar disorder in patients with a current : interim analysis from an international cross-sectional study (abstract). The Ninth International Review of Bipolar Disorders (IRBD) 6-8 May 2009, Lisbon Portugal; 2009; 2009. p. 63. 1265. Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Young AH. Detecting bipolar disorder in patients with a current major depressive episode: interim analysis from an international cross-sectional study (poster). The Ninth International Review of Bipolar Disorders (IRBD) 6-8 May 2009, Lisbon Portugal; 2009; 2009. 1266. Angst J, Gamma A, Adolfsson R, Skeppar P, Carta MG, Benazzi F, et al. Transcultural stability and variation in hypomania and their measurement. A preliminary report (abstract). The Ninth International Review of Bipolar Disorders (IRBD) 6-8 May 2009, Lisbon Portugal; 2009; 2009. p. 19. 1267. Angst J, Gamma A, Ajdacic-Gross V, Rössler W. Impact of childhood adversity and premorbid personality on the onset and course of major bipolar disorder (abstract S11-01). 17th Congress of Psychiatry, EPA, January 24-28 2009, Lisbon, Portugal; 2009: European Psychiatry; 2009. 1268. Angst J, Gamma A, Ajdacic-Gross V, Rössler W. Depression and gender (abstract). Lundbeck Symposia Insikt Psyskiatri 8102009 Stockholm, Schweden; 2009; Stockholm; 2009. 1269. Angst J, Gamma A, Baldwin DS, Ajdacic-Gross V, Rössler W. The generalized anxiety spectrum: prevalence, onset, course and outcome. Eur Arch Psychiatry Clin Neurosci. 2009;259:37-45. 1270. Angst J, Gamma A, Baldwin DS, Ajdacic-Gross V, Rössler W. The generalized anxiety spectrum: prevalence, onset, course and outcome. Eur Arch Psychiatry Clin Neurosci. 2009;259:37-45. 1271. Angst J, Gamma A, Benazzi F, Ajdacic V, Rössler W. Does psychomotor agitation in major depressive episodes indicate bipolarity? Evidence from the Zurich Study. Eur Arch Psychiatry Clin Neurosci. 2009;259:55-63. 1272. Angst J, Gamma A, Klein DN, Ajdacic-Gross V, Rössler W. Childhood adversity in mood disorder (abstract). 1 Statustagung zum Thema Depressive Störungen im Kindes- und Jugendalter 09-10 Oktober 2009 Berlin; 2009. 1273. Angst J, Gamma A, Meyer TD. Update on recent research with the Hypomania Checklist HCL-32 (abstract S22.03). 17th Congress of Psychiatry, EPA, January 24-28 2009, Lisbon, Portugal; 2009: European Psychiatry; 2009. 1274. Angst J, Gamma A, Rössler W, Ajdacic V, Klein DN. Long-term depression versus episodic major depression: results from the prospective Zurich Study of a community sample. J Affect Disord. 2009;115:112-21.

82 1275. Angst J, Zimmermann P, Merikangas KR. Does mania exist on a spectrum? Evidence from population studies (abstract S-18-5). XII International Congress of IFPE, April 16-19, 2009 Vienna, Austria; 2009; 2009. p. 46. 1276. Azorin JM, Angst J, Bowden C, Perugi G, Vieta E, Young A. Bipolar disorder in patients with a current diagnosis of major depressive episode (abstract P-13-007). 9th World Congress of Biological Psychiatry 28 June - 2 July 2009 Paris, France; 2009. p. 204. 1277. Hantouche E, Azorin JM, Lancrenon S, Garay R-P, Angst J. Prévalence de l'hypomanie dans les dépressions majeures récurrentes ou résistantes: enquêtes Bipolact. Ann Méd Psychol. 2009;167:30- 7. 1278. Hantouche E, Baylé FJ, Lancrenon S, Angst J. Preliminary data on the French version of the Hypomania Checklist (HCL-32) (abstract P-23-021). 9th World Congress of Biological Psychiatry 28 June - 2 July 2009 Paris, France; 2009. p. 248. 1279. Holtmann M, Pörtner F, Duketis E, Flechtner H, Angst J, Lehmkuhl H. Validation of the Hypomania Checklist (HCL-32) in a nonclinical sample of German adolescents. J Adolesc. 2009;32:1075-88. 1280. Kvist K, Andersen PK, Angst J, Kessing LV. Event dependent sampling of recurrent events. (Research Report). Copenhagen: Department of Biostatistics, ; 2009. 1281. Marikangas K, Angst J, He J-P, Cui L, Avenevoli S, Kessler RC. Spectrum of mood disorders in a national sample of adolescents (abstract S-18-4). XII International Congress of IFPE, April 16-19, 2009 Vienna, Austria; 2009; 2009. p. 46. 1282. Rothen S, Angst J, Cui L, Kessler RC, Merikangas KR. Prevalence and correlates of the spectrum of mood disorders in the National Comorbidity Survey Replication (abstract S-18-3). XII International Congress of IFPE, April 16-19, 2009 Vienna, Austria; 2009; 2009. p. 45-6. 1283. Vieta E, Angst J, Reed C, Bertsch J, Haro JM, Emblem Advisory Board. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM). J Affect Disord. 2009;118:118-23. 1284. Young AH, Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E. Characteristics of patients with bipolar disorder presenting a current major depressive episode: analysis in eight countries. 22nd ECNP Congress, 12-16 September 2009 Istanbul, Turkey; 2009. 1285. Young AH, Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E. Characteristics of patients with bipolar disorder presenting a current major depressive episode: analysis in 8 countries. Eur Neuropsychopharmacol. 2009;19(suppl 3):S454-S5. 1286. Zimmermann P, Brückl T, Nocon A, Pfister H, Lieb R, Wittchen H-U, et al. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry. 2009;66:1341-52. 1287. Zimmermann P, Wittchen H-U, Lieb R, Angst J. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity (abstract S-18-1). XII International Congress of IFPE, April 16-19, 2009 Vienna, Austria; 2009; 2009. p. 45. 1288. Ajdacic-Gross V, Landolt K, Passardi M, Gamma A, Angst J, Theodoridou A, et al. The network structure of common mental disorders (abstract FV-031-003). DGPPN Kongress 2010 Berlin 26112010; 2010; 2010.

83 1289. Angst J. Biological research into depression: a clinician's commentary. World Psychiatry. 2010;9:163-4. 1290. Angst J. The mood spectrum: from depression via bipolar disorders to mania. WPA Regional Meeting Traditions and Innovations in Psychiatry 10 - 12062010 St Petersburg, Russia; 2010; 2010. p. 35-6. 1291. Angst J. A new concept of bipolar disorders: results of the international bridge study. WPA Regional Meeting Traditions and Innovations in Psychiatry 10 - 12062010 St Petersburg, Russia (Sanofi-Aventis Satellite Symposium); 2010; 2010. 1292. Angst J. A new concept of bipolar disorders: results of the international bridge study (Russian version). WPA Regional Meeting Traditions and Innovations in Psychiatry 10 - 12062010 St Petersburg, Russia (Sanofi-Aventis Satellite Symposium); 2010; 2010. 1293. Angst J. Antidepressants and : clinical action, long-term effects on dementia, sucides and mortality (abstract). British Association for Psychopharmacology Summer Meeting 25-28 July 2010, Harrogate International Centre (UK); 2010; 2010. 1294. Angst J. Depressed people missing out on treatment (press release). In: British Association for Psychopharmacology, editor. British Association for Psychopharmacology Summer Meeting 25-28 July 2010, Harrogate International Centre (UK); 2010; 2010. 1295. Angst J. Bipolar disorder: transcultural findings based on a new definition (abstract). International Juan Jose Lopez Ibor Award. WPa International Congress 1-5 September 2010, Beijing; 2010: WPA; 2010. p. 59. 1296. Angst J. The mood spectrum - problems and trends in diagnosing bipolar disorders (abstract). 47 Kongress der Deutschen Gesellschaft für Psychologie Bremen 26-30092010; 2010; 2010. 1297. Angst J. Affektive Störungen im Jahre 2011 - eine Perspektive (abstract). DGPPN Kongress 2010 Berlin AstraZeneca Closed-Door-Symposium 26112010; 2010; 2010. 1298. Angst J, Bauer M, Morris R, Weiss R. Diagnosis and treatment of bipolar disorders (audio file). 47 Kongress der Deutschen Gesellschaft für Psychologie Bremen 26-30092010; 2010; 2010. 1299. Angst J, Cui L, Swendsen J, Rothen S, Cravchik A, Kessler R, et al. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry. 2010;167:1194-201. 1300. Angst J, Fava G, Möller H-J. Is drug treatment necessary for preventing recurrence in depression (abstract)? FMPP annual Congress of Psychiatry and Psychotherapie 20th IFP World Congress of Psychotherapy 16 - 19 June 2010 Lucerne Switzerland; 2010; 2010. 1301. Angst J, Gamma A. Transcultural stability and variation of hypomania assessed by the HCL-32 (abstract S10.2). ISAD 5th Biennal Conference, 16. - 19. April 2010. Vancouver Canada.; 2010: J Affect Disord Vol. 122 (suppl. 1): S25-S26; 2010. 1302. Angst J, Gamma A, Ajdacic V, Rössler W. Commentary on nosologic relationship between generalized anxiety disorder and major depression. In: Goldberg D, Kendler KS, Sirovatka PJ, Regier DA, editors. Diagnostic issues in depression and generalized anxiety disorder. Arlington: American Psychiatric Association; 2010. p. 41-4. 1303. Angst J, Gamma A, Ajdacic-Gross V, Rössler W. Symptoms and course of unipolar and bipolar depression (abstract SO 0501). 10th International Forum on Mood and Anxiety Disorders Vienna, 17- 19 November 2010; 2010: Int J Psychiat Clin Pract; 2010. p. 8.

84 1304. Angst J, Gamma A, Clarke D, Ajdacic-Gross V, Rössler W, Regier D. Subjective distress predicts treatment seeking for depression, bipolar, anxiety, panic, neurasthenia and insomnia severity spectra. Acta Psychiatr Scand. 2010;122:488-98. 1305. Angst J, Meyer TD, Adolfsson R, Skeppar P, Carta M, Benazzi F, et al. Hypomania: a transcultural perspective. World Psychiatry. 2010;9:41-9. 1306. Angst J, Zimmermann P, Merikangas K. The mood spectrum: a new perspective (abstract S8.1). ISAD 5th Biennal Conference, 16. - 19. April 2010. Vancouver Canada.; 2010: J Affect Disord Vol. 122 (suppl. 1): S22; 2010. 1307. Angst J, Zimmermann P, Merikangas K, Gamma A. Diagnosis and comorbidity: progress towards a new diagnostic classification of mood disorders (poster CS02-01). 18th European Congress of Psychiatry, 27. February - 2. March 2010, Munich.; 2010: Eur Psychiatry; 2010. 1308. Angst J, Zimmermann P, Merikangas K, Gamma A. Komorbidität: Neues aus der Sicht einer valideren diagnostischen Klassifikation von Stimmungserkrankungen (abstract). Psychiatrie im Dialog AstraZeneca 18062010, München; 2010; 2010. 1309. Baldwin DS, Allgulander C, Altamura AC, Angst J, Bandelow B, den Boer J, et al. Manifesto for a European Anxiety Disorders Research Network. Eur Neuropsychopharmacol. 2010;20:426-32. 1310. Brand S, Angst J, Holsboer-Trachsler E. Is the increase of hypomanic stages during adolescence related to gender and developmental tasks? J Affect Disord. 2010;11:594-602. 1311. Campos RN, Taragano RO, Campos SC, Cordas TA, Angst J, Moreno RA. Bipolarity in eating disorder: comparison of HCL-32 and bipolarity index. (poster WC0124). 4th Biennial Conference of the International Society of Bipolar Disorders, 17-20 March 2010, São Paulo, Brazil.; 2010: Bipolar Disord 2010. 1312. Hantouche E, Angst J, Azorin JM. Explained factors of suicide attempts in major depression. J Affect Disord. 2010;127:305-8. 1313. Kvist K, Andersen PK, Angst J, Kessing LV. Event dependent sampling of recurrent events. Lifetime Data Anal. 2010;16:580-98. 1314. Landolt K, Ajdacic-Gross V, Angst J, Merikangas KR, Gamma A, Gutzwiller F, et al. Smoking and psychiatric disorders: have subthreshold disorders been overlooked? Nicotine Tob Res. 2010;12:516- 20. 1315. Nierenberg AA, Akiskal HS, Angst J, Hirschfeld RM, Merikangas KR, Petukhova M, et al. Bipolar disorder with frequent mood episodes in the national comorbidity survey replication (NCS-R). Mol Psychiatry. 2010;15:1075-87. 1316. Nunes Campos R, Rodrigues dos Santos D, Oliveira Taragano R, Cordás TA, Angst J, Moreno RA. Measuring impulsivity and hypomanic symptoms in eating disorders (poster). Simpósio International: "Trastornos do Humor e seu Espectro" University of São Paolo, Brazil 11082010; 2010; 2010. 1317. Nunes Campos R, Rodrigues dos Santos D, Oliveira Taragano R, Correira Campos S, Cordás TA, Angst J, et al. Impulsivity and amphetamine use in eating disorders (poster). Rio International Eating Disorders and Obesity Conference 19 - 20 November 2010; 2010; 2010.

85 1318. Perugi G, Angst J, Azorin JM, Bowden CL, Vieta E, Young AH. Frequency of mixed states in patients with a major depressive episode: the BRIDGE MIX study (poster P.2.e.018). ECNP Amsterdam 2011; 2010: European Neuropsychopharmacology; 2010. p. S412. 1319. Rössler W, Angst J, Gamma A, Ajdacic-Gross V. Die Häufigkeit psychotischer Symptome in der Allgemeinbevölkerung - Konsequenzen für die Psychoseforschung. In: Möller H-J, editor. Schizophrenie - Zukunftsperspektiven in Klinik und Forschung. Wien / New York: Springer; 2010. p. 41- 51. 1320. Rybakowski F, Kiejna A, Angst J, Pawlowski T, Siwek M, Lojko D, et al. Increased scores on the Hypomania Checklist-32 and on the Mood Disorder Questionnaire in treatment-resistant depression: Polish TRES-DEP Study (poster PW01-30). 18th European Congress of Psychiatry, 27. February - 2. March 2010, Munich.; 2010: Eur Psychiatry; 2010. 1321. Rybakowski JK, Angst J, Dudek D, Pawlowski T, Lojko D, Siwek M, et al. Polish version of the Hypomania Checklist (HCL-32) scale: the results in treatment-resistant depression. Eur Arch Psychiat Neurol Sci. 2010;260:139-44. 1322. Soares OT, Hupfeld Moreno D, De Moura EC, Angst J, Moreno RA. Reliability and validity of a Brazilian version of the Hypomania Checklist (HCL-32) compared to Mood Disorder Questionnaire (MDQ). Revista Brasileira de Psiquiatria. 2010;32:416-23. 1323. Vieta E, Angst J, Azorin JM, Bowden CL, Perugi G, Young AHfor the BRIDGE Study G. Characteristics of patients with hypomanic symptoms presenting a current major depressive episode identified with the HCL-32 patient questionnaire (poster PW01-39). 18th European Congress of Psychiatry, 27. February - 2. March 2010, Munich.; 2010: Eur Psychiatry; 2010. p. 1458. 1324. Young AH, Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E. Characteristics of patients with bipolar disorder presenting a current major depressive episode: analysis in eight countries (abstract S10.4). ISAD 5th Biennal Conference, 16. - 19. April 2010. Vancouver Canada.; 2010: J Affect Disord Vol. 122 (suppl. 1): S26-S27; 2010. 1325. Zimmermann P, Brueckl T, Nocon A, Pfister H, Lieb R, Wittchen H-U, et al. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity (poster P01-82). 18th European Congress of Psychiatry, 27. February - 2. March 2010, Munich.; 2010: Eur Psychiatry; 2010. 1326. Angst J. Unser Denken in der Psychiatrie aus der Perspektive einer lebenslangen Tätigkeit. In: Marneros A, editor. Scientia Wissenschaft Eine epistemische Anthologie anlässlich der Emeritierung. Bonn: Psychiatrie Verlag; 2011. p. 331-52. 1327. Angst J. Biography: Jules Angst: MD emeritus professor of psychiatry, Zurich university; Zurich, Switzerland. International Congress of the Royal College of Psychiatrists 2806-01072011, Brighton; 2011; 2011. 1328. Angst J. Problems in the current concepts and definitions of bipolar disorders. World Psychiatry. 2011;10:191-2. 1329. Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Gamma A, et al. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE Study. Arch Gen Psychiatry. 2011;68:791-9. 1330. Angst J, Gamma A. Mood disorders in 2011: the consequences of diagnostic changes (abstract). International Congress of the Royal College of Psychiatrists 2806-01072011, Brighton; 2011; 2011.

86 1331. Angst J, Gamma A, Ajdacic-Gross V, Rössler W. Reconceptualizing psychosis and consequences for DSM-V (abstract). The 16th Biennial Winter Workshop in Psychoses, Innsbruck, 3001 - 02022011; 2011; 2011. 1332. Angst J, Gamma A, Ajdacic-Gross V, W. R. Epidemiology of bipolar spectrum disorders beyond DSM- IV : new results from the Zurich Study (abstract SO 1102). 11th International Forum on Mood and Anxiety Disorders, IFMAD, November 09-11 2011, Budapest, Hungary; 2011: Int J Psychiatr Clin Pract; 2011. p. 13-4. 1333. Angst J, Gamma A, Bowden CL, Perugi G, Vieta E, Young AH. Evidence-based efforts to re-define bipolar disorders (abstract). Ninth International Conference on Bipolar Disorder, Pittsburgh, 08- 11062011; 2011: Bipolar Disord; 2011. p. 14. 1334. Angst J, Gamma A, Rössler W, Ajdacic-Gross V, Klein DN. Childhood adversity and chronicity of mood disorders. Eur Arch Psychiatry Clin Neurosci. 2011;261:21-7. 1335. Campos RN, Santos DJR, Angst J, Moreno RA. Prevalence of bipolar spectrum (BS) disorder in eating disorder (ED) patients (abstract). Ninth International Conference on Bipolar Disorder, Pittsburgh, 08- 11062011; 2011: Bipolar Disord; 2011. p. 33-4. 1336. Campos RN, Santos DJR, Cordas TA, Angst J, Moreno RA. Body image in eating disorder patients with bipolar spectrum disorder (abstract). Ninth International Conference on Bipolar Disorder, Pittsburgh, 08-11062011; 2011: Bipolar Disord; 2011. p. 33. 1337. Haghighi M, Bajoghli H, Angst J, Holsboer-Trachsler E, Brand S. The Farsi version of the Hypomania Check-List 32 (HCL-32): applicability and indication of a four-factorial solution. BMC Psychiatry. 2011;11:14. 1338. Kupfer DJ, Angst J, Berk M, Dickerson F, Frangou S, Frank E, et al. Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder. Ann NY Acad Sci. 2011;1242:1-25. 1339. Merikangas KR, Cui L, Richardson AK, Isler H, Khoromi S, Nakamura E, et al. Magnitude, impact, and stability of primary headache subtypes: 30 year prospective Swiss cohort study. BMC. 2011;343:521. 1340. Merikangas KR, Cui L, Richardson AK, Isler H, Khoromi S, Nakamura E, et al. Magnitude, impact, and stability of primary headache subtypes: 30 year prospective Swiss cohort study. BMC. 2011;343:doi:10.1136/bmj.d5076 1341. Miquel L, Usall J, Reed C, Bertsch J, Vieta E, Gonzalez-Pinto A, et al. Gender differences in outcomes of acute mania: a 12-month follow-up study. Arch Womens Ment Health. 2011;14:107-13. 1342. Nunes Campos R, Angst J, Cordas TA, Moreno RA. ESPECTRA: searching the bipolar spectrum in eating disorder patients. BMC Psychiatry. 2011;11:59. 1343. Rössler W, Angst J, Gamma A, Haker H, Stulz N, Merikangas K, et al. Reappraisal of the interplay between psychosis and depression symptoms in the pathogenesis of psychotic syndrome: results from a twenty-year prospective community study. Eur Arch Psychiat Neurol Sci. 2011;261:11-9. 1344. Rössler W, Hengartner M, Angst J, Ajdacic-Gross V. Linking substance use with symptoms of sub- clinical psychosis in a community cohort over 30 years. Addiction. 2011:doi: 10.1111/j.360- 0443.2011.03760.x.

87 1345. Rössler W, Hengartner MP, Ajdacic-Gross V, Haker H, Gamma A, Angst J. Sub-clinical psychosis symptoms in young adults are risk factors for subsequent common mental disorders. Schizophr Res. 2011;131:18-23. 1346. Stassen HH, Anghelescu IG, Angst J, Böker H, Lötscher K, Rujescu D, et al. Predicting response to psychopharmacological treatment: survey of recent results. Pharmacopsychiatrie. 2011;44:263-72. 1347. Yang HC, Yuan CM, Liu TB, Li LJ, Peng HJ, Liao CP, et al. Validity of the 32-item hypomania checkliste (HCL-32) in a clinical sample with mood disorders in China. BMC Psychiatry. 2011;11:84. 1348. Angst J. From psychoanalysis to pharmacotherapy: 1951-2011 (abstract CS07-01). 20th European Congress of Psychiatry, Prague, 03-06032012; 2012: Eur Psychiat; 2012. 1349. Angst J. Course of depression and bipolar disorders in the Zurich Study (abstract AS36-01). 20th European Congress of Psychiatry, Prague, 03-06032012; 2012: Eur Psychiat; 2012. 1350. Angst J, Gamma A, Bowden CL, Azorin JM, Perugi G, Vieta E, et al. Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes. Eur Arch Psychiatry Clin Neurosci. 2012;262:3-11. 1351. Angst J, Gamma A, Hengartner M, Ajdacic-Gross V, Rössler W. Differenzierung zwischen der unipolaren und bipolaren Depression (abstract). Symposium Depression unipolar - bipolar: relavant für die Therapie? AstraZeneca 15032012, Zürich; 2012; 2012. 1352. Chang YH, Chen SL, Chen SH, Chu CH, Lee SY, Yang HF, et al. Low anxiety disorder comorbidity rate in bipolar disorders in Han Chinese in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry. 2012;36:194-7. 1353. Eich D, Angst J, Frei A, Ajdacic-Gross V, Rössler W, Gamma A. A new rating scale for adult ADHD based on the Symptom Checklist 90 (SCL-90-R). Eur Arch Psychiatry Clin Neurosci. 2012:DOI 10.1007/s00406-011-0288-1. 1354. Ajdacic-Gross V, Landolt K, Angst J, Ring M, Gamma A, Rössler W. Multiple assessment and the prevalence rates of suicidal thoughts. Results from the Zurich Study. submitted. 1355. Ajdacic-Gross V, Landolt K, Ring M, Gamma A, Angst J, Rössler W. Multiple and repeated assessment of suicidal thoughts increased the lifetime prevalence rate to 50%. J Clin Epidemiol. submitted. 1356. Alciati A, Sarzi-Puttini P, Batticciotto A, Angst J. Overactive lifestyle in patients with fibromyalgia as a core feature of bipolar spectrum disorder. J Affect Disord. submitted. 1357. Angst J. Suizidalität im Verlauf bipolarer Störungen.; submitted. 1358. Angst J. Alles nur eine Frage der Zeit? Diagnosewechsel: Von der unipolaren Depression zur Bipolarität. DGBS-Heft Balance. submitted:2-3. 1359. Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Anxiety states in the Zurich Study: a perspective of the early phases.; submitted. 1360. Angst J, Gamma A, Ajdacic V, Rössler W. Comment to the paper of John M. Hettema. Validators of generalised anxiety disorder and major depression. submitted. 1361. Angst J, Gamma A, Ajdacic V, Rössler W. Commentary on "the nosologic relationship between generalized anxiety disorder and major depression". In: Association AP, editor.; submitted.

88 1362. Angst J, Gamma A, Azorin JM, Bowden CL, Perugi G, Vieta E, et al. Self-assessed hypomania across cultures in patients with major depressive episodes. submitted. 1363. Angst J, Gamma A, Azorin JM, Bowden CL, Perugi G, Vieta E, et al. Broad considerations of bipolar I and bipolar II disorder. submitted. 1364. Angst J, Gamma A, Bowden CL, Azorin JM, Perugi G, Vieta E, et al. Diagnostic criteria for bipolarity in patients with DSM-IV major depressive episodes: results of the international Bridge Study across 18 countries. Eur Arch Psychiatry Clin Neurosci. submitted. 1365. Angst J, Gamma A, Clarke D, Ajdacic-Gross V, Regier D. The depression, bipolar, anxiety, panic, neurasthenia and insomnia severity spectra: distress, not diagnosis, predicts treatment seeking. Acta Psychiatr Scand. submitted. 1366. Angst J, Gamma A, Hasler G, Ajdacic-Gross V, Rössler W. Somatic and psychological panic attacks: results from the prospective Zurich Study over thirteen years. Psychosom Med. submitted. 1367. Angst J, Gerber-Werder R, Zuberbühler H-U, Gamma A. Is bipolar I disorder heterogenous? Eur Arch Psychiatr Neurol Sci. submitted. 1368. Bowden CL, Angst J, Azorin JM, Perugi G, Vieta E, Young AH. Significant bipolar risk factors in patients presenting a current major depressive episode (abstract). 163rd Annual Meeting, American Psychiatric Association, 22-26 May 2010, New Orleans; submitted; submitted. 1369. Bowden CL, Young AH, Angst J, Azorin JM, Vieta E, Perugi G, et al. Author Letter in Reply to PSY12- 0027. Arch Gen Psychiat. submitted. 1370. Bschor T, Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, et al. Are bipolar disorders underdiagnosed in patients with depressive episodes? Results of the multicenter BRIDGE screening study in Germany. J Affect Disord. submitted. 1371. Carta MG, Angst J, Moro MF, Mura G, Hardoy MC, Balestrieri C, et al. Association of chronic hepatitis C with recurrent brief depression. J Affect Disord. submitted. 1372. Endrass J, Angst J, Urbaniok F, Laubacher A, Vetter S, Rossegger A. Delinquency in early adulthood as precursor to later sex or violent offending - a prospective study of a representative samplo of Swiss men. submitted. 1373. Endrass J, Angst J, Urbaniok F, Vetter S. Adolescent delinquency and antisocial personality as precursors to adult sex and/or violent re-offending. Int J Offender Ther Comp Criminol. submitted. 1374. Fornaro M, Perugi G, Maremmani I, Angst J. Discriminative hypomania check-list-32 (HCL-32) factors in unipolar and bipolar major depressive patients. submitted. 1375. Gamma A, Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, et al. Transcultural validity of the Hypomania Checklist-32 (HCL-32) in patients with major depressive episodes. Bipolar Disord. submitted. 1376. Gasquet I, Aubrun E, Angst J, Azorin JM, Falissard B, Luquiens A, et al. The opinion of patients on their psychotropic medication: validation of the 9-item "PAtient SAtisfaction with Psychotrobics" scale (PASAP). Eur Psychiatry. submitted. 1377. Kvist K, Andersen PK, Angst J, Kessing LV. Effect of sampling selection in analysis of recurrent events. submitted.

89 1378. Lamers F, Burstein M, He J-PA, S. Angst, J. Merikangas, K. The structure of major depressive disorder in adolescents and adults in the U.S. general population. Br J Psychiatry. submitted. 1379. Laubacher A, Rossegger A, Endrass J, Angst J, Urbaniok F, Vetter S. Adolescent delinquency and antisocial personality as precursors to adult sex and/or violent re-offending. A prospective study of a representative sample of Swiss men. Int J Offender Ther Comp Criminol. submitted. 1380. Lieb R, Schwender L, Nocon A, Hollenbach N, Angst J, Pfister H, et al. Obsessive compulsive disorder among adolescents and young adults: results from the prospective longitudinal EDSP-study. Arch Gen Psychiatry. submitted. 1381. Marneros A, Angst J. Schizoaffektive Psychosen: eine herausforderne klinische Realität. submitted. 1382. Merikangas KR, Cui L, Kattan G, Carlson G, Youngstrom EA, Angst J. Mania with and without depression in a community sample of U.S. adolescents. Arch Gen Psychiat. submitted. 1383. Perugi G, Azorin JM, Angst J, Bowden CL, Vieta E, Young AH. The Bipolar-Borderline Personality Disorders connection in Major Depressive patients: findings from the international BRIDGE study. J Clin Psychiatry. submitted. 1384. Perugi G, Fornaro M, Maremmani I, Canonico PL, Carbonato P, Mencacci C, et al. Discriminative hypomania check-list-32 (HCL-32) factors in unipolar and bipolar major depressive patients. BMC Psychiatry. submitted. 1385. Rössler W, Lauber C, Kessler RC, Haker H, Gamma A, Eich D, et al. Who uses complementary and alternative medicines - and for what reasons? Results from a panel study. Psychol Med. submitted.

90